
<html lang="en"     class="pb-page"  data-request-id="083e89b6-00d4-4bf5-86b0-e576c2d5a6db"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.6b01539;issue:issue:10.1021/jmcmar.2017.60.issue-1;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)" /></meta><meta name="dc.Creator" content="Chi B.  Vu" /></meta><meta name="dc.Creator" content="Robert J.  Bridges" /></meta><meta name="dc.Creator" content="Cecilia  Pena-Rasgado" /></meta><meta name="dc.Creator" content="Antonio E.  Lacerda" /></meta><meta name="dc.Creator" content="Curtis  Bordwell" /></meta><meta name="dc.Creator" content="Abby  Sewell" /></meta><meta name="dc.Creator" content="Andrew J.  Nichols" /></meta><meta name="dc.Creator" content="Sachin  Chandran" /></meta><meta name="dc.Creator" content="Pallavi  Lonkar" /></meta><meta name="dc.Creator" content="Dominic  Picarella" /></meta><meta name="dc.Creator" content="Amal  Ting" /></meta><meta name="dc.Creator" content="Allison  Wensley" /></meta><meta name="dc.Creator" content="Maisy  Yeager" /></meta><meta name="dc.Creator" content="Feng  Liu" /></meta><meta name="dc.Description" content="A depressed autophagy has previously been reported in cystic fibrosis patients with the common F508del-CFTR mutation. This report describes the synthesis and preliminary biological characterization..." /></meta><meta name="Description" content="A depressed autophagy has previously been reported in cystic fibrosis patients with the common F508del-CFTR mutation. This report describes the synthesis and preliminary biological characterization..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 23, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01539" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01539" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01539" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01539" /></link>
        
    
    

<title>Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01539" /></meta><meta property="og:title" content="Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0014.jpeg" /></meta><meta property="og:description" content="A depressed autophagy has previously been reported in cystic fibrosis patients with the common F508del-CFTR mutation. This report describes the synthesis and preliminary biological characterization of a novel series of autophagy activators involving fatty acid cysteamine conjugates. These molecular entities were synthesized by first covalently linking cysteamine to docosahexaenoic acid. The resulting conjugate 1 synergistically activated autophagy in primary homozygous F508del-CFTR human bronchial epithelial (hBE) cells at submicromolar concentrations. When conjugate 1 was used in combination with the corrector lumacaftor and the potentiator ivacaftor, it showed an additive effect, as measured by the increase in the chloride current in a functional assay. In order to obtain a more stable form for oral dosing, the sulfhydryl group in conjugate 1 was converted into a functionalized disulfide moiety. The resulting conjugate 5 is orally bioavailable in the mouse, rat, and dog and allows a sustained delivery of the biologically active conjugate 1." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01539"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01539">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01539&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01539&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01539&amp;href=/doi/10.1021/acs.jmedchem.6b01539" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 458-473</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01516" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01611" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chi+B.++Vu">Chi B. Vu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-6516-8846" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++Bridges">Robert J. Bridges</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cecilia++Pena-Rasgado">Cecilia Pena-Rasgado</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio+E.++Lacerda">Antonio E. Lacerda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Curtis++Bordwell">Curtis Bordwell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Abby++Sewell">Abby Sewell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Nichols">Andrew J. Nichols</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sachin++Chandran">Sachin Chandran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pallavi++Lonkar">Pallavi Lonkar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dominic++Picarella">Dominic Picarella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amal++Ting">Amal Ting</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allison++Wensley">Allison Wensley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maisy++Yeager">Maisy Yeager</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Liu">Feng Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Chicago Medical School, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, Illinois 60064, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Charles River Laboratories, 14656 Neo Parkway, Cleveland, Ohio 44128, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-349-1971, extension 420. Fax: 617-273-2637. E-mail: <a href="/cdn-cgi/l/email-protection#e3809596a3808297828182908a90cd808c8e"><span class="__cf_email__" data-cfemail="3a594c4f7a595b4e5b585b49534914595557">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01539&amp;href=/doi/10.1021%2Facs.jmedchem.6b01539" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 458–473</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 15, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 October 2016</li><li><span class="item_label"><b>Published</b> online</span>23 December 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 January 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01539" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01539</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D458%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChi%2BB.%2BVu%252C%2BRobert%2BJ.%2BBridges%252C%2BCecilia%2BPena-Rasgado%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D1%26contentID%3Dacs.jmedchem.6b01539%26title%3DFatty%2BAcid%2BCysteamine%2BConjugates%2Bas%2BNovel%2Band%2BPotent%2BAutophagy%2BActivators%2BThat%2BEnhance%2Bthe%2BCorrection%2Bof%2BMisfolded%2BF508del-Cystic%2BFibrosis%2BTransmembrane%2BConductance%2BRegulator%2B%2528CFTR%2529%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D473%26publicationDate%3DJanuary%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01539"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1820</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">27</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01539" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chi&quot;,&quot;last_name&quot;:&quot;B. Vu&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. Bridges&quot;},{&quot;first_name&quot;:&quot;Cecilia&quot;,&quot;last_name&quot;:&quot;Pena-Rasgado&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;E. Lacerda&quot;},{&quot;first_name&quot;:&quot;Curtis&quot;,&quot;last_name&quot;:&quot;Bordwell&quot;},{&quot;first_name&quot;:&quot;Abby&quot;,&quot;last_name&quot;:&quot;Sewell&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Nichols&quot;},{&quot;first_name&quot;:&quot;Sachin&quot;,&quot;last_name&quot;:&quot;Chandran&quot;},{&quot;first_name&quot;:&quot;Pallavi&quot;,&quot;last_name&quot;:&quot;Lonkar&quot;},{&quot;first_name&quot;:&quot;Dominic&quot;,&quot;last_name&quot;:&quot;Picarella&quot;},{&quot;first_name&quot;:&quot;Amal&quot;,&quot;last_name&quot;:&quot;Ting&quot;},{&quot;first_name&quot;:&quot;Allison&quot;,&quot;last_name&quot;:&quot;Wensley&quot;},{&quot;first_name&quot;:&quot;Maisy&quot;,&quot;last_name&quot;:&quot;Yeager&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;458-473&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01539&quot;},&quot;abstract&quot;:&quot;A depressed autophagy has previously been reported in cystic fibrosis patients with the common F508del-CFTR mutation. This report describes the synthesis and preliminary biological characterization of a novel series of autophagy activators involving fatty acid cysteamine conjugates. These molecular entities were synthesized by first covalently linking cysteamine to docosahexaenoic acid. The resulting conjugate 1 synergistically activated autophagy in primary homozygous F508del-CFTR human bronchial epithelial (hBE) cells at submicromolar concentrations. When conjugate 1 was used in combination with the corrector lumacaftor and the potentiator ivacaftor, it showed an additive effect, as measured by the increase in the chloride current in a functional assay. In order to obtain a more stable form for oral dosing, the sulfhydryl group in conjugate 1 was converted into a functionalized disulfide moiety. The resulting conjugate 5 is orally bioavailable in the mouse, rat, and dog and allows a sustained delivery of th&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01539&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01539" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01539&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01539" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01539&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01539" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01539&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01539&amp;href=/doi/10.1021/acs.jmedchem.6b01539" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01539" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01539" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01539%26sid%3Dliteratum%253Aachs%26pmid%3D27976892%26genre%3Darticle%26aulast%3DVu%26date%3D2017%26atitle%3DFatty%2BAcid%2BCysteamine%2BConjugates%2Bas%2BNovel%2Band%2BPotent%2BAutophagy%2BActivators%2BThat%2BEnhance%2Bthe%2BCorrection%2Bof%2BMisfolded%2BF508del-Cystic%2BFibrosis%2BTransmembrane%2BConductance%2BRegulator%2B%2528CFTR%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D1%26spage%3D458%26epage%3D473%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291137" title="Lipids">Lipids</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292527" title="Autophagy">Autophagy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/jmcmar.2017.60.issue-1/20170112/jmcmar.2017.60.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A depressed autophagy has previously been reported in cystic fibrosis patients with the common F508del-CFTR mutation. This report describes the synthesis and preliminary biological characterization of a novel series of autophagy activators involving fatty acid cysteamine conjugates. These molecular entities were synthesized by first covalently linking cysteamine to docosahexaenoic acid. The resulting conjugate <b>1</b> synergistically activated autophagy in primary homozygous F508del-CFTR human bronchial epithelial (hBE) cells at submicromolar concentrations. When conjugate <b>1</b> was used in combination with the corrector lumacaftor and the potentiator ivacaftor, it showed an additive effect, as measured by the increase in the chloride current in a functional assay. In order to obtain a more stable form for oral dosing, the sulfhydryl group in conjugate <b>1</b> was converted into a functionalized disulfide moiety. The resulting conjugate <b>5</b> is orally bioavailable in the mouse, rat, and dog and allows a sustained delivery of the biologically active conjugate <b>1</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Network pharmacology is a versatile and important tool for a medicinal chemist when faced with a challenging therapeutic target. This drug design technique, sometimes referred to as pathway pharmacology or polypharmacology,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> involves the modulation of multiple therapeutic pathways in order to achieve a desired pharmacological response. We have recently described a variation of this technique that allowed network pharmacology to take place when two bioactives are delivered intracellularly at the same time and in equimolar concentrations.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In our approach, a plasma stable linker was used to first covalently join the two bioactives. Once delivered inside cells, intracellular enzymes could readily cleave the linker to simultaneously release the two bioactives. Since multiple biological pathways were simultaneously impacted by this type of intracellular delivery, the resulting pharmacology that could be produced was unique and could not be replicated by giving the two bioactives either individually or in combination. We have demonstrated the utility of our methodology with two examples: the first involves the use of a fatty acid niacin conjugate in the inhibition of sterol regulatory element binding protein (SREBP), and the second involves the use of a fatty acid salicylate conjugate in the inhibition of NF-κB. Both of these therapeutic targets have historically been known to be difficult to attenuate by traditional medicinal chemistry approaches. In this communication, we will demonstrate how this approach could be used again to address another challenging therapeutic target, this time involving the activation of autophagy. Even though a depressed autophagy has been implicated in numerous diseases,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> this report focuses primarily on its impact in cystic fibrosis (CF).</div><div class="NLM_p">CF is a deadly orphan disease that affects over 70 000 patients worldwide, predominantly in the Caucasian population. It is caused by a defective cystic fibrosis transmembrane conductance regulator (CFTR),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> a cAMP-dependent ion channel that regulates the flow of chloride ions across epithelial cell membranes. A malfunctioning CFTR ion channel will cause an imbalance in ion and fluid transport, and over time, this can have a debilitating effect on the pancreas, liver, kidneys, intestine, and especially the lungs. Even though there are more than 1900 reported mutations in CF, more than 80% of CF patients worldwide carry the F508del-CFTR mutation in either the homozygous or heterozygous form. With this particular mutation, the misfolded F508del-CFTR cannot be transported out of the endoplasmic reticulum (ER) and instead is degraded by the proteasome before it can rise to the cell surface. A restoration of F508del-CFTR function therefore requires the use of two agents: (1) a CFTR corrector to help transport the misfolded CFTR to the cell surface; (2) a CFTR potentiator to help keep this ion channel open at the cell surface. Intense research efforts in this field have recently resulted in the approval of the combination consisting of the corrector lumacaftor (VX-809)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and the potentiator ivacaftor (VX-770)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> in CF patients with the homozygous F508del-CFTR mutation (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). However, the clinical efficacy for this particular combination of drugs is modest, with an average improvement of 3% in lung function.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Therefore, numerous efforts are currently being taken to identify more effective CFTR correctors or potentiators,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> as well as agents that can potentially improve the efficacy of the current combination of lumacaftor and ivacaftor.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In this report, we will demonstrate that the autophagy pathway is intricately linked to the trafficking of the CFTR, and an effective autophagy activator can enhance the transport of the misfolded CFTR to the cell surface and be useful as part of a triple drug combination to treat CF patients with the F508del-CFTR mutation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0015.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative CFTR modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Autophagy and the Trafficking of the F508del-CFTR</h3><div class="NLM_p">Normal cells typically use autophagy as a means for removing sources of reactive oxygen species, damaged mitochondria, misfolded proteins, and foreign pathogens. The autophagy process involves the initial formation and elongation of a membrane sac called the phagophore, which eventually develops into an autophagosome.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This is a double-membrane vesicle that is used to sequester the dysfunctional cellular components into the cytoplasmic cargo. The autophagosomes themselves will eventually fuse with the lysosomes to enable the degradation of the cargo. This process is used to essentially convert damaged cellular constituents into amino acids, lipids, sugars, and nucleotides, all basic building blocks for the regeneration of new proteins and organelles. In CF patients with the common F508del-CFTR mutation, a depressed autophagy could be traced back to decreased levels of the beclin-1, a key protein that is needed for the autophagosome formation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The defective F508del-CFTR is believed to induce an up-regulation of reactive oxygen species (ROS) and a corresponding increase in transglutaminase (TG2) activity. The increased TG2 activity, in turn, drives the cross-linking and the subsequent disabling of beclin-1. Once autophagy is depressed, there is a corresponding accumulation of p62. Since p62 has been shown to regulate aggresome formation, its accumulation effectively traps the misfolded CFTR and prevents its trafficking to the cell surface. The sequestered CFTR is then targeted for rapid degradation by the proteasome (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). A successful activation of autophagy could potentially allow this sequence of events to be reversed and thereby allow more of the F508del-CFTR to rise to the cell membrane. Previous proof-of-concept studies using human epithelial cell lines (CFBE41o- and IB3-1 cells) that were transfected with the F508del-CFTR have shown that overexpression of beclin-1 or knock-down of p62 via siRNA did indeed result in more of the misfolded CFTR being transported to the cell surface.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Even though this autophagy-based approach has the potential to address one of the underlying causes of CF, it has not been investigated extensively in the clinic. This is perhaps due in part to the lack of safe and effective agents that could selectively activate this particular pathway. Among the agents that have been reported to date (i.e., brefeldin A, rapamycin, valproic acid, trehalose, tunicamycin, carbamazepine, penitrem A) some could only activate autophagy at high concentrations while others displayed many off-target side effects or nondruglike properties, which precluded their evaluation in the clinic.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Cysteamine and its disulfide form, namely, cystamine, appear to be promising leads for autophagy activation, based on their safe and long-term use in the clinic for patients with nephropathic cystinosis.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Administration of cysteamine to CFTR<sup><i>F508del</i></sup> mice over a 5 week period showed a reduction in inflammatory markers (TNF, Cxcl2) and an increase in body weight, CFTR protein, and the autophagy marker beclin-1. Maiuri and co-workers have shown that cystamine (at 250 μM) could activate autophagy in brushed nasal epithelial cells from CF patients (homozygous F508del-CFTR) to allow the trafficking of the misfolded CFTR to the cell membrane.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Cysteamine has since been evaluated in a pilot clinical trial involving homozygous F508del-CFTR CF patients, in combination with epigallocatechin gallate.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> Cysteamine administration, however, comes with many challenges because of its poor PK profile (i.e., short half-life) and the associated GI side effects (i.e., nausea, emesis). Because of its low potency, it is not clear if cysteamine could be administered at doses high enough to allow a restoration of autophagy without resulting in significant off-target effects. Furthermore, cysteamine itself has an unpleasant thiol odor and taste which can present significant patient compliance issues upon chronic dosing.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0016.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In CF, the defective CFTR induces an upregulation of TG2, which causes the cross-linking of beclin-1 and the subsequent impairment of autophagy. This results in an increase in the p62 aggresomes, which can further trap the F508del-CFTR for the eventual degradation by the proteasome. A successful activation of autophagy would reverse these steps to allow more of the F508del-CFTR to reach the cell membrane. The fatty acid cysteamine conjugate <b>1</b> allows the simultaneous inhibition of TG2 and upregulation of AMPK to take place in order to activate autophagy more effectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As outlined below, we have identified a more effective way of activating autophagy via the use of fatty acid cysteamine conjugates. These covalent conjugates have the potential of filling the current gap in the availability of more potent, yet safe and effective autophagy activators suitable for definitive proof-of-concept studies. These NCEs were prepared by covalently linking cysteamine to the ω-3 fatty acid (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoic acid (DHA). This process allows the simultaneous delivery of the two bioactives without having to address the individual PK and tissue distribution of the individual components. Our fatty acid cysteamine conjugates synergistically activated autophagy in cultured primary homozygous F508del-CFTR hBE cells at concentrations that were significantly lower than what had previously been reported with cysteamine.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synergistic Activation of Autophagy with a Fatty Acid Cysteamine Conjugate</h3><div class="NLM_p">Cysteamine has been reported by Maiuri and co-workers to activate autophagy in certain human epithelial cell lines (CFBE41o- and IB3-1 cells) by restoring beclin-1 via the inhibition of TG2.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, the effect was modest and a high concentration of cysteamine (250 μM) was required. We therefore hypothesized that if we could simultaneously deliver cysteamine along with a second bioactive, another pathway could perhaps work in concert with the TG2 inhibition to amplify the autophagy activation. We selected DHA as this second bioactive. This ω-3 fatty acid, by itself, has previously been shown to increase autophagosome formation via the AMPK pathway.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> In order to achieve a simultaneous intracellular delivery, we employed the same methodology that we described earlier<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> by first covalently linking cysteamine to DHA to form the fatty acid cysteamine conjugate <b>1</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The amide bond that is present in the covalent conjugate <b>1</b> is susceptible to cleavage by the intracellular enzyme, fatty acid amide hydrolase (FAAH). We have evaluated this hydrolysis process using the purified recombinant enzyme FAAH-1.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, recombinant FAAH-1 readily hydrolyzed the amide bond to release DHA in a time-dependent fashion. Interestingly, FAAH is localized inside cells at the ER, the same compartment where autophagy is initiated. The covalent conjugate <b>1</b> allows cysteamine and DHA to be delivered at the same time, in equimolar concentrations, to the same subcellular compartment in which the mutant F508del-CFTR is trapped by the p62 aggresomes. This simultaneous intracellular delivery enables an unprecedented level of synergy to occur in terms of autophagy activation. <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a> summarizes an experiment where cultured primary homozygous F508del-CFTR hBE cells were incubated with the following treatment groups: (1) vehicle; (2) DHA (250 μM); (3) cysteamine (250 μM); (4) combination of cysteamine (250 μM) + DHA (250 μM); (5) fatty acid cysteamine conjugate <b>1</b> (3 μM). It should be noted that the fatty acid cysteamine conjugates have limited water solubility and need to be solubilized along with a protein carrier, such as FBS, prior to the serial dilution with the assay media in order to obtain the optimal effect. Compound <b>1</b>, at a concentration of 3 μM, increased beclin-1, and this, in turn, activated autophagy, as noted by the increase in the ratio of LC3-II to LC3-I, a commonly used marker for this catabolic process.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Autophagy activation was further accompanied by a corresponding decrease in p62, a key protein that participates in the sequestration of the F508del-CFTR. This synergistic activation in autophagy was observed only with the covalent fatty acid cysteamine conjugate <b>1</b> and not with the individual components (i.e., cysteamine, DHA) or a combination with the individual components.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In cultured primary CF hBE cells obtained from this particular donor, cysteamine, by itself, did not activate autophagy even at a concentration of 250 μM. The ω-3 fatty acid DHA, as well as the combination consisting of cysteamine and DHA, did not activate autophagy in primary CF hBE cells at a concentration of 250 μM.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. List of covalent fatty acid conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hydrolysis of the fatty acid cysteamine conjugate <b>1</b> using purified recombinant FAAH-1. Shown are measurements of DHA that was released upon hydrolysis of <b>1</b> using recombinant FAAH-1. Measurements were taken in the presence or absence of the recombinant enzyme FAAH-1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Representative immunoblots of primary homozygous F508del-CFTR hBE cells (patient code KKCFFT004I) that were treated for 24 h at 37 °C with the following: (lane a) vehicle; (lane b) cysteamine (250 μM); (lane c) DHA (250 μM); (lane d) combination of cysteamine (250 μM) + DHA (250 μM); (lane e) fatty acid cysteamine conjugate <b>1</b> (3 μM). (B) Quantification of the immunoblots shown in (A) for beclin-1 levels. (C) Quantification of the immunoblots shown in (A) for the ratio of LC3-II to LC3-I. (D) Quantification of the immunoblots shown in (A) for the p62 levels. Error bars represent standard error of the mean (SEM, <i>n</i> = 3): (∗) <i>p</i> < 0.05, compared to the vehicle with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next assessed how restoration of autophagy would affect the overall correction of the F508del-CFTR upon chronic exposure to the CFTR corrector lumacaftor and the potentiator ivacaftor. <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> summarizes an experiment where cultured primary homozygous F508del-CFTR hBE cells (patient code KKCFFT006F) were incubated for 24 h with <b>1</b> (3 μM) along with lumacaftor (3 μM) and ivacaftor (0.10 μM) in differentiation media.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Compared to the vehicle-treated group, treatment with lumacaftor/ivacaftor resulted in the expected increase in the CFTR band B (the immature, core-glycosylated isoform) and band C (the mature, complex-glycosylated isoform). When lumacaftor and ivacaftor were used in combination with the fatty acid cysteamine conjugate <b>1</b> (3 μM), a restoration of autophagy was observed, as noted by the increase in the level of beclin-1 and the ratio of LC3-II to LC3-I (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). Consistent with the previously proposed mechanism, an increase in autophagy was accompanied by a corresponding decrease in the level of p62, which, in turn, allowed some of F508del-CFTR to rise to the cell surface. As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A and <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B, the combination consisting of <b>1</b> (3 μM) and lumacaftor/ivacaftor clearly produced an increase in both the CFTR band B and band C. With cultured primary homozygous F508del-CFTR hBE cells from this particular donor (KKCFFT006F), we have observed autophagy activation even when <b>1</b> was used at the lower concentrations of 0.018–0.60 μM (these data are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf" class="ext-link">Supporting Information</a>). Maiuri and co-workers<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> have previously reported that once autophagy is activated, a reduction in the turnover of plasma membrane-located F508del-CFTR in human CF airway epithelial cells is observed. This could potentially translate to an increase in the chloride current across the F508del-CFTR when the proper CFTR corrector and potentiator are available. The next stage of our validation involves measurement of the chloride current across the F508del-CFTR hBE cells.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Determination of CFTR band B and band C. (A) Immunoblots of primary homozygous F508del-CFTR hBE cells (patient code KKCFFT006F) when treated for 24 h with the following: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) <b>1</b> (3 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). (B) Quantification of the immunoblots shown in (A) for the corresponding CFTR band B, the CFTR band C, and the ratio of band C to band B. (C) Quantification of the corresponding immunoblots for beclin-1, the ratio of LC3-II/LC3-I and p62, expressed as a % of the lumacaftor/ivacaftor control group. Error bars represent standard deviation (SD): (∗) <i>p</i> < 0.05, SD, <i>n</i> = 3, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> A Triple Combination To Correct F508del-CFTR</h3><div class="NLM_p">A successful correction of the F508del-CFTR needs to translate to an actual increase in the chloride current to be of benefit to CF patients. This important functional activity was assessed using the TECC-24 semiautomated format with cultured primary homozygous F508del-CFTR hBE cells. Unlike the traditional Ussing chamber assays, where the short circuit current (<i>I</i><sub>SC</sub>) is measured as an index of CFTR correction, the TECC-24 assay measures the equivalent current (<i>I</i><sub>EQ</sub>). The TECC-24 assay format offers some advantages over the Ussing chamber assay, one of which is the higher throughput; the other involves the ability to measure the <i>I</i><sub>EQ</sub> with the test compounds continuously present in the recording medium. However, since the <i>I</i><sub>EQ</sub> was recorded in 5 min intervals, one disadvantage with the TECC-24 in the present format is the lack of sensitivity of the assay during the forskolin activation phase. Nevertheless, once steady state has been achieved, the bumetanide-inhibited CFTR chloride current obtained from a TECC-24 assay represents a reliable measure of functional efficacy. There are two basic protocols that are used to assess functional activity: (1) the acute ivacaftor protocol and (2) the chronic ivacaftor preincubation protocol. In the acute ivacaftor protocol, cultured primary homozygous F508del-CFTR hBE cells were incubated with the fatty acid cysteamine conjugate <b>1</b> along with the CFTR corrector lumacaftor for 24 h. Forskolin and the CFTR potentiator ivacaftor were then added acutely just after benzamil was added to the apical side to inhibit sodium transport prior to the <i>I</i><sub>EQ</sub> measurements. This is the standard set of assay conditions that were used originally to assess the functional activity of the corrector lumacaftor.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In the chronic ivacaftor preincubation protocol, cultured primary homozygous F508del-CFTR hBE cells were incubated with the fatty acid cysteamine conjugate <b>1</b> along with both the corrector lumacaftor and the potentiator ivacaftor for 24 h prior to the <i>I</i><sub>EQ</sub> measurements. This protocol was introduced more recently based on the findings from Cholon<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and Veit<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> that the potentiator ivacaftor actually had a destabilizing effect on the corrected CFTR upon chronic preincubation with lumacaftor, and the chloride current measured under this protocol was significantly less than what was previously reported with the acute addition of ivacaftor. When a triple combination is used in a clinical setting, this chronic preincubation protocol might be more representative of what cells would be exposed to at a given time period. We have assessed the functional activity of <b>1</b> using this chronic ivacaftor preincubation protocol and have found a significant additive effect on top of lumacaftor/ivacaftor.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a> summarizes an experiment using the chronic ivacaftor preincubation protocol. Here, primary homozygous F508del-CFTR hBE cells (patient code CFFT0018I) were incubated in differentiation medium for 24 h at 37 °C with the following treatment groups: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) <b>1</b> (0.075 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). The next day, the differentiation medium was replaced with Coon’s F12 (without serum or bicarbonate) medium; with the same concentrations of the test compounds added back to this new medium.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> To initiate the run, benzamil was added first to the apical side to block currents through the epithelial sodium channel (ENaC). Forskolin was added, and the <i>I</i><sub>EQ</sub> was recorded over a 27 min period. The antagonist bumetanide was then added to the basolateral side to inhibit the Na-K-2Cl cotransporter and block chloride secretion from the CFTR. The resulting bumetanide-inhibited CFTR chloride current (Δbumetanide, μA/cm<sup>2</sup>) is a reflection of the functional activity of the now corrected F508del-CFTR. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A and <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B, the triple combination consisting of <b>1</b> (0.075 μM) along with lumacaftor/ivacaftor showed a statistically significant increase in the bumetanide-inhibited CFTR chloride current (Δbumetanide = 3.08 ± 0.24 μA/cm<sup>2</sup>) over the lumacaftor/ivacaftor treatment group (Δbumetanide = 1.91 ± 0.22 μA/cm<sup>2</sup>). This increase in the CFTR chloride current could also be expressed as a % of the lumacaftor/ivacaftor control group, with the appropriate subtraction of the Δbumetanide value corresponding to the vehicle group from both the triple combination and the lumacaftor/ivacaftor treatment group, in order to allow for a more direct comparison across the different assay runs. For this particular run, the triple combination allowed a 184% increase in the bumetanide-inhibited CFTR chloride current relative to the lumacaftor/ivacaftor treatment group, a nearly 2-fold increase in the response (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B, with the appropriate subtraction of the Δbumetanide value for the vehicle group of 0.52 ± 0.14 μA/cm<sup>2</sup>). In this assay format using primary cells from this particular patient donor, we did not observe a noticeable change in the forskolin-stimulated Δ<i>I</i><sub>EQ</sub> for the triple combination. However, there was a statistically significant increase in the AUC for the triple combination over the lumacaftor/ivacaftor treatment group (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C, triple combination AUC = 173.3 ± 18.5 μA/(27 min·cm<sup>2</sup>) vs lumacaftor/ivacaftor control group AUC = 134.2 ± 5.6 μA/(27 min·cm<sup>2</sup>); vehicle group AUC = 22.3 ± 4.9 μA/(27 min·cm<sup>2</sup>)). With this particular assay setup, the solubility of <b>1</b> in the Coon’s F12 medium was a limiting factor. At concentrations of >0.075 μM, some of the precipitated, oily fatty acid conjugates began to interfere with the current recording. The <i>I</i><sub>EQ</sub> readings became much more variable, and the results were more difficult to interpret.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. TECC-24 assay, Rosalind Franklin University, patient code CFFT018I: chronic ivacaftor preincubation protocol. Primary homozygous F508del-CFTR hBE cells were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) compound <b>1</b> (0.075 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). The medium was then switched to Coon’s F12, with test compounds added back. Plate was incubated at 37 °C for 4 h prior to <i>I</i><sub>EQ</sub> measurements. (A) Representative <i>I</i><sub>EQ</sub> traces following the addition of benzamil (3 μM) to first block currents deriving from ENaC. Forskolin (10 μM) was added, and the <i>I</i><sub>EQ</sub> was recorded over a 27 min period at 37 °C. Bumetanide (20 μM) was added to block the chloride secretion from the CFTR. (B) Quantification of the bumetanide-inhibited CFTR chloride current for the three indicated treatment groups, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (C) Quantification of the AUC (computed for the time period that spans the <i>I</i><sub>EQ</sub> value at the time of forskolin addition up to the <i>I</i><sub>EQ</sub> value at the time of bumetanide addition): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 3, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Triple Combinations Using Primary CF hBE Cells from Different Donors</h3><div class="NLM_p">We have also evaluated the functional activity of <b>1</b> in a similar TECC-24 assay format using primary CF hBE cells from different donors. <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> summarizes a TECC-24 assay that was carried out at a different laboratory, using cultured primary homozygous F508del-CFTR hBE cells from patient code KKCFFT006F. These primary hBE cells are of the same patient code as the one used in the band B/C Western blots shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>. By use of the chronic ivacaftor preincubation protocol, cells were treated with the following groups: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) <b>1</b> (0.15 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). As detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>, there are some minor differences between the two TECC-24 assay formats. However, the basic protocol remains essentially the same. One major difference is in the antagonist that is used to block the chloride secretion from the CFTR. With this setup, CFTR<sub>172</sub>-inh was used instead of bumetanide, and the antagonist-inhibited CFTR chloride current, Δ<i>I</i><sub>EQ</sub> (CFTR<sub>inh</sub>-172), represents essentially the same functional readout as the Δbumetanide described in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>. With this particular TECC-24 setup, using cells from this particular patient donor, a significant increase in the peak forskolin response was observed with the triple combination (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A). As shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B, the peak forskolin Δ<i>I</i><sub>EQ</sub> for the triple combination was 24.47 ± 0.62 μA/cm<sup>2</sup>. This increase in the peak forskolin response was statistically significant over the lumacaftor/ivacaftor treatment group (Δ<i>I</i><sub>EQ</sub> = 16.61 ± 2.16 μA/cm<sup>2</sup>). When expressed as a % of the lumacaftor/ivacaftor control group, with the appropriate subtraction of the Δ<i>I</i><sub>EQ</sub> value of 7.50 ± 0.44 μA/cm<sup>2</sup> for the vehicle group, the triple combination with <b>1</b> afforded a 186% increase in the peak forskolin response, a nearly 2-fold increase in the response. In terms of the CFTR<sub>inh</sub>-172 inhibited chloride current, the triple combination (Δ<i>I</i><sub>EQ</sub> = 7.47 ± 0.16 μA/cm<sup>2</sup>) still showed a statistically significant increase over the lumacaftor/ivacaftor treatment group (Δ<i>I</i><sub>EQ</sub> = 5.45 ± 0.48 μA/cm<sup>2</sup>). When expressed as a % of the lumacaftor/ivacaftor control group, this represents a 149% increase in the antagonist-inhibited chloride current (with the appropriate subtraction of the vehicle group Δ<i>I</i><sub>EQ</sub> = 1.37 ± 0.23 μA/cm<sup>2</sup>). There was also a statistically significant increase in the AUC for the triple combination (triple combination AUC = 607.3 μA/(60 min·cm<sup>2</sup>) vs lumacaftor/ivacaftor control AUC = 430.6 ± 40.5 μA/(60 min·cm<sup>2</sup>); vehicle group AUC = 137.2 ± 20.3 μA/(60 min·cm<sup>2</sup>). Even though the solubility of <b>1</b> was still limited in this TECC-24 assay setup, it did not appear to interfere with the <i>I</i><sub>EQ</sub> measurements as much as in the previous setup. We have evaluated <b>1</b> in concentrations of up to 0.6 μM and observed an additive effect on top of lumacaftor/ivacaftor (the entire data set is shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf" class="ext-link">Supporting Information</a>, along with the corresponding band B/band C data for this lower concentration of 0.15 μM of conjugate <b>1</b>). In this particular assay setup, at concentrations of ≥1.2 μM <b>1</b>, solubility became an issue in the Coon’s F12 medium, and we began to experience an inhibition in the chloride current.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. TECC-24 assay, Charles River Laboratories, patient code KKCFFT006F: chronic ivacaftor preincubation protocol. Primary homozygous F508del-CFTR hBE cells were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) compound <b>1</b> (0.15 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). The medium was then switched to Coon’s F12, with the test compounds added back. Plate was incubated at 37 °C for 4 h prior to <i>I</i><sub>EQ</sub> measurements. (A) Average <i>I</i><sub>EQ</sub> traces for the three treatment groups following the addition of benzamil (10 μM) to first block currents deriving from ENaC. Forskolin (10 μM) was then added, and the <i>I</i><sub>EQ</sub> was recorded over a 60 min period at 37 °C. CFTR<sub>inh</sub>-172 (20 μM) was added to block the chloride secretion from the CFTR. (B) Quantification of the peak forskolin-activated chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (C) Quantification of the CFTR<sub>inh</sub>-172 inhibited chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (D) Quantification of the AUC (computed for the time period that spans the <i>I</i><sub>EQ</sub> value at the time of forskolin addition up to the <i>I</i><sub>EQ</sub> value at the time of CFTR<sub>inh</sub>-172 addition): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 4, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A statistically significant increase in the peak forskolin response was also observed when <b>1</b> was evaluated in the same TECC-24 setup using primary cells from a different patient donor. <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a> summarizes an experiment where primary homozygous F508del-CFTR hBE cells (patient code KKCFFT004I) were treated with the following groups for 24 h at 37 °C prior to <i>I</i><sub>EQ</sub> measurements: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) <b>1</b> (0.30 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). Under this chronic ivacaftor preincubation protocol, there was a statistically significant increase in the peak forskolin-activated CFTR chloride current with the triple combination. Even though the magnitude of the increase was smaller than what was observed with the previous patient code, the Δ<i>I</i><sub>EQ</sub> (peak forskolin) for the triple combination still represents a 167% increase over the lumacaftor/ivacaftor treatment group (triple combination, Δ<i>I</i><sub>EQ</sub> = 8.24 ± 1.18 μA/cm<sup>2</sup> vs lumacaftor/ivacaftor control group Δ<i>I</i><sub>EQ</sub> = 6.250 ± 0.36 μA/cm<sup>2</sup>; vehicle group, Δ<i>I</i><sub>EQ</sub> = 3.90 ± 0.88 μA/cm<sup>2</sup>). With primary cells from this particular donor, we began to see an inhibition in the chloride current at concentrations of ≥0.60 μM <b>1</b> (additional data are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf" class="ext-link">Supporting Information</a>). Having evaluated <b>1</b> in TECC-24 setups from different laboratories, using primary CF cells from different patient donors, we have noticed a wide range of responses. With some primary hBE cells, we did not experience any chloride current inhibition until we reached a concentration of ≥1.2 μM <b>1</b>. In others, we began to experience significant variability and some chloride current inhibition at much lower concentrations. There are many contributing factors to the observed variations, including the following: (a) different laboratories cultured and maintained primary hBE cells from different donors on different TECC-24 filter inserts; (b) different protocols were used to remove the mucus film on the apical side of the hBE monolayers prior to <i>I</i><sub>EQ</sub> measurements; (c) different sources of FBS were used to solubilize <b>1</b> prior to the serial dilution. However, one observation that was consistent across the different setups was the additive effect of <b>1</b> on top of lumacaftor/ivacaftor when used at lower concentrations, where solubility of <b>1</b> in the recording medium was less of a factor. Thus, far, because of the low solubility of <b>1</b> in the Coon’s F12 medium using this TECC-24 assay format, we have not been able to assess its functional activity at the higher concentration of 3 μM (i.e, the concentration where we observed a significant increase in the CFTR band C, <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). In order to evaluate <b>1</b> at the higher concentrations, we have looked into different functional assay formats, including the forskolin-induced swelling of organoids.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The results from those studies will be disclosed in a separate communication.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. TECC-24 assay, Charles River Laboratories, patient code KKCFFT004I: chronic ivacaftor preincubation protocol. Primary homozygous F508del-CFTR hBE cells were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) compound <b>1</b> (0.30 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). Protocols are the same as detailed in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>. (A) Average <i>I</i><sub>EQ</sub> traces for the three treatment groups. (B) Quantification of the peak forskolin-activated chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 6, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Design of a Plasma-Stable and Orally Bioavailable Fatty Acid Cysteamine Conjugate</h3><div class="NLM_p">Even though the covalent conjugate <b>1</b> showed promising functional activity, when used in combination with lumacaftor/ivacaftor, it is rather unstable when exposed to air, presumably because of the sulfhydryl moiety. A more stable form is therefore needed for the appropriate in vivo studies. Converting the sulfhydryl group to the disulfide form, as shown with the cystamine derivative <b>2</b>, should enhance the overall stability of the covalent conjugate (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). In theory, the bis-fatty acid cystamine conjugate <b>3</b> should allow the intracellular delivery of the same covalent conjugate <b>1</b>. In practice, however, this type of bis-fatty acid was rather difficult to formulate for oral dosing, as well as for standard in vitro work. We therefore sought to replace one of the two fatty acids with a smaller substituent. On the basis of our earlier work with fatty acid niacin conjugates,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> similar to the one shown with structure <b>6</b>, we selected nicotinic acid as the capping group for our first proof-of-concept compound. What we found was that the cystamine linker in <b>4</b> was still unstable in the plasma. To improve the plasma stability of our fatty acid cysteamine conjugate, a bis-geminal methyl group was installed adjacent to the disulfide moiety.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> As shown in <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>, compound <b>5</b> was stable in rat, mouse, dog, and human plasma. Unlike the related compound <b>6</b>, which had significant inhibitory activity against SREBP,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> the fatty acid cysteamine conjugate <b>5</b>, with this type of disulfide linker, did not show any SREBP activity at the highest tested concentration of 50 μM. Compound <b>5</b>, in turn, was prepared according to the synthetic sequence outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Cysteamine was first reacted with 1,2-di(pyridin-2-yl)disulfane (<b>7</b>) to form the mixed disulfide derivative <b>8</b>. Treatment of <b>8</b> with DHA afforded the fatty acid derivative <b>9</b>. This was subsequently treated with 1-amino-2-methylpropane-2-thiol to afford the bis-geminal methyl derivative <b>9</b>. Standard amide coupling with nicotinic acid afforded the fatty acid cysteamine conjugate <b>5</b>. Unlike compound <b>1</b>, the fatty acid cysteamine conjugate <b>5</b> is now sufficiently stable at room temperature and can be conveniently stored in the freezer over an extended period (initial stability of >1 year). Compound <b>5</b> can be conveniently formulated as a self-emulsifying dispersion (SED) using an aqueous mixture consisting of Tween, PEG400, and Peceol (glyceryl monoleate type 40) for oral gavage administration. In a typical PK experiment, Sprague Dawley rats were dosed orally with 30 mg/kg of compound <b>5</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). Serial blood collection was carried out at 0.125, 0.25, 0.5, 1, 2, 4, 5, 8, and 12 h. In order to quantify the unstable thiol metabolite <b>1</b>, the corresponding Ellman’s adduct <b>15</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) was prepared and used to prepare the necessary standard curve. A small quantity of the parent compound <b>5</b> was detected in the plasma upon oral dosing (<i>C</i><sub>max</sub> = 24.6 ± 4.39 ng/mL; AUC<sub>last</sub> = 37.7 ± 16.2 h·ng/mL). There was a significantly higher and more sustained level of the biologically active metabolite <b>1</b> (<i>C</i><sub>max</sub> = 777 ± 435 ng/mL, AUC<sub>last</sub> = 2929 ± 1282 h·ng/mL), and this was detected in the plasma even at the 8 and 12 h time point.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> This plasma level would support the feasibility of either a b.i.d. or q.d. dosing and is sufficient to support the functional activity displayed by <b>1</b> in the various assays discussed earlier.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) cysteamine, MeOH, rt; (b) DHA, HATU, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 1-amino-2-methylpropane-2-thiol, MeOH/DMF (1:1), rt; (d) nicotinoyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Plasma stability for the fatty acid cysteamine conjugate <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Plasma concentrations of the parent compound <b>5</b> and the biologically active metabolite <b>1</b> upon oral dosing to Sprague Dawley rats (30 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0010.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Potential metabolites obtained from oral dosing with <b>5</b> to Sprague Dawley rats. Compound <b>15</b> represents the corresponding Ellman’s adduct of conjugate <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Even as the disulfide form, when <b>5</b> was administered to primary hBE cells, the disulfide bond should undergo the appropriate intracellular reduction to afford the biologically active metabolite <b>1</b>. The functional activity of the disulfide derivative <b>5</b> was evaluated in the TECC-24 assay format, and some of the results are described herein. <a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a> summarizes an experiment where <b>5</b> was evaluated along with the corrector lumacaftor, upon acute exposure to the potentiator ivacaftor (additional TECC-24 assay data for <b>5</b> under the chronic ivacaftor preincubation protocol, as well as other functional data, can also be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf" class="ext-link">Supporting Information</a>). With this setup using primary hBE cells from this particular patient code (homozygous F508del-CFTR, CFFT028H), there was no significant change in the forskolin response. However, a 2-fold increase in the bumetanide-inhibited CFTR chloride current was observed when <b>5</b> (0.0375 μM) was used in combination with lumacaftor and ivacaftor (triple combination, Δbumetanide = 3.73 ± 0.41 μA/cm<sup>2</sup> vs lumacaftor/ivacaftor control, Δbumetanide = 1.54 ± 0.04 μA/cm<sup>2</sup>). <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a> summarizes an experiment where <b>5</b> (0.018 μM) was evaluated in a different laboratory using primary homozygous F508del-CFTR hBE cells from another patient code (KKCFFT0012I) along with lumacaftor and ivacaftor. With this setup, although there was no change in the peak forskolin response, there was a significant additive effect for the triple combination when we looked at other parameters such as the CFTR<sub>inh</sub>172-inhibited CFTR chloride current (triple combination, Δ<i>I</i><sub>EQ</sub> = 3.05 ± 0.18 μA/cm<sup>2</sup> vs lumacaftor/ivacaftor control, Δ<i>I</i><sub>EQ</sub> = 1.74 ± 0.29 μA/cm<sup>2</sup>; vehicle group, Δ<i>I</i><sub>EQ</sub> = 0.18 ± 0.11 μA/cm<sup>2</sup>) and the AUC (triple combination, AUC = 326.36 ± 17.16 μA/(60 min * cm<sup>2</sup>) vs lumacaftor/ivacaftor control, AUC = 209.24 ± 40.42 μA/(60 min·cm<sup>2</sup>); vehicle group, AUC = 63.83 ± 5.44 μA/(60 min·cm<sup>2</sup>)). When expressed as a % of the lumacaftor/ivacaftor control group, both of these responses showed a ≥180% increase for the triple combination, a nearly 2-fold increase over the lumacaftor/ivacaftor treatment group. In total, cultured primary homozygous F508del-CFTR hBE cells from five different patients were used to demonstrate the functional activity of conjugate <b>1</b> and the disulfide derivative <b>5</b> in the TECC-24 assay format, using either the chronic ivacaftor preincubation protocol or the standard acute ivacaftor protocol.</div><figure id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0011.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. TECC-24 assay, Rosalind Franklin University, patient code CFFT028H: acute ivacaftor protocol. Primary homozygous F508del-CFTR hBE cells were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle; (2) lumacaftor (3 μM); (3) compound <b>5</b> (0.0375 μM) + lumacaftor (3 μM). The medium was then switched to Coon’s F12, with test compounds added back. Plate was incubated at 37 °C for 30 min prior to <i>I</i><sub>EQ</sub> measurements. (A) Representative <i>I</i><sub>EQ</sub> traces following the addition of benzamil (3 μM) to first block the epithelial Na channel. Forskolin (10 μM) was then added, followed by ivacaftor (0.10 μM). <i>I</i><sub>EQ</sub> was recorded over a 45 min period at 37 °C. Bumetanide (20 μM) was added to block the chloride secretion from the CFTR. (B) Quantification of the bumetanide-inhibited CFTR chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (C) Quantification of the AUC (computed for the time period that spans the <i>I</i><sub>EQ</sub> value at the time of forskolin addition up to the <i>I</i><sub>EQ</sub> value at the time of bumetanide addition): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 3, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0012.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. TECC-24 assay, Charles River Laboratories, patient code KKCFFT0012I: acute ivacaftor protocol. Primary homozygous F508del-CFTR hBE cells (<i>n</i> = 4) were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle; (2) lumacaftor (3 μM); (3) compound <b>5</b> (0.018 μM) + lumacaftor (3 μM). The medium was then switched to Coon’s F12, with the test compounds added back. Plate was incubated at 37 °C for 30 min prior to <i>I</i><sub>EQ</sub> measurements. (A) Average <i>I</i><sub>EQ</sub> traces for the indicated treatment groups following the addition of benzamil (10 μM) to first block currents deriving from ENaC. Forskolin (10 μM) and ivacaftor (0.10 μM) were then added, and the <i>I</i><sub>EQ</sub> was recorded over a 60 min period at 37 °C. CFTR<sub>inh</sub>-172 (20 μM) was added to block the chloride secretion from the CFTR. (B) Quantification of the CFTR<sub>inh</sub>-172 inhibited chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (C) Quantification of the AUC (computed for the time period that spans the <i>I</i><sub>EQ</sub> value at the time of forskolin addition up to the <i>I</i><sub>EQ</sub> value at the time of CFTR<sub>inh</sub>-172 addition): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 4, statistically significant relative to the lumacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, we have demonstrated the use of fatty acid cysteamine conjugates as novel autophagy activators that could enhance the correction of misfolded F508del-CFTR when used in combination with established CFTR modulators. Previous work by Maiuri and co-workers has demonstrated that autophagy could play a role in the trafficking of the mutant F508del-CFTR.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> However, the reagent employed in their studies, cysteamine, was a weak autophagy activator, and the effect was observed only at 250 μM in certain cell lines. This high concentration of cysteamine would be difficult to achieve in the various tissues because of its poor PK properties. By employing our covalent linking methodology, we have demonstrated that the fatty acid cysteamine conjugate <b>1</b> could synergistically activate autophagy in primary homozygous F508del-CFTR hBE cells at much lower concentrations. This level of activity could not be replicated by using the individual components (i.e., cysteamine, DHA) or a combination of the individual components, even at much higher concentrations. Immunoblotting and chloride conductance assays using cultured primary homozygous F508del-CFTR hBE cells were used to verify the functional activity of the fatty acid cysteamine conjugate <b>1</b>. Depending on the primary CF cells used, we have observed an improvement of nearly 2-fold in either the peak forskolin response or the bumetanide-inhibited CFTR chloride current when the conjugate <b>1</b> was used in combination with lumacaftor/ivacaftor. In order to obtain a more stable form for oral dosing, as well as to improve patient compliance, we converted the sulfhydryl group present in <b>1</b> to the corresponding odorless disulfide derivative. The resulting conjugate <b>5</b> is orally bioavailable in the mouse, rat, and dog when formulated as a self-emulsifying dispersion. This disulfide form allowed a sustained delivery of the biologically active metabolite <b>1</b>, with plasma concentrations that were significantly higher than the concentrations at which functional activity was observed in primary homozygous F508del-CFTR hBE cells (0.075–0.3 μM). Since the biologically active metabolite <b>1</b> is so effective in activating autophagy, we are anticipating that a much lower dose of it would be needed in an in vivo setting. This would minimize the unpleasant smell, taste, body odor, and off-target side effects that are associated with the chronic administration of high doses of cysteamine.</div><div class="NLM_p last">This communication focuses primarily on the effect of autophagy on the correction of the misfolded F508del-CFTR. However, it is not the only significant biological activity that is associated with an autophagy activator such as <b>1</b> and its disulfide form <b>5</b>. The autophagy mechanism has previously been reported to have an important role in the innate and adaptive immunity, and this could have a significant impact on the intracellular clearance of bacteria.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> While an autophagy activator can be helpful in enhancing CFTR correction, we believe that this unique antibacterial effect can potentially be just as useful in CF. It is widely known that the lack of a proper functioning CFTR in the lungs of CF patients causes a chronic bacterial infection that further deteriorates their lung function.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a><i>Pseudomonas aeruginosa</i> is a particularly difficult pathogen to treat because of its ability to internalize within cells.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Airway epithelial cells thus become a reservoir of intracellular bacteria during chronic <i>P. aeruginosa</i> infection. Autophagy activation enables an alternative mechanism to clear the bacterial infection out of the bronchial epithelial cells<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and therefore could potentially be useful when used in combination with anti-infective agents. We have evaluated the ability of compound <b>5</b> (CAT-5571) to activate autophagy and induce an intracellular clearance of <i>P. aeruginosa</i> in a number of in vitro and in vivo studies.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The results from those studies will be discussed in more detail in a separate communication.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Information</h3><div class="NLM_p last">All chemical reagents and solvents were commercially available and used as received. (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-Docosa-4,7,10,13,16,19-hexaenoic acid (DHA) was purchased from Nu-Chek Prep. Lumacaftor was purchased from Astatech, and ivacaftor was purchased from D-L-Chiral Chemicals. Reactions were generally run under argon or nitrogen. <sup>1</sup>H NMR (400 MHz) and <sup>13</sup>C NMR (100 MHz) spectra were recorded on a Varian 400 MHz Unity Inova system in CDCl<sub>3</sub> unless otherwise noted. Chemical shifts are expressed in parts per million (ppm, δ); coupling constants are in hertz (Hz). Splitting patterns describe multiplicities s (singlet), d (double), t (triplet), q (quartet), m (multiplet), br (broad). High resolution mass spectroscopy data were analyzed by direct flow injection, utilizing electrospray ionization (ESI) on a Waters Qtof API US instrument in the positive mode. Analytical and other mass spectra were collected on an Agilent Technologies 1200 series system with an Agilent Technologies 6120 quadruple LC–MS detector in positive mode. A SiliCycle C18 XDB, 3 mm × 100 mm column was used with a gradient of H<sub>2</sub>O and acetonitrile each with 0.1% formic acid; UV detection was at 254 and 210 nm. Normal phase flash chromatography was accomplished on Teledyne Isco systems using prepacked silica gel columns. Sample purity was determined by LC–MS; all compounds were of >95% purity, as determined by at least two different HPLC methods. For the hydrolysis experiments and PK study, the samples were analyzed on the Agilent 6410 Triple Quad LC/MS mass spectrometer. Separation was achieved using a Gemini 3 μm C6 phenyl column with a gradient using water containing 0.1% formic acid (solvent A) and methanol containing 0.1% formic acid (solvent B).</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-<i>N</i>-(2-Mercaptoethyl)docosa-4,7,10,13,16,19-hexaenamide (<b>1</b>)</h3><div class="NLM_p last">The fatty acid cysteamine conjugate <b>1</b> was generated fresh from the well-characterized disulfide form prior to each assay and was not isolated due to its unstable nature. In a typical run, the bis-fatty acid derivative (4<i>Z</i>,4′<i>Z</i>,7<i>Z</i>,7′<i>Z</i>,10<i>Z</i>,10′<i>Z</i>,13<i>Z</i>,13′<i>Z</i>,16<i>Z</i>,16′<i>Z</i>,19<i>Z</i>,19′<i>Z</i>)-<i>N</i>,<i>N</i>′-(disulfanediylbis(ethane-2,1-diyl))bis(docosa-4,7,10,13,16,19-hexaenamide)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> (125 mg, 0.162 mmol) was taken up in absolute EtOH (1.75 mL). Racemic dithiothreitol (DTT, 30 mg, 0.194 mmol) was added at rt, followed by aqueous NaOH (1 N solution, 250 μL). The resulting reaction mixture was stirred at rt for 30 min to allow for a complete reduction of the disulfide group. It was then diluted with DMSO (4.5 mL) to form a 50 mM DMSO stock solution of <b>1</b>. This freshly prepared stock solution was purged with inert gas and used directly for the assay. This stock solution should not be kept at rt for more than 3 h. If necessary, the stock solution could be stored at −80 °C up to 5 days or at −20 °C for up to 3 days. Upon thawing to rt, it should be used (without refreezing) within 3 h and then discarded appropriately.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>N</i>-(2-((2-((4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-Docosa-4,7,10,13,16,19-hexaenamido)ethyl)disulfanyl)-2-methylpropyl)nicotinamide (<b>5</b>)</h3><div class="NLM_p last">(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-<i>N</i>-(2-((1-Amino-2-methylpropan-2-yl)disulfanyl)ethyl)docosa-4,7,10,13,16,19-hexaenamide (<b>10</b>, 3.2 g, 6.5 mmol) and nicotinoyl chloride (1.8 g, 13 mmol) were taken up in CH<sub>2</sub>Cl<sub>2</sub> (30 mL). Triethylamine (3 mL, 19.5 mmol) was added dropwise at 0 °C. The resulting mixture was stirred at rt for 18 h. It was then diluted with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with water (2 × 50 mL), brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (pentanes/EtOAc) to afford <i>N</i>-(2-((2-((4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenamido)ethyl)disulfanyl)-2-methylpropyl)nicotinamide (2.2 g, 57% yield) as a light brown oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.01 (s, 1H), 8.71–8.65 (m, 2H), 8.21–8.17 (m, 1H), 8.04–8.00 (m, 1H), 7.52–7.47 (m, 1H), 5.39–5.25 (m, 12H), 3.49–3.47 (m, 2H), 3.35–3.28 (m, 3H), 2.82–2.78 (m, 11H), 2.29–2.22 (m, 2H), 2.13–1.76 (m, 4H), 1.29 (s, 6H), 0.94–0.88 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>, 5 overlapping peaks corresponding to the CH group present in the omega-3 fatty acid portion): δ 172.08, 165.92, 152.26, 148.98, 135.59, 131.99, 130.54, 129.27, 128.58, 128.52, 128.36, 128.31, 128.21, 128.15, 127.39, 123.81, 51.95, 48.35, 39.18, 38.69, 35.66, 25.79, 25.69, 25.65, 25.60, 23.56, 20.53, 14.59. MS calcd for C<sub>34</sub>H<sub>49</sub>N<sub>3</sub>O<sub>2</sub>S<sub>2</sub>: 595.3; found, 596.3 [M + H]<sup>+</sup>. High resolution MS (ES<sup>+</sup>) calcd for C<sub>34</sub>H<sub>49</sub>N<sub>3</sub>O<sub>2</sub>S<sub>2</sub> (M + H<sup>+</sup>) <i>m</i>/<i>z</i>, 596.3270; found, 596.3345.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 2-(Pyridin-2-yldisulfaneyl)ethan-1-amine (<b>8</b>)</h3><div class="NLM_p last">A solution containing 1,2-di(pyridin-2-yl)disulfane (<b>7</b>, 26 g, 0.227 mmol) in MeOH (200 mL) was added dropwise at rt to a solution containing cysteamine (50 g, 0.227 mmol) in MeOH (200 mL). The resulting reaction mixture was stirred at rt for 2 h under an inert atmosphere of nitrogen and then concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 10/1) to afford 2-(pyridin-2-yldisulfanyl)ethan-1-amine (39 g, 92% yield). <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>): δ 8.50 (m, 1 H), 7.78–7.92 (m, 2 H), 7.28 (m, 1 H), 4.58 (br s, 2 H), 2.80–3.00 (m, 4 H). <sup>13</sup>C NMR (100 MHz, DMSO<i>-d</i><sub>6</sub>): δ 159.37, 150.19, 138.65, 122.28, 119.96, 49.04, 38.49. <i>R<sub>f</sub></i> = 0.22 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/AcOH = 85:15:5). MS calcd for C<sub>7</sub>H<sub>10</sub>N<sub>2</sub>S<sub>2</sub>: 186.03; found, 187 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-<i>N</i>-(2-(Pyridin-2-yldisulfaneyl)ethyl)docosa-4,7,10,13,16,19-hexaenamide (<b>9</b>)</h3><div class="NLM_p last">A mixture containing 2-(pyridin-2-yldisulfanyl)ethan-1-amine (<b>8</b>, 5 g, 26.8 mmol), DHA (9.2 g, 26.8 mmol), and HATU (10.2 g, 26.8 mmol) was taken up in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and stirred at rt. Triethylamine (18 mL, 40.3 mmol) was then added dropwise at rt. The resulting reaction mixture was stirred at rt for 18 h. It was then diluted with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with water (3 × 100 mL), brine (100 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (pentanes/EtOAc) to afford (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-<i>N</i>-(2-(pyridin-2-yldisulfanyl)ethyl)docosa-4,7,10,13,16,19-hexaenamide (10 g, 75% yield) as a light brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>):): δ 8.49 (d, <i>J</i> = 4.4 Hz, 1 H), 7.65 (m, 1 H), 7.53 (d, <i>J</i> = 8.0 Hz, 1 H), 7.10–7.20 (m, 2 H), 5.22–5.40 (m, 12 H), 3.55 (m, 2 H), 2.95 (m, 2 H), 2.80–2.95 (m, 8 H), 2.42 (m, 2 H), 2.05 (m, 2 H), 0.97 (t, <i>J</i> = 7.2 Hz, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, 3 overlapping peaks due to the CH group of the ω-3 fatty acid) δ 172.46, 165.75, 159.17, 149.73, 137.01, 132.04, 129.25, 128.56, 128.11, 128.08, 127.87, 127.01, 121.31, 121.06, 38.87, 38.62, 37.23, 36.60, 31.43, 29.38, 25.84, 25.64, 25,54, 23.48, 20.57, 14.3. <i>R<sub>f</sub></i> = 0.50 (EtOAc/hexane = 1:2). MS calcd for C<sub>29</sub>H<sub>40</sub>N<sub>2</sub>OS<sub>2</sub>: 496.3; found, 497.5 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-<i>N</i>-(2-((1-Amino-2-methylpropan-2-yl)disulfaneyl)ethyl)docosa-4,7,10,13,16,19-hexaenamide (<b>10</b>)</h3><div class="NLM_p last">1-Amino-2-methylpropane-2-thiol (1.14 g, 8 mmol) was added dropwise at rt to a solution containing (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-<i>N</i>-(2-(pyridin-2-yldisulfanyl)ethyl)docosa-4,7,10,13,16,19-hexaenamide <b>9</b> (4 g, 8 mmol) in a 1:1 mixture of MeOH/DMF (10 mL). The resulting reaction mixture was stirred at rt for 18 h. It was then diluted with water and extracted with EtOAc. The combined organic layers were washed with water (2 × 50 mL), brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (pentanes/EtOAc) to afford (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-<i>N</i>-(2-((1-amino-2-methylpropan-2-yl)disulfanyl)ethyl)docosa-4,7,10,13,16,19-hexaenamide (3.2 g, 81% yield) as a light brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 6.37 (m, 1 H), 5.25–5.40 (m, 12 H), 4.30–4.50 (m, 2 H), 3.55 (m, 2 H), 2.95 (s, 2 H), 2.75–2.90 (m, 12 H), 2.40 (m, 2 H), 2.25 (m, 2 H), 2.05 (m, 2 H), 1.36 (s, 6 H), 0.97 (t, <i>J</i> = 7.2 Hz, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, 4 overlapping peaks due to CH group of the ω-3 fatty acid): 172.88, 132.05, 129.33, 128.58, 128.30, 128.29, 128.27, 128.21, 128.11, 128.07, 127.87, 127.01, 50.90, 49.23, 38.99, 38.49, 36.35, 29.71, 25.64, 25.54, 25.46, 23.36, 20.58, 14.32. <i>R<sub>f</sub></i> = 0.25 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 10:1). MS calcd for C<sub>28</sub>H<sub>46</sub>N<sub>2</sub>OS<sub>2</sub>: 490.31; found, 491.30 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 5-((2-((4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-Docosa-4,7,10,13,16,19-hexaenamido)ethyl)disulfaneyl)-2-nitrobenzoic Acid (<b>15</b>)</h3><div class="NLM_p last">In a typical run, (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-<i>N</i>-(2-(pyridin-2-yldisulfanyl)ethyl)docosa-4,7,10,13,16,19-hexaenamide (compound <b>9</b>, 1.0 g, 2.02 mmol) was taken up in 20 mL of MeOH/DMF (1:1) along with 5,5′-disulfanediylbis(2-nitrobenzoic acid) (Ellman’s reagent, 0.8 g, 2.02 mmol). The resulting reaction mixture was stirred at rt for 4 h. Then it was concentrated under reduced pressure and purified by preparative-HPLC using an aqueous mixture of CH<sub>3</sub>CN, buffered with 0.1% TFA, to provide 5-((2-((4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenamido)ethyl)disulfanyl)-2-nitrobenzoic acid (0.337 g, 28.6% yield) as a brown oil. This Ellman’s adduct was then used to prepare the standard curves for the quantification of the fatty acid cysteamine conjugate <b>1</b> in the various mouse, rat, and dog PK studies. This Ellman’s adduct was stable in the −80 °C freezer for approximately 2 months. After this period, a fresh batch of the Ellman’s adduct would need to be remade. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.02–8.05 (m, 2 H), 7.88–7.91 (m, 2 H), 5.28–5.36 (m, 12 H), 3.28–3.33 (m, 2 H), 2.75–2.90 (m, 12 H), 2.23–2.25 (m, 2 H), 2.00–2.11 (m, 4 H), 0.89–0.93 (t, 3 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>, 3 overlapping peaks corresponding to the CH group present in the ω-3 fatty acid portion): δ 174.52, 167.63, 145.78, 145.04, 132.17, 129.87, 129.49, 128.71, 128.52, 128.42, 128.19, 128.07, 127.99, 127.89, 127.13, 126.55, 124.78, 53.62, 38.57, 37.85, 36.27, 25.77, 25.76, 25.75, 25.68, 23.51, 20.70, 14.42. MS (ES<sup>+</sup>) calcd for C<sub>31</sub>H<sub>46</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> 584.24; found 585 [M + H]<sup>+</sup>.This basic procedure could be repeated to form the corresponding Ellman’s adduct for the thiol metabolites shown in <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Immunoblotting</h3><div class="NLM_p last">Primary CF cells (homozygous F508del-CFTR hBE, source: ChanTest, KKCFFT006F) were prepared and grown on Snapwell filter inserts as previously described. The test compounds, solubilized in FBS according to the procedure outlined above and diluted to the desired concentration, were then added to the individual Snapwell filter inserts in differentiation media at 37 °C. Twenty-four hours after the drug addition, cells were snap frozen and later lysed in RIPA buffer. The amounts of proteins were determined by Bio-Rad protein assay. An amount of 50 μg of total cell lysates was analyzed by immunoblotting with anti-beclin-1, anti-p62, and anti-LC3 antibodies. The immunoreactivity was normalized with actin as the loading control. Data were presented as beclin-1/actin, p62/actin, and LC3-II/LC3-I ratio compared to vehicle treated samples. Antibodies against LC3A/B antibodies (Cell Signaling Technology, 12741), beclin-1 (Cell Signaling Technology, 3495), p62 (Cell Signaling Technology, 5114), and β-actin (Cell Signaling Technology, 4970) were used as primary antibodies.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Determination of CFTR Band B/Band C</h3><div class="NLM_p">Materials and reagents were the following. (1) Lysis buffer (Thermo Scienfic Pierce IP lysis buffer, PI-87788). (2) Protease Inhibitors: Complete Ultra Tablets, Mini, EDTA-free (ThermoFisher Scientific 88666). (3) Sample loading buffer: NuPAGE LDS sample buffer, 4× (Life Technologies NP0007) NuPAGE reducing agent, 10× (Life Technologies NP0004). (4) Running buffer: NuPAGE Tris-acetate SDS running buffer, 20× (ThermoFisher Scientific LA0041). (5) Gel: NuPAGE 3–8% Tris-acetate gel, 1.5 mm × 15 wells (EA03785BOX). (6) Transfer system: Xcell II blot module (ThermoFisher Scientific EI0002). (7) Transfer buffer: NuPAGE transfer buffer, 20× (Life Technologies NP0006-1). (8) Blocking buffer: blotting grade blocker (Bio-Rad 170-6404, 5% in TBS containing 0.2% Tween-20). (9) PVDF: Amersham HyBond (GE Healthcare Life Sciences 10600023). (10) Chemiluminescent detection reagent: SuperSignal West Pico OR SuperSignal West Femto (ThermoFisher Scientific, 34080 and 34095, respectively).</div><div class="NLM_p">The test compounds, solubilized in FBS according to the procedure outlined below and diluted to the desired concentration, were added to primary homozygous F508del-CFTR hBE cells, grown on individual Snapwell filter inserts in differentiation media at 37 °C. Twenty-four hours after the drug addition, cells were lysed on ice, using ice-cooled buffers, as follows: (1) The growth medium was removed and cells were rinsed with 2 × 500 μL of ice cold DPBS. (2) The second wash was removed, and 150 μL of DPBS was added to each well. (3) Cells were gently removed from Snapwell inserts by directly rinsing them with DPBS. (4) Cells were collected in suspension and placed into microcentrifuge tube on ice. (5) An additional 200 μL of ice cold DPBS was added to each well, and steps 3–4 were repeated. (6) An additional 700 μL of ice cold DPBS was added to each microcentrifuge tube. (7) Tubes were centrifuged at 1000<i>g</i> for 5 min at 4 °C. (8) The supernatant was removed as much as possible without disturbing the cell pellet (some mixing of the pellet with mucus may occur). (9) Each cell pellet was gently resuspended in 30 μL of ice cold lysis buffer with protease inhibitor and incubated on ice for 20 min. (10) Samples were centrifuged at 12 500<i>g</i> for 10 min at 4 °C to pellet cellular debris. The supernatant was removed to a fresh tube.</div><div class="NLM_p">For the SDS–PAGE and electrophoretic transfer, each sample was prepared by adding the following: (a) 15 μL of the lysate; (b) 5 μL of 4× LDS sample buffer; (c) 2.5 μL of 10× reducing agent; (d) 2.5 μL of Milli-Q water (<i>Note: Samples are not to be heated before loading gel</i>). The gel and running buffer were prepared according to manufacturer’s protocol. Gel was run at 150 V constant for 1 h, and proteins were transferred to PVDF overnight at 10 V constant in Xcell II blot module.</div><div class="NLM_p">For the Western blot, the PVDF membrane was removed from transfer sandwich and placed directly into 5% blocking buffer. This was allowed to incubate for 1 h at rt with shaking. The primary antibody was prepared by adding 5 μL of UNC-596 primary antibody to 10 mL of blocking buffer (per membrane). Membranes were incubated with primary antibody overnight at 4 °C with gentle shaking. Membranes were removed from 4 °C and rinsed 3 × 10 min in TBST at rt. The secondary antibody was prepared by adding 1 μL goat anti-mouse IgG-HRP in 10 mL of blocking buffer (per membrane). Secondary antibody was applied to the membrane and incubated for 1 h at rt with shaking. Membranes were rinsed 3 × 10 min in TBST and 2 × 10 min in TBS. SuperSignal West Femto was applied to membranes and then allowed to incubate for 5 min in low light. Membranes were exposed to X-ray film at regular intervals for up to 1 h. Membrane was washed with 3 × 5 min to remove substrate. The subsequent primary antibody was prepared by adding 0.5 μL of mouse anti-Na/K-ATPase antibody in 10 mL blocking buffer. Membranes were incubated with primary antibody for 1 h at rt with shaking and then washed 3 × 10 min in TBST. SuperSignal West Pico was applied to membranes and incubated for 5 min in low light. Membranes were exposed to X-ray film at regular intervals for up to 1 h.</div><div class="NLM_p last">In order to increase sensitivity at the lower concentrations (e.g., 0.15 μM conjugate <b>1</b>), the following modified protocols were used: Cells were rinsed in DPBS two times, followed by direct lysis in IP lysis buffer (Thermo) for 20 min. Cellular debris was pelleted, and supernatants were used directly in samples without determination of protein concentration. Unheated samples were run on a 3–8% Tris-acetate gel (Life Technologies) at 150 V for 2.5 h. Separated proteins were transferred to PVDF using the Xcell blot module (Life Technologies) for 1 h at 25 V constant. After overnight transfer, blots were blocked in 5% blotting grade blocker (Bio-Rad) for 1 h at room temperature (rt) and followed by primary antibody treatment.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Hydrolysis Experiment Using FAAH-1</h3><div class="NLM_p last">FAAH-1-32-579 (the N-term transmembrane region truncated) was cloned into pFastBacI (Invitrogen) with N-terminal FLAG and C-terminal His tags and then expressed in SF9 insect cells. Compound <b>1</b> was tested in a hydrolysis experiment using this recombinant FAAH-1 at an enzyme concentration of 1 nM and substrate concentration of 25 μM.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> For the hydrolysis portion, compound <b>1</b> and enzyme were incubated for 2 h at 37 °C. For the quantification portion, the samples were analyzed on the Agilent 6410 Triple Quad LC/MS mass spectrometer using the appropriate standard curves.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Automated Equivalent Current (<i>I</i><sub>EQ</sub>) Assay for Compound Evaluation on F508del-CFTR Chloride Channel Function in Primary Cultures of CF hBE Cells</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> TECC-24 Assay Setup 1, Rosalind Franklin University: Primary Homozygous F508del-CFTR hBE Cells, Patient Code CFFT0018I or CFFT0028H</h4><div class="NLM_p">Primary CF hBE cells from patients homozygous for F508del-CFTR were grown on Costar 24-well HTS filter plates at an air liquid interface for 4–6 weeks. Cells were fed three times a week with differentiation medium and maintained in an incubator at 37 °C and 90% humidity. The mucus film was removed 3 days before the experiment by incubating the apical surface of the cells with 70 μL of differentiation medium plus 3 mM DTT for approximately 30 min followed by aspiration of the mucus and medium. The apical surface was washed again with 70 μL of PBS for 30 min 24 h before the cells were treated with test compounds. For the experiment, the test and control compounds were applied to cells as prepared dilutions of DMSO stock solutions into FBS and differentiation medium to the basolateral side only. The fatty acid cysteamine conjugates are highly lipophilic and need to be solubilized with FBS in order to obtain the optimal effect. This was done by diluting the DMSO stock solution with FBS prior to the serial dilution: 100 μL of a 25 mM DMSO stock solution of the test compound was diluted in 10.0 mL of FBS in a centrifuge tube to prepare an intermediate 250 μM intermediate dilution 10× stock (1% DMSO, 99% FBS). To prepare the 0.3 μM solution of the fatty acid conjugate in 10 mL of differentiation medium, 12 μL of the 10× stock solution was added to 9000 μL of differentiation medium and 988 μL of 1% DMSO, 99% FBS solution. Other concentrations of the test compound could be prepared by adding the appropriate volume of the 10× stock solution to the differentiation medium and 1% DMSO, 99% FBS solution. Both the vehicle and the positive control group were similarly solubilized with FBS and diluted with differentiation medium to give a final concentration of 10% FBS. Cells were incubated with either the control or test compounds for 24 h. For the chronic ivacaftor preincubation protocol, all treatment groups (vehicle, positive control, and fatty acid cysteamine conjugate-treated groups) were incubated along with 0.10 μM of ivacaftor for 24 h. For the electrophysiological measurements, the differentiation medium was changed to an experimental medium that has been supplemented with either the control or test compounds (in the same concentration used during the 24 h incubation period). HEPES-buffered Coon’s F12 medium without serum or bicarbonate was used as the experimental assay solution. The fatty acid cysteamine conjugates were solubilized in this experimental assay solution using the same FBS solubilization protocol described above (substituting the differentiation medium with the HEPES-buffered Coon’s F12 medium without serum and bicarbonate). Cells were incubated for 4 h in a CO<sub>2</sub> free incubator at 37 °C. Cells were then placed in prewarmed heating blocks at 36 <sup>o</sup> C ± 0.5 for an additional 15 min before initiating the electrophysiological measurements.</div><div class="NLM_p last">In order to obtain the <i>I</i><sub>EQ</sub>, the transepithelial voltage (<i>V</i><sub>T</sub>) and conductance (<i>G</i><sub>T</sub>) were measured under current clamp conditions using a custom designed 24-channel current clamp (TECC-24) and a 24-well electrode manifold (EP Design BVBA, Bertem, Belgium). Measurements were made at approximately 5 min intervals on a robotic workstation with custom software. Electrodes were washed after each test plate. To initiate the run, baseline <i>V</i><sub>T</sub> and <i>G</i><sub>T</sub> were measured for approximately 20 min and benzamil (3 μM final concentration) was added to the apical solution as a 25 μL volume. The apical solution was mixed gently by pipetting up and down several times. After an additional 15 min, forskolin (10 μM final concentration) was added to the apical (25 μL) and basolateral (75 μL) solutions. Forskolin, along with the potentiator ivacaftor, will maximally activate any CFTR that is expressed in the apical membrane. For the acute ivacaftor protocol, ivacaftor (0.1 μM) was added 10 min after the addition of forskolin. After an additional 27 min, bumetanide (20 μM final concentration) was added to the basolateral solution (75 μL) to terminate the run. Bumetanide inhibits the basolateral membrane Na-K-2Cl cotransporter and thereby blocks chloride secretion. For the chronic ivacaftor preincubation protocol, ivacaftor (0.10 μM) was incubated along with the test article and lumacaftor (3 μM) for 24 h. With the chronic ivacaftor preincubation protocol, only forskolin was needed to initiate the run. For the data analysis portion, the measured <i>V</i><sub>T</sub> values were corrected for the electrode offset potentials and <i>G</i><sub>T</sub> values were corrected for the series resistance (<i>R</i><sub>S</sub>) of the solution and blank filter at each time point. These corrected <i>V</i><sub>T</sub> and <i>G</i><sub>T</sub> values were used to calculate the <i>I</i><sub>EQ</sub> at each time point by using Ohm’s law where <i>I</i><sub>EQ</sub> = <i>V</i><sub>T</sub><i>G</i><sub>T</sub>. Responses to reagents (benzamil, forskolin, and bumetanide) were calculated as the change (Δ) in the <i>I</i><sub>EQ</sub> using the <i>I</i><sub>EQ</sub> values before and after the reagent addition. In addition, the peak response to forskolin and the area under the curve (AUC) were calculated. The time period included in the AUC calculation spanned the <i>I</i><sub>EQ</sub> value at the time of forskolin addition up to the <i>I</i><sub>EQ</sub> value at the time of the bumetanide addition, a duration of 27 min. A one-third trapezoid method was used to calculate the AUC. For the acute ivacaftor protocol, cells were incubated with the test compounds with lumacaftor in differentiation medium for 24 h at 37 °C. The next day, the medium was replaced with HEPES-buffered Coon’s F12 medium, with the test compounds added back. The plate was incubated for 30 min in a CO<sub>2</sub> free incubator before the sequential addition of forskolin and ivacaftor. With this set up, the <i>I</i><sub>EQ</sub> was recorded over a 45 min period.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> TECC-24 Assay Setup 2, Charles River Laboratories, Cleveland, OH: Primary Homozygous F508del-CFTR hBE Cells, Patient Code KKCFFT006F, KKCFFT004I, or KKCFFT0012I</h4><div class="NLM_p">The chloride transport function of primary homozygous F508-del-CFTR hBE monolayers grown on Corning HTS Transwell-24 filter inserts (permeable support) can be monitored as the CFTR agonist evoked equivalent current (<i>I</i><sub>EQ</sub>) calculated from the output of a TECC-24 current clamp system as described above.</div><div class="NLM_p last">Primary homozygous F508del-CFTR hBE cells were prepared and grown on Corning HTS Transwell-24 filter inserts according to established procedures. Primary CF cells were kept in differentiation medium. Prior to the assay, the mucus film was removed by adding 100 μL of the blank medium to the apical side of the filter inserts. This was allowed to stand for 30–60 min and then removed prior to the incubation with the test articles. For the assay, the fatty acid cysteamine conjugates were solubilized in FBS prior to the serial dilution in differentiation medium in the same manner as described above. With the chronic ivacaftor preincubation protocol, cells were incubated in differentiation medium for 24 h in a CO<sub>2</sub> free incubator at 37 °C with the indicated treatment groups. For the <i>I</i><sub>EQ</sub> measurements, the differentiation medium was first replaced with HEPES buffered Coon’s F12 medium (without serum or bicarbonate) with the test compounds added back to this new medium (in the same concentration used during the 24 h incubation period and with the prior solubilization in FBS before the serial dilution with Coon’s F-12 medium). The plate was then allowed to incubate at 37 °C for 4 h (CO<sub>2</sub> free incubator) prior to the <i>I</i><sub>EQ</sub> measurements at ∼35 °C. To initiate the run, benzamil (10 μM) was added to the apical side of the Transwell-24 filter inserts to block any currents deriving from ENaC. Ten minutes later, forskolin (10 μM) was added and the <i>I</i><sub>EQ</sub> was then recorded over a 60 min period, with measurements made at approximately 5 min intervals on a robotic workstation using custom software. The antagonist CFTR<sub>inh</sub>-172 (20 μM) was then added to inhibit the CFTR chloride current. With the acute ivacaftor protocol, cells were incubated with the indicated treatment groups in differentiation medium for 24 h in a CO<sub>2</sub> free incubator at 37 °C. The differentiation medium was then first replaced with HEPES buffered Coon’s F12 medium (without serum or bicarbonate) with the test compounds added back to this new medium. The plate was allowed to incubate at 37 °C for 30 min in a CO<sub>2</sub> free incubator. Forskolin and ivacaftor were added simultaneously, and the <i>I</i><sub>EQ</sub> was recorded over a 60 min period. Data analyses were performed using Microsoft Excel software. Comparison of agonist evoked <i>I</i><sub>EQ</sub> among both the corrector positive control, negative control and test compound-treated epithelia was obtained with one-way ANOVA followed by Dunnett’s multiple comparison test and/or Student’s <i>t</i>-test when appropriate. Significant correction was defined at the level of <i>p</i> < 0.05.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Plasma Stability Studies</h3><div class="NLM_p last">The in vitro stability of compound <b>5</b> was studied in human, mouse, beagle, and rat plasma using detailed protocols that have been previously been described.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Rat PK Study</h3><div class="NLM_p last">The fatty acid cysteamine conjugate <b>5</b> was solubilized in a mixture of excipients consisting of 40% Tween, 50% Peceol (glyceryl monoleate type 40), 10% PEG400 and diluted with water to form a self-emulsifying aqueous mixture for oral administration to animals.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> For this study, Sprague Dawley rats that had been surgically implanted with indwelling jugular vein cannulae (JVC) were used (Agilux, Worcester, MA). Serial blood collection was carried out at the following time points: 0.125, 0.25, 0.5, 1, 2, 4, 5, 8, and 12 h postdose. The bioanalytical portion of the PK study was carried out using an LC/MS/MS system (Agilent model: HPLC, 1200; MS, 6410) and analyzed with the appropriate software (WinNonlin Phoenix 64 6.3.0 395). The various thiol metabolites were quantitated by using the corresponding Ellman’s adduct to prepare the standard curves.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01539">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01539" class="ext-link">10.1021/acs.jmedchem.6b01539</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Autophagy activation, details of runs depicted in <a class="ref internalNav" href="#fig7" aria-label="Figures 7">Figures 7</a>–<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a> and <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>, effect of FBS on chloride current, and evaluations of compounds <b>1</b> and <b>5</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf">jm6b01539_si_001.pdf (1.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_002.csv">jm6b01539_si_002.csv (0.31 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01539" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chi B. Vu</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6516-8846" title="Orcid link">http://orcid.org/0000-0002-6516-8846</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ec8f9a99ac8f8d988d8e8d9f859fc28f8381"><span class="__cf_email__" data-cfemail="3d5e4b487d5e5c495c5f5c4e544e135e5250">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. Bridges</span> - <span class="hlFld-Affiliation affiliation">Chicago
Medical School, Rosalind Franklin University
of Medicine and Science, 3333 Green Bay Road, North Chicago, Illinois 60064, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cecilia Pena-Rasgado</span> - <span class="hlFld-Affiliation affiliation">Chicago
Medical School, Rosalind Franklin University
of Medicine and Science, 3333 Green Bay Road, North Chicago, Illinois 60064, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio E. Lacerda</span> - <span class="hlFld-Affiliation affiliation">Charles River Laboratories, 14656 Neo Parkway, Cleveland, Ohio 44128, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Curtis Bordwell</span> - <span class="hlFld-Affiliation affiliation">Charles River Laboratories, 14656 Neo Parkway, Cleveland, Ohio 44128, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abby Sewell</span> - <span class="hlFld-Affiliation affiliation">Charles River Laboratories, 14656 Neo Parkway, Cleveland, Ohio 44128, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Nichols</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sachin Chandran</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pallavi Lonkar</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dominic Picarella</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amal Ting</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allison Wensley</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maisy Yeager</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Liu</span> - <span class="hlFld-Affiliation affiliation">Catabasis Pharmaceuticals, One Kendall Square, Suite B14202, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d89e2520-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Martin Mense from the Cystic Fibrosis Foundation Therapeutics for helpful discussions and guidance. We also thank Steven Freedman, Michael Jirousek, and David Carney for additional input. Primary CF cells were provided by University of North Carolina, Chapel Hill (Grant CFF BOUCHE15R0).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i27" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i27"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> Abbreviations Used</h2><tr><td class="NLM_term">CF</td><td class="NLM_def"><p class="first last">cystic fibrosis</p></td></tr><tr><td class="NLM_term">CFTR</td><td class="NLM_def"><p class="first last">cystic fibrosis transmembrane conductance regulatory protein</p></td></tr><tr><td class="NLM_term">ENaC</td><td class="NLM_def"><p class="first last">epithelial sodium channel</p></td></tr><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">hBE</td><td class="NLM_def"><p class="first last">human bronchial epithelial</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SED</td><td class="NLM_def"><p class="first last">self-emulsifying dispersion</p></td></tr><tr><td class="NLM_term">TG2</td><td class="NLM_def"><p class="first last">transglutaminase 2</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Drug Discovery: Predicting Promiscuity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1038/462167a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2F462167a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=19907483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSjsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=167-168&author=A.+L.+Hopkins&title=Drug+Discovery%3A+Predicting+Promiscuity&doi=10.1038%2F462167a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery: Predicting promiscuity</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7270</span>),
    <span class="NLM_cas:pages">167-168</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Computational methods that reliably predict the biol. activities of compds. have long been sought.  The validation of one such method suggests that in silico predictions for drug discovery have come of age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQeKOdE7MUxLVg90H21EOLACvtfcHk0liX4y-nPUi5Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSjsrnI&md5=d7a2f49900632ba698ed3790f3b3c4d5</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2F462167a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F462167a%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DDrug%2520Discovery%253A%2520Predicting%2520Promiscuity%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D167%26epage%3D168%26doi%3D10.1038%2F462167a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Network Pharmacology: The Next Paradigm in Drug Discovery</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span><span class="refDoi"> DOI: 10.1038/nchembio.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fnchembio.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=18936753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=682-690&author=A.+L.+Hopkins&title=Network+Pharmacology%3A+The+Next+Paradigm+in+Drug+Discovery&doi=10.1038%2Fnchembio.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology: the next paradigm in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">682-690</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The dominant paradigm in drug discovery is the concept of designing maximally selective ligands to act on individual drug targets.  However, many effective drugs act via modulation of multiple proteins rather than single targets.  Advances in systems biol. are revealing a phenotypic robustness and a network structure that strongly suggests that exquisitely selective compds., compared with multi-target drugs, may exhibit lower than desired clin. efficacy.  This new appreciation of the role of polypharmacol. has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity.  Integrating network biol. and polypharmacol. holds the promise of expanding the current opportunity space for druggable targets.  However, the rational design of polypharmacol. faces considerable challenges in the need for new methods to validate target combinations and optimize multiple structure-activity relationships while maintaining drug-like properties.  Advances in these areas are creating the foundation of the next paradigm in drug discovery: network pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqHy4FqkK-h7Vg90H21EOLACvtfcHk0liX4y-nPUi5Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK&md5=03b8be3ddbcab7dc65afd17df7ee8395</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.118%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DNetwork%2520Pharmacology%253A%2520The%2520Next%2520Paradigm%2520in%2520Drug%2520Discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D682%26epage%3D690%26doi%3D10.1038%2Fnchembio.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zimmermann, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, C. T.</span><span> </span><span class="NLM_article-title">Multi-target Therapeutics: When the Whole is Greater than the Sum of the Parts</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1016/j.drudis.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leharauthor=C.+T.+Keith&title=Multi-target+Therapeutics%3A+When+the+Whole+is+Greater+than+the+Sum+of+the+Parts&doi=10.1016%2Fj.drudis.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2eZNagKL9aSz6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520Therapeutics%253A%2520When%2520the%2520Whole%2520is%2520Greater%2520than%2520the%2520Sum%2520of%2520the%2520Parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42%26doi%3D10.1016%2Fj.drudis.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span> </span><span class="NLM_article-title">Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5906</span><span class="NLM_x">–</span> <span class="NLM_lpage">5914</span><span class="refDoi"> DOI: 10.1021/jm100293f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100293f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5906-5914&author=C.+Melchiorreauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiatti&title=Polyamines+in+Drug+Discovery%3A+From+the+Universal+Template+Approach+to+the+Multitarget-Directed+Ligand+Design+Strategy&doi=10.1021%2Fjm100293f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1021%2Fjm100293f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100293f%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26atitle%3DPolyamines%2520in%2520Drug%2520Discovery%253A%2520From%2520the%2520Universal%2520Template%2520Approach%2520to%2520the%2520Multitarget-Directed%2520Ligand%2520Design%2520Strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5906%26epage%3D5914%26doi%3D10.1021%2Fjm100293f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Peters, J.-U.</span><span> </span><span class="NLM_article-title">Polypharmacology-Foe or Friend?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8955</span><span class="NLM_x">–</span> <span class="NLM_lpage">8971</span><span class="refDoi"> DOI: 10.1021/jm400856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8955-8971&author=J.-U.+Peters&title=Polypharmacology-Foe+or+Friend%3F&doi=10.1021%2Fjm400856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology - Foe or Friend?</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8955-8971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Polypharmacol. describes the activity of compds. at multiple targets.  Current research focuses on two aspects of polypharmacol.: (1) unintended polypharmacol. can lead to adverse effects; (2) polypharmacol. across several disease-relevant targets can improve therapeutic efficacy, prevent drug resistance, or reduce therapeutic-target-related adverse effects.  This perspective reviews these interconnected aspects of polypharmacol.  The first part discusses the relevance of polypharmacol. for the safety of drugs, the mitigation of safety risks, and methods to identify polypharmacol. compds. early in the drug discovery process.  The second part discusses the advantages of polypharmacol. in the treatment of multigenic diseases and infections, and opportunities for drug discovery and drug repurposing.  This perspective aims to provide a balanced view on polypharmacol., which can compromise the safety of drugs, but can also confer superior efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5vnFGPfTnGLVg90H21EOLACvtfcHk0ljLeMuDQqJvvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO&md5=f4aeb6efddd4bfdf4e94656303323cba</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400856t%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3DPolypharmacology-Foe%2520or%2520Friend%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8955%26epage%3D8971%26doi%3D10.1021%2Fjm400856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Azmi, A. S.</span><span> </span><span class="NLM_article-title">Network Pharmacology for Cancer Drug Discovery: Are We There Yet?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.4155/fmc.12.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4155%2Ffmc.12.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=22650234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVOrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=939-941&author=A.+S.+Azmi&title=Network+Pharmacology+for+Cancer+Drug+Discovery%3A+Are+We+There+Yet%3F&doi=10.4155%2Ffmc.12.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology for cancer drug discovery: are we there yet?</span></div><div class="casAuthors">Azmi, Asfar S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">939-941</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The emergence of network biol. has improved the knowledge of multi-pathway interactions in cancer and helped to make sense of drug-response signature datasets that collectively decode the complex mechanisms of drug action.  Network pharmacol. showed that promiscuity often engages a synergistic combination of appropriate high-value targets in cancer cells to develop treatment success.  In general, it holds promise to revolutionize the approach towards next-generation cancer drug design and development.  Thus, it certainly has the potential to modify the view of drug design and understanding mechanisms of action and, if used correctly, is predicted to significantly de-risk cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-nEGlIwnic7Vg90H21EOLACvtfcHk0ljLeMuDQqJvvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVOrsrc%253D&md5=b545e162e850a4ada587a447bf9b82b6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.44%26sid%3Dliteratum%253Aachs%26aulast%3DAzmi%26aufirst%3DA.%2BS.%26atitle%3DNetwork%2520Pharmacology%2520for%2520Cancer%2520Drug%2520Discovery%253A%2520Are%2520We%2520There%2520Yet%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D939%26epage%3D941%26doi%3D10.4155%2Ffmc.12.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bista, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ting, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wensley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirousek, M. R.</span><span> </span><span class="NLM_article-title">Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC28XptlKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1217-1231&author=C.+B.+Vuauthor=J.+E.+Bemisauthor=E.+Bensonauthor=P.+Bistaauthor=D.+Carneyauthor=R.+Fahrnerauthor=D.+Leeauthor=F.+Liuauthor=P.+Lonkarauthor=J.+C.+Milneauthor=A.+J.+Nicholsauthor=D.+Picarellaauthor=A.+Shoelsonauthor=J.+Smithauthor=A.+Tingauthor=A.+Wensleyauthor=M.+Yeagerauthor=M.+Zimmerauthor=M.+R.+Jirousek&title=Synthesis+and+Characterization+of+Fatty+Acid+Conjugates+of+Niacin+and+Salicylic+Acid&doi=10.1021%2Facs.jmedchem.5b01961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid</span></div><div class="casAuthors">Vu, Chi B.; Bemis, Jean E.; Benson, Ericka; Bista, Pradeep; Carney, David; Fahrner, Richard; Lee, Diana; Liu, Feng; Lonkar, Pallavi; Milne, Jill C.; Nichols, Andrew J.; Picarella, Dominic; Shoelson, Adam; Smith, Jesse; Ting, Amal; Wensley, Allison; Yeager, Maisy; Zimmer, Michael; Jirousek, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1217-1231</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes the synthesis and preliminary biol. characterization of novel fatty acid niacin conjugates and fatty acid salicylate conjugates.  These mol. entities were created by covalently linking two bioactive mols., either niacin or salicylic acid, to an omega-3 fatty acid.  This methodol. allows the simultaneous intracellular delivery of two bioactives in order to elicit a pharmacol. response that could not be replicated by administering the bioactives individually or in combination.  The fatty acid niacin conjugate 5 has been shown to be an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metab. proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1.  On the other hand, the fatty acid salicylate conjugate 11 has been shown to have a unique anti-inflammatory profile based on its ability to modulate the NF-κB pathway through the intracellular release of the two bioactives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2DZ5fMPvPNLVg90H21EOLACvtfcHk0lgMqOOE_L7djg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptlKhuw%253D%253D&md5=937f6757357d8bef388b49f153ffa0a7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01961%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBenson%26aufirst%3DE.%26aulast%3DBista%26aufirst%3DP.%26aulast%3DCarney%26aufirst%3DD.%26aulast%3DFahrner%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DLonkar%26aufirst%3DP.%26aulast%3DMilne%26aufirst%3DJ.%2BC.%26aulast%3DNichols%26aufirst%3DA.%2BJ.%26aulast%3DPicarella%26aufirst%3DD.%26aulast%3DShoelson%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DTing%26aufirst%3DA.%26aulast%3DWensley%26aufirst%3DA.%26aulast%3DYeager%26aufirst%3DM.%26aulast%3DZimmer%26aufirst%3DM.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Fatty%2520Acid%2520Conjugates%2520of%2520Niacin%2520and%2520Salicylic%2520Acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1217%26epage%3D1231%26doi%3D10.1021%2Facs.jmedchem.5b01961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mizushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, M.</span><span> </span><span class="NLM_article-title">Autophagy: Renovation of Cells and Tissues</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span><span class="refDoi"> DOI: 10.1016/j.cell.2011.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1016%2Fj.cell.2011.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=22078875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKgsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=728-741&author=N.+Mizushimaauthor=M.+Komatsu&title=Autophagy%3A+Renovation+of+Cells+and+Tissues&doi=10.1016%2Fj.cell.2011.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: Renovation of Cells and Tissues</span></div><div class="casAuthors">Mizushima, Noboru; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">728-741</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Autophagy is the major intracellular degrdn. system by which cytoplasmic materials are delivered to and degraded in the lysosome.  However, the purpose of autophagy is not the simple elimination of materials, but instead, autophagy serves as a dynamic recycling system that produces new building blocks and energy for cellular renovation and homeostasis.  Here we provide a multidisciplinary review of our current understanding of autophagy's role in metabolic adaptation, intracellular quality control, and renovation during development and differentiation.  We also explore how recent mouse models in combination with advances in human genetics are providing key insights into how the impairment or activation of autophagy contributes to pathogenesis of diverse diseases, from neurodegenerative diseases such as Parkinson disease to inflammatory disorders such as Crohn disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphHJHJXZsr6bVg90H21EOLACvtfcHk0lgMqOOE_L7djg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKgsLnN&md5=c749750db767f05549db0b22ec5068c7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DAutophagy%253A%2520Renovation%2520of%2520Cells%2520and%2520Tissues%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D728%26epage%3D741%26doi%3D10.1016%2Fj.cell.2011.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><div class="note"><p class="first last">For a review, see the following:</p></div><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorscher, E. J.</span><span> </span><span class="NLM_article-title">Mechanisms of Disease: Cystic Fibrosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1992</span><span class="NLM_x">–</span> <span class="NLM_lpage">2001</span><span class="refDoi"> DOI: 10.1056/NEJMra043184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1056%2FNEJMra043184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=15888700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFyrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1992-2001&author=S.+M.+Roweauthor=S.+Millerauthor=E.+J.+Sorscher&title=Mechanisms+of+Disease%3A+Cystic+Fibrosis&doi=10.1056%2FNEJMra043184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cystic fibrosis</span></div><div class="casAuthors">Rowe, Steven M.; Miller, Stacey; Sorscher, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1992-2001</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Important advances have improved our understanding of the role of the CFTR protein in the progression of suppurative pulmonary failure in cystic fibrosis.  These discoveries are ushering in a new era of translational research that incorporates specific therapeutic targets and new cellular pathways.  Progress in research on cystic fibrosis will continue to rely on an improved understanding of CFTR function and its relationship to mucociliary clearance, airway secretion, and other ion channels.  Clin. advances directed at the correction of CFTR function predict an optimistic future for patients with cystic fibrosis and their families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKiiafli4tp7Vg90H21EOLACvtfcHk0lgMqOOE_L7djg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFyrtLY%253D&md5=e6bc05b49d7b177d43dd7592ad63f0fb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMra043184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra043184%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DSorscher%26aufirst%3DE.%2BJ.%26atitle%3DMechanisms%2520of%2520Disease%253A%2520Cystic%2520Fibrosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1992%26epage%3D2001%26doi%3D10.1056%2FNEJMra043184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCartney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wine, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frizzell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashlock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P. A.</span><span> </span><span class="NLM_article-title">Correction of the F508del-CFTR Protein Processing Defect In Vitro by the Investigational Drug lumacaftor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">18843</span><span class="NLM_x">–</span> <span class="NLM_lpage">18848</span><span class="refDoi"> DOI: 10.1073/pnas.1105787108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1073%2Fpnas.1105787108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18843-18848&author=F.+Van+Goorauthor=S.+Hadidaauthor=P.+D.+Grootenhuisauthor=B.+Burtonauthor=J.+H.+Stackauthor=K.+S.+Straleyauthor=C.+J.+Deckerauthor=M.+Millerauthor=J.+McCartneyauthor=E.+R.+Olsonauthor=J.+J.+Wineauthor=R.+A.+Frizzellauthor=M.+Ashlockauthor=P.+A.+Negulescu&title=Correction+of+the+F508del-CFTR+Protein+Processing+Defect+In+Vitro+by+the+Investigational+Drug+lumacaftor&doi=10.1073%2Fpnas.1105787108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1105787108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1105787108%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DStack%26aufirst%3DJ.%2BH.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DMcCartney%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DE.%2BR.%26aulast%3DWine%26aufirst%3DJ.%2BJ.%26aulast%3DFrizzell%26aufirst%3DR.%2BA.%26aulast%3DAshlock%26aufirst%3DM.%26aulast%3DNegulescu%26aufirst%3DP.%2BA.%26atitle%3DCorrection%2520of%2520the%2520F508del-CFTR%2520Protein%2520Processing%2520Defect%2520In%2520Vitro%2520by%2520the%2520Investigational%2520Drug%2520lumacaftor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D18843%26epage%3D18848%26doi%3D10.1073%2Fpnas.1105787108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCartney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazlewood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span> </span><span class="NLM_article-title">Discovery of <i>N-</i>(2,4-Di-<i>tert</i>-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9776</span><span class="NLM_x">–</span> <span class="NLM_lpage">9795</span><span class="refDoi"> DOI: 10.1021/jm5012808</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012808" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9776-9795&author=S.+Hadidaauthor=F.+Van+Goorauthor=J.+Zhouauthor=V.+Arumugamauthor=J.+McCartneyauthor=A.+Hazlewoodauthor=C.+Deckerauthor=P.+Negulescuauthor=P.+D.+J.+Grootenhuis&title=Discovery+of+N-%282%2C4-Di-tert-butyl-5-hydroxyphenyl%29-4-oxo-1%2C4-dihydroquinoline-3-carboxamide+%28VX-770%2C+Ivacaftor%29%2C+a+Potent+and+Orally+Bioavailable+CFTR+Potentiator&doi=10.1021%2Fjm5012808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator</span></div><div class="casAuthors">Hadida, Sabine; Van Goor, Fredrick; Zhou, Jinglan; Arumugam, Vijayalaksmi; McCartney, Jason; Hazlewood, Anna; Decker, Caroline; Negulescu, Paul; Grootenhuis, Peter D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9776-9795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation.  Extensive medicinal chem. and iterative structure-activity relationship (SAR) studies to evaluate potency, selectivity, and pharmacokinetic properties resulted in the identification of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, 48, ivacaftor), an investigational drug candidate approved by the FDA for the treatment of CF patients 6 years of age and older carrying the G551D mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCmDwR5g0hbVg90H21EOLACvtfcHk0liWbfDR1xsWOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsb%252FO&md5=c4ed161be3b5d7752e7591d2c4847637</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm5012808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012808%26sid%3Dliteratum%253Aachs%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DArumugam%26aufirst%3DV.%26aulast%3DMcCartney%26aufirst%3DJ.%26aulast%3DHazlewood%26aufirst%3DA.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DNegulescu%26aufirst%3DP.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26atitle%3DDiscovery%2520of%2520N-%25282%252C4-Di-tert-butyl-5-hydroxyphenyl%2529-4-oxo-1%252C4-dihydroquinoline-3-carboxamide%2520%2528VX-770%252C%2520Ivacaftor%2529%252C%2520a%2520Potent%2520and%2520Orally%2520Bioavailable%2520CFTR%2520Potentiator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9776%26epage%3D9795%26doi%3D10.1021%2Fjm5012808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wainwright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elborn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marigowda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Boeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flume, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstan, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKone, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratjen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. P.</span><span> </span><span class="NLM_article-title">Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del <i>CFTR</i>. <i>N. Eng</i></span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="refDoi"> DOI: 10.1056/NEJMoa1409547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1056%2FNEJMoa1409547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=25981758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKrtbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=220&author=C.+E.+Wainwrightauthor=J.+S.+Elbornauthor=B.+W.+Ramseyauthor=G.+Marigowdaauthor=X.+Huangauthor=M.+Cipolliauthor=C.+Colomboauthor=J.+C.+Daviesauthor=K.+De+Boeckauthor=P.+A.+Flumeauthor=M.+W.+Konstanauthor=S.+A.+McColleyauthor=K.+McCoyauthor=E.+F.+McKoneauthor=A.+Munckauthor=F.+Ratjenauthor=S.+M.+Roweauthor=D.+Waltzauthor=M.+P.+Boyle&title=Lumacaftor-Ivacaftor+in+Patients+with+Cystic+Fibrosis+Homozygous+for+Phe508del+CFTR.+N.+Eng&doi=10.1056%2FNEJMoa1409547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR</span></div><div class="casAuthors">Wainwright, C. E.; Elborn, J. S.; Ramsey, B. W.; Marigowda, G.; Huang, X.; Cipolli, M.; Colombo, C.; Davies, J. C.; De Boeck, K.; Flume, P. A.; Konstan, M. W.; McColley, S. A.; McCoy, K.; McKone, E. F.; Munck, A.; Ratjen, F.; Rowe, S. M.; Waltz, D.; Boyle, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-231</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Cystic fibrosis is a life-limiting disease that is caused by defective or deficient cystic fibrosis transmembrane conductance regulator (CFTR) protein activity.  Phe508del is the most common CFTR mutation.  We conducted two phase 3, randomized, double-blind, placebo-controlled studies that were designed to assess the effects of lumacaftor (VX-809), a CFTR corrector, in combination with ivacaftor (VX-770), a CFTR potentiator, in patients 12 years of age or older who had cystic fibrosis and were homozygous for the Phe508del CFTR mutation.  In both studies, patients were randomly assigned to receive either lumacaftor (600 mg once daily or 400 mg every 12 h) in combination with ivacaftor (250 mg every 12 h) or matched placebo for 24 wk.  The primary end point was the abs. change from baseline in the percentage of predicted forced expiratory vol. in 1 s (FEV1) at week 24.  A total of 1108 patients underwent randomization and received study drug.  The mean baseline FEV1 was 61% of the predicted value.  In both studies, there were significant improvements in the primary end point in both lumacaftor-ivacaftor dose groups; the difference between active treatment and placebo with respect to the mean abs. improvement in the percentage of predicted FEV1 ranged from 2.6 to 4.0 percentage points (P<0.001), which corresponded to a mean relative treatment difference of 4.3 to 6.7% (P<0.001).  Pooled analyses showed that the rate of pulmonary exacerbations was 30 to 39% lower in the lumacaftor-ivacaftor groups than in the placebo group; the rate of events leading to hospitalization or the use of i.v. antibiotics was lower in the lumacaftor-ivacaftor groups as well.  The incidence of adverse events was generally similar in the lumacaftor-ivacaftor and placebo groups.  The rate of discontinuation due to an adverse event was 4.2% among patients who received lumacaftor-ivacaftor vs. 1.6% among those who received placebo.  These data show that lumacaftor in combination with ivacaftor provided a benefit for patients with cystic fibrosis homozygous for the Phe508del CFTR mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZ6NBA6wsbbVg90H21EOLACvtfcHk0liWbfDR1xsWOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKrtbzJ&md5=223bb13c5c677a4db798be91ccedc665</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1409547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1409547%26sid%3Dliteratum%253Aachs%26aulast%3DWainwright%26aufirst%3DC.%2BE.%26aulast%3DElborn%26aufirst%3DJ.%2BS.%26aulast%3DRamsey%26aufirst%3DB.%2BW.%26aulast%3DMarigowda%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCipolli%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DJ.%2BC.%26aulast%3DDe%2BBoeck%26aufirst%3DK.%26aulast%3DFlume%26aufirst%3DP.%2BA.%26aulast%3DKonstan%26aufirst%3DM.%2BW.%26aulast%3DMcColley%26aufirst%3DS.%2BA.%26aulast%3DMcCoy%26aufirst%3DK.%26aulast%3DMcKone%26aufirst%3DE.%2BF.%26aulast%3DMunck%26aufirst%3DA.%26aulast%3DRatjen%26aufirst%3DF.%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DWaltz%26aufirst%3DD.%26aulast%3DBoyle%26aufirst%3DM.%2BP.%26atitle%3DLumacaftor-Ivacaftor%2520in%2520Patients%2520with%2520Cystic%2520Fibrosis%2520Homozygous%2520for%2520Phe508del%2520CFTR.%2520N.%2520Eng%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D220%26doi%3D10.1056%2FNEJMoa1409547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ruah, S. S. H.; Grootenhuis, P. D. J.; Van Goor, F.; Zhou, J.; Bear, B.; Miller, M. T.; McCartney, J.; Numa, M. M. D.</span><span> </span><span class="NLM_article-title">Indolyl Cycloalkylcarboxamide Compounds as Modulators of ATP-Binding Cassette Transporters and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases</span>. US 7645789,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+S.+H.+Ruah&author=P.+D.+J.+Grootenhuis&author=F.+Van+Goor&author=J.+Zhou&author=B.+Bear&author=M.+T.+Miller&author=J.+McCartney&author=M.+M.+D.+Numa&title=Indolyl+Cycloalkylcarboxamide+Compounds+as+Modulators+of+ATP-Binding+Cassette+Transporters+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRuah%26aufirst%3DS.%2BS.%2BH.%26atitle%3DIndolyl%2520Cycloalkylcarboxamide%2520Compounds%2520as%2520Modulators%2520of%2520ATP-Binding%2520Cassette%2520Transporters%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Der Plas, S. E.; Mammoliti, O.; Menet, C.; Tricarico, G.; De Blieck, A.; Joanesse, C.; De Munck, T.; Kelgtermans, H.</span><span> </span><span class="NLM_article-title">Preparation of 5-Sulfonylthiophene-3-carboxamide Compounds and Pharmaceutical Compositions Thereof for the Treatment of Cystic Fibrosis</span>. US 20150005275,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+E.+Van+Der+Plas&author=O.+Mammoliti&author=C.+Menet&author=G.+Tricarico&author=A.+De+Blieck&author=C.+Joanesse&author=T.+De+Munck&author=H.+Kelgtermans&title=Preparation+of+5-Sulfonylthiophene-3-carboxamide+Compounds+and+Pharmaceutical+Compositions+Thereof+for+the+Treatment+of+Cystic+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BPlas%26aufirst%3DS.%2BE.%26atitle%3DPreparation%2520of%25205-Sulfonylthiophene-3-carboxamide%2520Compounds%2520and%2520Pharmaceutical%2520Compositions%2520Thereof%2520for%2520the%2520Treatment%2520of%2520Cystic%2520Fibrosis%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Van Der Plas, S. E.; Martina, S. L. X.; Dropsit-Montovert, S. J.-J. C.; Andrews, M. J. I.; Kelgtermans, H.</span><span> </span><span class="NLM_article-title">Thieno[2,3-c]pyrans as CFTR Modulators</span>. US 20150045327,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+E.+Van+Der+Plas&author=S.+L.+X.+Martina&author=S.+J.-J.+C.+Dropsit-Montovert&author=M.+J.+I.+Andrews&author=H.+Kelgtermans&title=Thieno%5B2%2C3-c%5Dpyrans+as+CFTR+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BPlas%26aufirst%3DS.%2BE.%26atitle%3DThieno%255B2%252C3-c%255Dpyrans%2520as%2520CFTR%2520Modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Miller, M. T.; Anderson, C.; Arumugam, V.; Bear, B. R.; Binch, H. M.; Clemens, J.; Cleveland, T.; Conroy, E.; Coon, T. R.; Frieman, B.A.; Grootenhuis, P. D. J.; Gross, R. S.; Hadida-Ruah, S. S.; Haripada, K.; Joshi, P. V.; Krenitsky, P. J.; Lin, C.-C.; Marelius, G. E.; Melilo, V.; McCartney, J.; Nicholls, G. M.; Pierre, F. J. D.; Silina, A.; Termin, A. P.; Uly, J.; Zhou, J.</span><span> </span><span class="NLM_article-title">Preparation of N-Aroylsulfonamide Derivatives as Cystic Fibrosis Transmembrane Conductance Regulator Modulators</span>. WO 2016057572,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+T.+Miller&author=C.+Anderson&author=V.+Arumugam&author=B.+R.+Bear&author=H.+M.+Binch&author=J.+Clemens&author=T.+Cleveland&author=E.+Conroy&author=T.+R.+Coon&author=B.A.+Frieman&author=P.+D.+J.+Grootenhuis&author=R.+S.+Gross&author=S.+S.+Hadida-Ruah&author=K.+Haripada&author=P.+V.+Joshi&author=P.+J.+Krenitsky&author=C.-C.+Lin&author=G.+E.+Marelius&author=V.+Melilo&author=J.+McCartney&author=G.+M.+Nicholls&author=F.+J.+D.+Pierre&author=A.+Silina&author=A.+P.+Termin&author=J.+Uly&author=J.+Zhou&title=Preparation+of+N-Aroylsulfonamide+Derivatives+as+Cystic+Fibrosis+Transmembrane+Conductance+Regulator+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BT.%26atitle%3DPreparation%2520of%2520N-Aroylsulfonamide%2520Derivatives%2520as%2520Cystic%2520Fibrosis%2520Transmembrane%2520Conductance%2520Regulator%2520Modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tait, B.; Cullen, M.</span><span> </span><span class="NLM_article-title">Methods of Modulating CFTR Activity</span>. WO 2014210159 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Tait&author=M.+Cullen&title=Methods+of+Modulating+CFTR+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTait%26aufirst%3DB.%26atitle%3DMethods%2520of%2520Modulating%2520CFTR%2520Activity%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bastos, C. M.; Munoz, B.; Tait, B.</span><span> </span><span class="NLM_article-title">Compounds, Compositions, and Methods for Increasing CFTR Activity</span>. WO 2015138934 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+M.+Bastos&author=B.+Munoz&author=B.+Tait&title=Compounds%2C+Compositions%2C+and+Methods+for+Increasing+CFTR+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBastos%26aufirst%3DC.%2BM.%26atitle%3DCompounds%252C%2520Compositions%252C%2520and%2520Methods%2520for%2520Increasing%2520CFTR%2520Activity%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bastos, C. M.; Tait, B.; Munoz, B.</span><span> </span><span class="NLM_article-title">Compounds, Compositions, and Methods of Increasing CFTR Activity</span>. WO 2015196071 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+M.+Bastos&author=B.+Tait&author=B.+Munoz&title=Compounds%2C+Compositions%2C+and+Methods+of+Increasing+CFTR+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBastos%26aufirst%3DC.%2BM.%26atitle%3DCompounds%252C%2520Compositions%252C%2520and%2520Methods%2520of%2520Increasing%2520CFTR%2520Activity%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><div class="note"><p class="first last">For a review on autophagy see the following:</p></div><span class="NLM_contrib-group">Levine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Autophagy in the Pathogenesis of Disease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1016%2Fj.cell.2007.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=18191218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFehtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2008&pages=27-42&author=B.+Levineauthor=G.+Kroemer&title=Autophagy+in+the+Pathogenesis+of+Disease&doi=10.1016%2Fj.cell.2007.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy in the pathogenesis of disease</span></div><div class="casAuthors">Levine, Beth; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The role of mTOR kinase-related multiple pathways as regulators of autophagy in diseases is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJaHO5xPdGbVg90H21EOLACvtfcHk0lgl0gfZ85ifdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFehtb8%253D&md5=330b3696429911990b51385919e2bd39</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DAutophagy%2520in%2520the%2520Pathogenesis%2520of%2520Disease%26jtitle%3DCell%26date%3D2008%26volume%3D132%26spage%3D27%26epage%3D42%26doi%3D10.1016%2Fj.cell.2007.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Luciani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villella, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettoello-Mantovani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnuccio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Matteis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, L.</span><span> </span><span class="NLM_article-title">Targeting Autophagy as a Novel Strategy for Facilitating the Therapeutic Action of Potentiators on ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1657</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span><span class="refDoi"> DOI: 10.4161/auto.21483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.21483" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=1657-1672&author=A.+Lucianiauthor=V.+R.+Villellaauthor=S.+Espositoauthor=M.+Gavinaauthor=I.+Russoauthor=M.+Silanoauthor=S.+Guidoauthor=M.+Pettoello-Mantovaniauthor=R.+Carnuccioauthor=B.+Scholteauthor=A.+De+Matteisauthor=M.+C.+Maiuriauthor=V.+Raiaauthor=A.+Luiniauthor=G.+Kroemerauthor=L.+Maiuri&title=Targeting+Autophagy+as+a+Novel+Strategy+for+Facilitating+the+Therapeutic+Action+of+Potentiators+on+%CE%94F508+Cystic+Fibrosis+Transmembrane+Conductance+Regulator&doi=10.4161%2Fauto.21483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4161%2Fauto.21483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.21483%26sid%3Dliteratum%253Aachs%26aulast%3DLuciani%26aufirst%3DA.%26aulast%3DVillella%26aufirst%3DV.%2BR.%26aulast%3DEsposito%26aufirst%3DS.%26aulast%3DGavina%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DI.%26aulast%3DSilano%26aufirst%3DM.%26aulast%3DGuido%26aufirst%3DS.%26aulast%3DPettoello-Mantovani%26aufirst%3DM.%26aulast%3DCarnuccio%26aufirst%3DR.%26aulast%3DScholte%26aufirst%3DB.%26aulast%3DDe%2BMatteis%26aufirst%3DA.%26aulast%3DMaiuri%26aufirst%3DM.%2BC.%26aulast%3DRaia%26aufirst%3DV.%26aulast%3DLuini%26aufirst%3DA.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DL.%26atitle%3DTargeting%2520Autophagy%2520as%2520a%2520Novel%2520Strategy%2520for%2520Facilitating%2520the%2520Therapeutic%2520Action%2520of%2520Potentiators%2520on%2520%25CE%2594F508%2520Cystic%2520Fibrosis%2520Transmembrane%2520Conductance%2520Regulator%26jtitle%3DAutophagy%26date%3D2012%26volume%3D8%26spage%3D1657%26epage%3D1672%26doi%3D10.4161%2Fauto.21483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Luciani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villella, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetti-Pierri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settembre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulze, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettoello-Mantovani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Apolito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quaratino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballabio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, L.</span><span> </span><span class="NLM_article-title">Defective CFTR Induces Aggresome Formation and Lung Inflammation in Cystic Fibrosis through ROS-Mediated Autophagy Inhibition</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span><span class="refDoi"> DOI: 10.1038/ncb2090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fncb2090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=20711182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSju7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=863-875&author=A.+Lucianiauthor=V.+R.+Villellaauthor=S.+Espositoauthor=N.+Brunetti-Pierriauthor=D.+Medinaauthor=C.+Settembreauthor=M.+Gavinaauthor=L.+Pulzeauthor=I.+Giardinoauthor=M.+Pettoello-Mantovaniauthor=M.+D%E2%80%99Apolitoauthor=S.+Guidoauthor=E.+Masliahauthor=B.+Spencerauthor=S.+Quaratinoauthor=V.+Raiaauthor=A.+Ballabioauthor=L.+Maiuri&title=Defective+CFTR+Induces+Aggresome+Formation+and+Lung+Inflammation+in+Cystic+Fibrosis+through+ROS-Mediated+Autophagy+Inhibition&doi=10.1038%2Fncb2090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition</span></div><div class="casAuthors">Luciani, Alessandro; Villella, Valeria Rachela; Esposito, Speranza; Brunetti-Pierri, Nicola; Medina, Diego; Settembre, Carmine; Gavina, Manuela; Pulze, Laura; Giardino, Ida; Pettoello-Mantovani, Massimo; D'Apolito, Maria; Guido, Stefano; Masliah, Eliezer; Spencer, Brian; Quaratino, Sonia; Raia, Valeria; Ballabio, Andrea; Maiuri, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">863-875</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulation of unwanted/misfolded proteins in aggregates has been obsd. in airways of patients with cystic fibrosis (CF), a life-threatening genetic disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR).  Here we show how the defective CFTR results in defective autophagy and decreases the clearance of aggresomes.  Defective CFTR-induced upregulation of reactive oxygen species (ROS) and tissue transglutaminase (TG2) drive the crosslinking of beclin 1, leading to sequestration of phosphatidylinositol-3-kinase (PI(3)K) complex III and accumulation of p62, which regulates aggresome formation.  Both CFTR knockdown and the overexpression of green fluorescent protein (GFP)-tagged-CFTRF508del induce beclin 1 downregulation and defective autophagy in non-CF airway epithelia through the ROS-TG2 pathway.  Restoration of beclin 1 and autophagy by either beclin 1 overexpression, cystamine or antioxidants rescues the localization of the beclin 1 interactome to the endoplasmic reticulum and reverts the CF airway phenotype in vitro, in vivo in Scnn1b-transgenic and CftrF508del homozygous mice, and in human CF nasal biopsies.  Restoring beclin 1 or knocking down p62 rescued the trafficking of CFTRF508del to the cell surface.  These data link the CFTR defect to autophagy deficiency, leading to the accumulation of protein aggregates and to lung inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVfOWG7VtDybVg90H21EOLACvtfcHk0ljhe88GMuKw-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSju7%252FF&md5=34a5b1873c0110ea7d28f1018aa414a8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncb2090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2090%26sid%3Dliteratum%253Aachs%26aulast%3DLuciani%26aufirst%3DA.%26aulast%3DVillella%26aufirst%3DV.%2BR.%26aulast%3DEsposito%26aufirst%3DS.%26aulast%3DBrunetti-Pierri%26aufirst%3DN.%26aulast%3DMedina%26aufirst%3DD.%26aulast%3DSettembre%26aufirst%3DC.%26aulast%3DGavina%26aufirst%3DM.%26aulast%3DPulze%26aufirst%3DL.%26aulast%3DGiardino%26aufirst%3DI.%26aulast%3DPettoello-Mantovani%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Apolito%26aufirst%3DM.%26aulast%3DGuido%26aufirst%3DS.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DSpencer%26aufirst%3DB.%26aulast%3DQuaratino%26aufirst%3DS.%26aulast%3DRaia%26aufirst%3DV.%26aulast%3DBallabio%26aufirst%3DA.%26aulast%3DMaiuri%26aufirst%3DL.%26atitle%3DDefective%2520CFTR%2520Induces%2520Aggresome%2520Formation%2520and%2520Lung%2520Inflammation%2520in%2520Cystic%2520Fibrosis%2520through%2520ROS-Mediated%2520Autophagy%2520Inhibition%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D863%26epage%3D875%26doi%3D10.1038%2Fncb2090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span> </span><span class="NLM_article-title">Application and Interpretation of Current Autophagy Inhibitors and Activators</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1038/aps.2013.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Faps.2013.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=23524572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVartLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=625-635&author=Y.+Yangauthor=L.+Huauthor=H.+Zhengauthor=C.+Maoauthor=W.+Huauthor=K.+Xiongauthor=F.+Wangauthor=C.+Liu&title=Application+and+Interpretation+of+Current+Autophagy+Inhibitors+and+Activators&doi=10.1038%2Faps.2013.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Application and interpretation of current autophagy inhibitors and activators</span></div><div class="casAuthors">Yang, Ya-ping; Hu, Li-fang; Zheng, Hui-fen; Mao, Cheng-jie; Hu, Wei-dong; Xiong, Kang-ping; Wang, Fen; Liu, Chun-feng</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-635</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy is the major intracellular degrdn. system, by which cytoplasmic materials are delivered to and degraded in the lysosome.  As a quality control mechanism for cytoplasmic proteins and organelles, autophagy plays important roles in a variety of human diseases, including neurodegenerative diseases, cancer, cardiovascular disease, diabetes and infectious and inflammatory diseases.  The discovery of ATG genes and the dissection of the signaling pathways involved in regulating autophagy have greatly enriched our knowledge on the occurrence and development of this lysosomal degrdn. pathway.  In addn. to its role in degrdn., autophagy may also promote a type of programmed cell death that is different from apoptosis, termed type II programmed cell death.  Owing to the dual roles of autophagy in cell death and the specificity of diseases, the exact mechanisms of autophagy in various diseases require more investigation.  The application of autophagy inhibitors and activators will help us understand the regulation of autophagy in human diseases, and provide insight into the use of autophagy-targeted drugs.  In this review, we summarize the latest research on autophagy inhibitors and activators and discuss the possibility of their application in human disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF6qWsq47jlbVg90H21EOLACvtfcHk0ljhe88GMuKw-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVartLg%253D&md5=5440d4cab70344584d5c1b08df328e6b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Faps.2013.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2013.5%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DXiong%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DApplication%2520and%2520Interpretation%2520of%2520Current%2520Autophagy%2520Inhibitors%2520and%2520Activators%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2013%26volume%3D34%26spage%3D625%26epage%3D635%26doi%3D10.1038%2Faps.2013.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">High doses of cysteamine have been administered chronically to nephropathic cystinosis patients (up to 2 g/day) to enable the clearance of cystine crystals out of the kidney in order to preserve its function. For a review on nephropathic cystinosis, see the following:</p></div><span class="NLM_contrib-group">Wilmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levtchenko, E. N.</span><span> </span><span class="NLM_article-title">The Pathogenesis of Cystinosis: Mechanisms Beyond Cystine Accummulation</span> <span class="citation_source-journal">Am. J. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">F905</span><span class="NLM_x">–</span> <span class="NLM_lpage">F916</span><span class="refDoi"> DOI: 10.1152/ajprenal.00318.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1152%2Fajprenal.00318.2010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=F905-F916&author=M.+Wilmerauthor=F.+Emmaauthor=E.+N.+Levtchenko&title=The+Pathogenesis+of+Cystinosis%3A+Mechanisms+Beyond+Cystine+Accummulation&doi=10.1152%2Fajprenal.00318.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00318.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00318.2010%26sid%3Dliteratum%253Aachs%26aulast%3DWilmer%26aufirst%3DM.%26aulast%3DEmma%26aufirst%3DF.%26aulast%3DLevtchenko%26aufirst%3DE.%2BN.%26atitle%3DThe%2520Pathogenesis%2520of%2520Cystinosis%253A%2520Mechanisms%2520Beyond%2520Cystine%2520Accummulation%26jtitle%3DAm.%2520J.%2520Phys.%26date%3D2010%26volume%3D299%26spage%3DF905%26epage%3DF916%26doi%3D10.1152%2Fajprenal.00318.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><div class="note"><p class="first last">For a review on autophagy and cystic fibrosis, see the following:</p></div><span class="NLM_contrib-group">Junkins, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-J.</span><span> </span><span class="NLM_article-title">The Emerging Potential of Autophagy-Based Therapies in the Treatment of Cystic Fibrosis Lung Infections</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.4161/auto.27750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.27750" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=538-547&author=R.+D.+Junkinsauthor=C.+McCormickauthor=T.-J.+Lin&title=The+Emerging+Potential+of+Autophagy-Based+Therapies+in+the+Treatment+of+Cystic+Fibrosis+Lung+Infections&doi=10.4161%2Fauto.27750"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.4161%2Fauto.27750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.27750%26sid%3Dliteratum%253Aachs%26aulast%3DJunkins%26aufirst%3DR.%2BD.%26aulast%3DMcCormick%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DT.-J.%26atitle%3DThe%2520Emerging%2520Potential%2520of%2520Autophagy-Based%2520Therapies%2520in%2520the%2520Treatment%2520of%2520Cystic%2520Fibrosis%2520Lung%2520Infections%26jtitle%3DAutophagy%26date%3D2014%26volume%3D10%26spage%3D538%26epage%3D547%26doi%3D10.4161%2Fauto.27750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">De Stefano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villella, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Gregorio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettoello-Mantovani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venerando, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raia, V.</span><span> </span><span class="NLM_article-title">Restoration of CFTR Function in Patients with Cystic Fibrosis Carrying the F508del-CFTR Mutation</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2053</span><span class="NLM_x">–</span> <span class="NLM_lpage">2074</span><span class="refDoi"> DOI: 10.4161/15548627.2014.973737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2F15548627.2014.973737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=25350163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=2053-2074&author=D.+De+Stefanoauthor=V.+R.+Villellaauthor=S.+Espositoauthor=A.+Toscoauthor=A.+Sepeauthor=F.+De+Gregorioauthor=L.+Salvadoriauthor=R.+Grassiaauthor=C.+A.+Leoneauthor=G.+De+Rosaauthor=M.+Maiuriauthor=M.+Pettoello-Mantovaniauthor=S.+Guidoauthor=A.+Bossiauthor=A.+Zolinauthor=A.+Venerandoauthor=L.+A.+Pinnaauthor=A.+Mehtaauthor=G.+Bonaauthor=G.+Kroemerauthor=L.+Maiuriauthor=V.+Raia&title=Restoration+of+CFTR+Function+in+Patients+with+Cystic+Fibrosis+Carrying+the+F508del-CFTR+Mutation&doi=10.4161%2F15548627.2014.973737"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation</span></div><div class="casAuthors">De Stefano, Daniela; Villella, Valeria R.; Esposito, Speranza; Tosco, Antonella; Sepe, Angela; De Gregorio, Fabiola; Salvadori, Laura; Grassia, Rosa; Leone, Carlo A.; De Rosa, Giuseppe; Maiuri, Maria C.; Pettoello-Mantovani, Massimo; Guido, Stefano; Bossi, Anna; Zolin, Anna; Venerando, Andrea; Pinna, Lorenzo A.; Mehta, Anil; Bona, Gianni; Kroemer, Guido; Maiuri, Luigi; Raia, Valeria</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2053-2074, 22 pp.</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Restoration of BECN1/Beclin 1-dependent autophagy and depletion of SQSTM1/p62 by genetic manipulation or autophagy-stimulatory proteostasis regulators, such as cystamine, have pos. effects on mouse models of human cystic fibrosis (CF).  These measures rescue the functional expression of the most frequent pathogenic CFTR mutant, F508del, at the respiratory epithelial surface and reduce lung inflammation in CftrF508del homozygous mice.  Cysteamine, the reduced form of cystamine, is an FDA-approved drug.  Here, we report that oral treatment with cysteamine greatly reduces the mortality rate and improves the phenotype of newborn mice bearing the F508del-CFTR mutation.  Cysteamine was also able to increase the plasma membrane expression of the F508del-CFTR protein in nasal epithelial cells from F508del homozygous CF patients, and these effects persisted for 24 h after cysteamine withdrawal.  Importantly, this cysteamine effect after washout was further sustained by the sequential administration of epigallocatechin gallate (EGCG), a green tea flavonoid, both in vivo, in mice, and in vitro, in primary epithelial cells from CF patients.  In a pilot clin. trial involving 10 F508del-CFTR homozygous CF patients, the combination of cysteamine and EGCG restored BECN1, reduced SQSTM1 levels and improved CFTR function from nasal epithelial cells in vivo, correlating with a decrease of chloride concns. in sweat, as well as with a redn. of the abundance of TNF/TNF-alpha (tumor necrosis factor) and CXCL8 (chemokine [C-X-C motif] ligand 8) transcripts in nasal brushing and TNF and CXCL8 protein levels in the sputum.  Altogether, these results suggest that optimal schedules of cysteamine plus EGCG might be used for the treatment of CF caused by the F508del-CFTR mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2A54UTj_n7Vg90H21EOLACvtfcHk0lgy-sXXunesEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKitb0%253D&md5=1b100eab0e1f08d91ec61c98ea80f6ab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4161%2F15548627.2014.973737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F15548627.2014.973737%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStefano%26aufirst%3DD.%26aulast%3DVillella%26aufirst%3DV.%2BR.%26aulast%3DEsposito%26aufirst%3DS.%26aulast%3DTosco%26aufirst%3DA.%26aulast%3DSepe%26aufirst%3DA.%26aulast%3DDe%2BGregorio%26aufirst%3DF.%26aulast%3DSalvadori%26aufirst%3DL.%26aulast%3DGrassia%26aufirst%3DR.%26aulast%3DLeone%26aufirst%3DC.%2BA.%26aulast%3DDe%2BRosa%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DM.%26aulast%3DPettoello-Mantovani%26aufirst%3DM.%26aulast%3DGuido%26aufirst%3DS.%26aulast%3DBossi%26aufirst%3DA.%26aulast%3DZolin%26aufirst%3DA.%26aulast%3DVenerando%26aufirst%3DA.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DBona%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DL.%26aulast%3DRaia%26aufirst%3DV.%26atitle%3DRestoration%2520of%2520CFTR%2520Function%2520in%2520Patients%2520with%2520Cystic%2520Fibrosis%2520Carrying%2520the%2520F508del-CFTR%2520Mutation%26jtitle%3DAutophagy%26date%3D2014%26volume%3D10%26spage%3D2053%26epage%3D2074%26doi%3D10.4161%2F15548627.2014.973737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tosco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Gregorio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stefano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sana, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buonpensiero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pasqua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lusa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raia, V.</span><span> </span><span class="NLM_article-title">A Novel Treatment of Cystic Fibrosis Acting On-Target: Cysteamine plus Epigallocatechin Gallate for the Autophagy-Dependent Rescue of Class II-Mutated CFTR</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span><span class="refDoi"> DOI: 10.1038/cdd.2016.22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fcdd.2016.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=27035618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvVahtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1380-1393&author=A.+Toscoauthor=F.+De+Gregorioauthor=S.+Espositoauthor=D.+De+Stefanoauthor=I.+Sanaauthor=E.+Ferrariauthor=A.+Sepeauthor=L.+Salvadoriauthor=P.+Buonpensieroauthor=A.+Di+Pasquaauthor=R.+Grassiaauthor=C.+A.+Leoneauthor=S.+Guidoauthor=G.+De+Rosaauthor=S.+Lusaauthor=G.+Bonaauthor=G.+Stollauthor=M.+C.+Maiuriauthor=A.+Mehtaauthor=G.+Kroemerauthor=L.+Maiuriauthor=V.+Raia&title=A+Novel+Treatment+of+Cystic+Fibrosis+Acting+On-Target%3A+Cysteamine+plus+Epigallocatechin+Gallate+for+the+Autophagy-Dependent+Rescue+of+Class+II-Mutated+CFTR&doi=10.1038%2Fcdd.2016.22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR</span></div><div class="casAuthors">Tosco, A.; De Gregorio, F.; Esposito, S.; De Stefano, D.; Sana, I.; Ferrari, E.; Sepe, A.; Salvadori, L.; Buonpensiero, P.; Di Pasqua, A.; Grassia, R.; Leone, C. A.; Guido, S.; De Rosa, G.; Lusa, S.; Bona, G.; Stoll, G.; Maiuri, M. C.; Mehta, A.; Kroemer, G.; Maiuri, L.; Raia, V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1380-1393</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We previously reported that the combination of two safe proteostasis regulators, cysteamine and epigallocatechin gallate (EGCG), can be used to improve deficient expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in patients homozygous for the CFTR Phe508del mutation.  Here we provide the proof-of-concept that this combination treatment restored CFTR function and reduced lung inflammation (P<0.001) in Phe508del/Phe508del or Phe508del/null-Cftr (but not in Cftr-null mice), provided that such mice were autophagy-competent.  Primary nasal cells from patients bearing different class II CFTR mutations, either in homozygous or compd. heterozygous form, responded to the treatment in vitro.  We assessed individual responses to cysteamine plus EGCG in a single-center, open-label phase-2 trial.  The combination treatment decreased sweat chloride from baseline, increased both CFTR protein and function in nasal cells, restored autophagy in such cells, decreased CXCL8 and TNF-α in the sputum, and tended to improve respiratory function.  These pos. effects were particularly strong in patients carrying Phe508del CFTR mutations in homozygosity or heterozygosity.  However, a fraction of patients bearing other CFTR mutations failed to respond to therapy.  Importantly, the same patients whose primary nasal brushed cells did not respond to cysteamine plus EGCG in vitro also exhibited deficient therapeutic responses in vivo.  Altogether, these results suggest that the combination treatment of cysteamine plus EGCG acts 'on-target' because it can only rescue CFTR function when autophagy is functional (in mice) and improves CFTR function when a rescuable protein is expressed (in mice and men).  These results should spur the further clin. development of the combination treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGPNDLbqZzmLVg90H21EOLACvtfcHk0lhxz7pafGlagA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvVahtLo%253D&md5=68938d9da2e6ea2909bf953c419cf9a9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2016.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2016.22%26sid%3Dliteratum%253Aachs%26aulast%3DTosco%26aufirst%3DA.%26aulast%3DDe%2BGregorio%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DS.%26aulast%3DDe%2BStefano%26aufirst%3DD.%26aulast%3DSana%26aufirst%3DI.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DSepe%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DL.%26aulast%3DBuonpensiero%26aufirst%3DP.%26aulast%3DDi%2BPasqua%26aufirst%3DA.%26aulast%3DGrassia%26aufirst%3DR.%26aulast%3DLeone%26aufirst%3DC.%2BA.%26aulast%3DGuido%26aufirst%3DS.%26aulast%3DDe%2BRosa%26aufirst%3DG.%26aulast%3DLusa%26aufirst%3DS.%26aulast%3DBona%26aufirst%3DG.%26aulast%3DStoll%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DM.%2BC.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DL.%26aulast%3DRaia%26aufirst%3DV.%26atitle%3DA%2520Novel%2520Treatment%2520of%2520Cystic%2520Fibrosis%2520Acting%2520On-Target%253A%2520Cysteamine%2520plus%2520Epigallocatechin%2520Gallate%2520for%2520the%2520Autophagy-Dependent%2520Rescue%2520of%2520Class%2520II-Mutated%2520CFTR%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D1380%26epage%3D1393%26doi%3D10.1038%2Fcdd.2016.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Jing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, K.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kweon, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, W.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K.</span><span> </span><span class="NLM_article-title">Docosahexaenoic Acid Induces Autophagy through p53/AMPK/mTOR Signaling and Promotes Apoptosis in Human Cancer Cells Harboring Wild-Type p53</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1358</span><span class="refDoi"> DOI: 10.4161/auto.7.11.16658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.7.11.16658" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=1348-1358&author=K.+Jingauthor=K.-S.+Songauthor=S.+Shinauthor=N.+Kimauthor=S.+Jeongauthor=H.-R.+Ohauthor=J.-H.+Parkauthor=K.-S.+Seoauthor=J.-Y.+Heoauthor=J.+Hanauthor=J.-I.+Parkauthor=C.+Hanauthor=T.+Wuauthor=G.+R.+Kweonauthor=S.+K.+Parkauthor=W.-H.+Yoonauthor=B.+D.+Hwangauthor=K.+Lim&title=Docosahexaenoic+Acid+Induces+Autophagy+through+p53%2FAMPK%2FmTOR+Signaling+and+Promotes+Apoptosis+in+Human+Cancer+Cells+Harboring+Wild-Type+p53&doi=10.4161%2Fauto.7.11.16658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.11.16658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.11.16658%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DK.-S.%26aulast%3DShin%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DJeong%26aufirst%3DS.%26aulast%3DOh%26aufirst%3DH.-R.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DSeo%26aufirst%3DK.-S.%26aulast%3DHeo%26aufirst%3DJ.-Y.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DJ.-I.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DKweon%26aufirst%3DG.%2BR.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DYoon%26aufirst%3DW.-H.%26aulast%3DHwang%26aufirst%3DB.%2BD.%26aulast%3DLim%26aufirst%3DK.%26atitle%3DDocosahexaenoic%2520Acid%2520Induces%2520Autophagy%2520through%2520p53%252FAMPK%252FmTOR%2520Signaling%2520and%2520Promotes%2520Apoptosis%2520in%2520Human%2520Cancer%2520Cells%2520Harboring%2520Wild-Type%2520p53%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26spage%3D1348%26epage%3D1358%26doi%3D10.4161%2Fauto.7.11.16658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Williams-Bey, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boularan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vural, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan-Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehrl, J. H.</span><span> </span><span class="NLM_article-title">Omega-3 Free Fatty Acids Suppress Macrophage Inflammasome Activation by Inhibiting NF-kappaB Activation and Enhancing Autophagy</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e97957</span><span class="refDoi"> DOI: 10.1371/journal.pone.0097957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1371%2Fjournal.pone.0097957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e97957&author=Y.+Williams-Beyauthor=C.+Boularanauthor=A.+Vuralauthor=N.-N.+Huangauthor=I.-Y.+Hwangauthor=C.+Shan-Shiauthor=J.+H.+Kehrl&title=Omega-3+Free+Fatty+Acids+Suppress+Macrophage+Inflammasome+Activation+by+Inhibiting+NF-kappaB+Activation+and+Enhancing+Autophagy&doi=10.1371%2Fjournal.pone.0097957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0097957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0097957%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams-Bey%26aufirst%3DY.%26aulast%3DBoularan%26aufirst%3DC.%26aulast%3DVural%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DN.-N.%26aulast%3DHwang%26aufirst%3DI.-Y.%26aulast%3DShan-Shi%26aufirst%3DC.%26aulast%3DKehrl%26aufirst%3DJ.%2BH.%26atitle%3DOmega-3%2520Free%2520Fatty%2520Acids%2520Suppress%2520Macrophage%2520Inflammasome%2520Activation%2520by%2520Inhibiting%2520NF-kappaB%2520Activation%2520and%2520Enhancing%2520Autophagy%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De97957%26doi%3D10.1371%2Fjournal.pone.0097957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mizushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimori, T.</span><span> </span><span class="NLM_article-title">How to Interpret LC3 Immunoblotting</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.4161/auto.4600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.4600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=17611390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOhs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=542-545&author=N.+Mizushimaauthor=T.+Yoshimori&title=How+to+Interpret+LC3+Immunoblotting&doi=10.4161%2Fauto.4600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">How to interpret LC3 immunoblotting</span></div><div class="casAuthors">Mizushima, Noboru; Yoshimori, Tamotsu</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-545</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Microtubule-assocd. protein light chain 3 (LC3) is now widely used to monitor autophagy.  One approach is to detect LC3 conversion (LC3-I to LC3-II) by immunoblot anal. because the amt. of LC3-II is clearly correlated with the no. of autophagosomes.  However, LC3-II itself is degraded by autophagy, making interpretation of the results of LC3 immunoblotting problematic.  Furthermore, the amt. of LC3 at a certain time point does not indicate autophagic flux, and therefore, it is important to measure the amt. of LC3-II delivered to lysosomes by comparing LC3-II levels in the presence and absence of lysosomal protease inhibitors.  Another problem with this method is that LC3-II tends to be much more sensitive to be detected by immunoblotting than LC3-I.  Accordingly, simple comparison of LC3-I and LC3-II, or summation of LC3-I and LC3-II for ratio detns., may not be appropriate, and rather, the amt. of LC3-II can be compared between samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruWJOF3diCsrVg90H21EOLACvtfcHk0lhxz7pafGlagA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOhs7jL&md5=f82d6ff49bcfdb0804ddc77c32d03300</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2Fauto.4600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.4600%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DYoshimori%26aufirst%3DT.%26atitle%3DHow%2520to%2520Interpret%2520LC3%2520Immunoblotting%26jtitle%3DAutophagy%26date%3D2007%26volume%3D3%26spage%3D542%26epage%3D545%26doi%3D10.4161%2Fauto.4600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">We have evaluated the fatty acid cysteamine <b>1</b> in cultured primary homozygous F508del-CFTR hBE cells from different donors (KKCFFT006F and CFFT028H) and have observed a similar level of autophagy activation (data not shown).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Neuberger, T.; Burton, B.; Clark, H.; Van Goor, F.</span> In  <span class="citation_source-book">Cystic Fibrosis</span>; <span class="NLM_contrib-group">Amaral, M. D.; Kunzelmann, K.</span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Chapter 4, pp  <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1007%2F978-1-61779-117-8_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=39-54&author=T.+Neuberger&author=B.+Burton&author=H.+Clark&author=F.+Van+Goorauthor=M.+D.+Amaral&author=K.+Kunzelmann&title=Cystic+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-117-8_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-61779-117-8_4%26sid%3Dliteratum%253Aachs%26aulast%3DNeuberger%26aufirst%3DT.%26btitle%3DCystic%2520Fibrosis%26aulast%3DAmaral%26aufirst%3DM.%2BD.%26pub%3DHumana%2520Press%26date%3D2011%26spage%3D39%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Cholon, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinney, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulcher, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esther, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokholyan, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randell, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentzsch, M.</span><span> </span><span class="NLM_article-title">Potentiator Ivacaftor Abrogates Pharmacological Correction of ΔF508 CFTR in Cystic Fibrosis</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">246ra96</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3008680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1126%2Fscitranslmed.3008680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=25101886" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=246ra96&author=D.+M.+Cholonauthor=N.+L.+Quinneyauthor=M.+L.+Fulcherauthor=C.+R.+Estherauthor=J.+Dasauthor=N.+V.+Dokholyanauthor=S.+H.+Randellauthor=R.+C.+Boucherauthor=M.+Gentzsch&title=Potentiator+Ivacaftor+Abrogates+Pharmacological+Correction+of+%CE%94F508+CFTR+in+Cystic+Fibrosis&doi=10.1126%2Fscitranslmed.3008680"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3008680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3008680%26sid%3Dliteratum%253Aachs%26aulast%3DCholon%26aufirst%3DD.%2BM.%26aulast%3DQuinney%26aufirst%3DN.%2BL.%26aulast%3DFulcher%26aufirst%3DM.%2BL.%26aulast%3DEsther%26aufirst%3DC.%2BR.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DDokholyan%26aufirst%3DN.%2BV.%26aulast%3DRandell%26aufirst%3DS.%2BH.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DGentzsch%26aufirst%3DM.%26atitle%3DPotentiator%2520Ivacaftor%2520Abrogates%2520Pharmacological%2520Correction%2520of%2520%25CE%2594F508%2520CFTR%2520in%2520Cystic%2520Fibrosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D246ra96%26doi%3D10.1126%2Fscitranslmed.3008680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Veit, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avramescu, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdomo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phuan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagdany, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apaja, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szollosi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkbeiner, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegedus, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, G. L.</span><span> </span><span class="NLM_article-title">Some Gating Potentiators, Including Ivacaftor, Diminish ΔF508-CFTR Functional Expression</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">246ra97</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3008889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1126%2Fscitranslmed.3008889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=25101887" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=246ra97&author=G.+Veitauthor=R.+G.+Avramescuauthor=D.+Perdomoauthor=P.+W.+Phuanauthor=M.+Bagdanyauthor=P.+M.+Apajaauthor=F.+Borotauthor=D.+Szollosiauthor=Y.-S.+Wuauthor=W.+E.+Finkbeinerauthor=T.+Hegedusauthor=A.+S.+Verkmanauthor=G.+L.+Lukacs&title=Some+Gating+Potentiators%2C+Including+Ivacaftor%2C+Diminish+%CE%94F508-CFTR+Functional+Expression&doi=10.1126%2Fscitranslmed.3008889"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3008889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3008889%26sid%3Dliteratum%253Aachs%26aulast%3DVeit%26aufirst%3DG.%26aulast%3DAvramescu%26aufirst%3DR.%2BG.%26aulast%3DPerdomo%26aufirst%3DD.%26aulast%3DPhuan%26aufirst%3DP.%2BW.%26aulast%3DBagdany%26aufirst%3DM.%26aulast%3DApaja%26aufirst%3DP.%2BM.%26aulast%3DBorot%26aufirst%3DF.%26aulast%3DSzollosi%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DY.-S.%26aulast%3DFinkbeiner%26aufirst%3DW.%2BE.%26aulast%3DHegedus%26aufirst%3DT.%26aulast%3DVerkman%26aufirst%3DA.%2BS.%26aulast%3DLukacs%26aufirst%3DG.%2BL.%26atitle%3DSome%2520Gating%2520Potentiators%252C%2520Including%2520Ivacaftor%252C%2520Diminish%2520%25CE%2594F508-CFTR%2520Functional%2520Expression%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D246ra97%26doi%3D10.1126%2Fscitranslmed.3008889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">We have also evaluated the fatty acid cysteamine conjugate <b>1</b> by itself (without the presence of the CFTR corrector lumacaftor) and have observed no significant change in the CFTR chloride current (data not shown).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Upon changing the differentiation medium to Coon’s F12 medium, the plate was incubated for 4 h in a CO<sub>2</sub> free incubator prior to <i>I</i><sub>EQ</sub> measurements. With the chronic ivacaftor preincubation protocol, we have found that the longer 4 h incubation period in Coon’s F12 medium was helpful, since it allowed primary hBE cells to process and hydrolyze the lipophilic fatty acid conjugate <b>1</b> more completely. Without this longer incubation time, some of the precipitated, oily fatty acid conjugates could interfere with the current recording; the results became more variable and harder to interpret.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">Additional TECC-24 assay data for this run, as well as for other runs, are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">In this TECC-24 assay setup using cells from the same donor (KKCFFT006F), we have also evaluated <b>1</b> at concentrations as low as 0.075 μM and still observed a statistically significant increase in the AUC. This data set is shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Dekkers, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegerinck, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronsveld, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssens, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Winter-de Groot, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandsma, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, N. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijvelds, M. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholte, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwenhuis, E. E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Brink, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clevers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Ent, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middendorp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beekman, J. M.</span><span> </span><span class="NLM_article-title">A Funtional CFTR Assay Using Primary Cystic Fibrosis Intestinal Organoids</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span><span class="refDoi"> DOI: 10.1038/nm.3201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fnm.3201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=23727931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFWqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=939-945&author=J.+F.+Dekkersauthor=C.+L.+Wiegerinckauthor=H.+R.+de+Jongeauthor=I.+Bronsveldauthor=H.+M.+Janssensauthor=K.+M.+de+Winter-de+Grootauthor=A.+M.+Brandsmaauthor=N.+W.+M.+de+Jongauthor=M.+J.+C.+Bijveldsauthor=B.+J.+Scholteauthor=E.+E.+S.+Nieuwenhuisauthor=S.+van+den+Brinkauthor=H.+Cleversauthor=C.+K.+van+der+Entauthor=S.+Middendorpauthor=J.+M.+Beekman&title=A+Funtional+CFTR+Assay+Using+Primary+Cystic+Fibrosis+Intestinal+Organoids&doi=10.1038%2Fnm.3201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A functional CFTR assay using primary cystic fibrosis intestinal organoids</span></div><div class="casAuthors">Dekkers, Johanna F.; Wiegerinck, Caroline L.; de Jonge, Hugo R.; Bronsveld, Inez; Janssens, Hettie M.; de Winter-de Groot, Karin M.; Brandsma, Arianne M.; de Jong, Nienke W. M.; Bijvelds, Marcel J. C.; Scholte, Bob J.; Nieuwenhuis, Edward E. S.; van den Brink, Stieneke; Clevers, Hans; van der Ent, Cornelis K.; Middendorp, Sabine; Beekman, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">939-945</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We recently established conditions allowing for long-term expansion of epithelial organoids from intestine, recapitulating essential features of the in vivo tissue architecture.  Here we apply this technol. to study primary intestinal organoids of people suffering from cystic fibrosis, a disease caused by mutations in CFTR, encoding cystic fibrosis transmembrane conductance regulator.  Forskolin induces rapid swelling of organoids derived from healthy controls or wild-type mice, but this effect is strongly reduced in organoids of subjects with cystic fibrosis or in mice carrying the Cftr F508del mutation and is absent in Cftr-deficient organoids.  This pattern is phenocopied by CFTR-specific inhibitors.  Forskolin-induced swelling of in vitro-expanded human control and cystic fibrosis organoids corresponds quant. with forskolin-induced anion currents in freshly excised ex vivo rectal biopsies.  Function of the CFTR F508del mutant protein is restored by incubation at low temp., as well as by CFTR-restoring compds.  This relatively simple and robust assay will facilitate diagnosis, functional studies, drug development and personalized medicine approaches in cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp13MmQ8EOOYLVg90H21EOLACvtfcHk0lj-2SSy_MRQJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFWqsrw%253D&md5=598d7aa08b0ee5a698cc0c35dd2d1c93</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnm.3201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3201%26sid%3Dliteratum%253Aachs%26aulast%3DDekkers%26aufirst%3DJ.%2BF.%26aulast%3DWiegerinck%26aufirst%3DC.%2BL.%26aulast%3Dde%2BJonge%26aufirst%3DH.%2BR.%26aulast%3DBronsveld%26aufirst%3DI.%26aulast%3DJanssens%26aufirst%3DH.%2BM.%26aulast%3Dde%2BWinter-de%2BGroot%26aufirst%3DK.%2BM.%26aulast%3DBrandsma%26aufirst%3DA.%2BM.%26aulast%3Dde%2BJong%26aufirst%3DN.%2BW.%2BM.%26aulast%3DBijvelds%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DScholte%26aufirst%3DB.%2BJ.%26aulast%3DNieuwenhuis%26aufirst%3DE.%2BE.%2BS.%26aulast%3Dvan%2Bden%2BBrink%26aufirst%3DS.%26aulast%3DClevers%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BEnt%26aufirst%3DC.%2BK.%26aulast%3DMiddendorp%26aufirst%3DS.%26aulast%3DBeekman%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Funtional%2520CFTR%2520Assay%2520Using%2520Primary%2520Cystic%2520Fibrosis%2520Intestinal%2520Organoids%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D939%26epage%3D945%26doi%3D10.1038%2Fnm.3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kellogg, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovtun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leece, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteman, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdison, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, R. V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, R. J.</span><span> </span><span class="NLM_article-title">Disulfide-Linked Antibody-Maytansinoid Conjugates: Optimization of in vivo Activity by Varying the Steric Hindrance at Carbon Atoms Adjacent to the Disulfide Linkage</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.1021/bc100480a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc100480a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=717-727&author=B.+A.+Kelloggauthor=L.+Garrettauthor=Y.+Kovtunauthor=K.+C.+Laiauthor=B.+Leeceauthor=M.+Millerauthor=G.+Payneauthor=R.+Steevesauthor=K.+R.+Whitemanauthor=W.+Widdisonauthor=H.+Xieauthor=R.+Singhauthor=R.+V.+J.+Chariauthor=J.+M.+Lambertauthor=R.+J.+Lutz&title=Disulfide-Linked+Antibody-Maytansinoid+Conjugates%3A+Optimization+of+in+vivo+Activity+by+Varying+the+Steric+Hindrance+at+Carbon+Atoms+Adjacent+to+the+Disulfide+Linkage&doi=10.1021%2Fbc100480a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage</span></div><div class="casAuthors">Kellogg, Brenda A.; Garrett, Lisa; Kovtun, Yelena; Lai, Katharine C.; Leece, Barbara; Miller, Michael; Payne, Gillian; Steeves, Rita; Whiteman, Kathleen R.; Widdison, Wayne; Xie, Hongsheng; Singh, Rajeeva; Chari, Ravi V. J.; Lambert, John M.; Lutz, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">717-727</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this report, we describe the synthesis of a panel of disulfide-linked huC242 (anti-CanAg) antibody maytansinoid conjugates (AMCs), which have varying levels of steric hindrance around the disulfide bond, in order to investigate the relationship between stability to redn. of the disulfide linker and antitumor activity of the conjugate in vivo.  The conjugates were first tested for stability to redn. by dithiothreitol in vitro and for plasma stability in CD1 mice.  It was found that the conjugates having the more sterically hindered disulfide linkages were more stable to reductive cleavage of the maytansinoid in both settings.  When the panel of conjugates was tested for in vivo efficacy in two human colon cancer xenograft models in SCID mice, it was found that the conjugate with intermediate disulfide bond stability having two Me groups on the maytansinoid side of the disulfide bond and no Me groups on the linker side of the disulfide bond (huC242-SPDB-DM4) displayed the best efficacy.  The ranking of in vivo efficacies of the conjugates was not predicted by their in vitro potencies, since all conjugates were highly active in vitro, including a huC242-SMCC-DM1 conjugate with a noncleavable linkage which showed only marginal activity in vivo.  These data suggest that factors in addn. to intrinsic conjugate potency and conjugate half-life in plasma influence the magnitude of antitumor activity obsd. for an AMC in vivo.  We provide evidence that bystander killing of neighboring nontargeted tumor cells by diffusible cytotoxic metabolites produced from target cell processing of disulfide-linked antibody-maytansinoid conjugates may be one addnl. factor contributing to the activity of these conjugates in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGmGw-cH238bVg90H21EOLACvtfcHk0lj-2SSy_MRQJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsro%253D&md5=ef2969ceaaea23e81da2edf06f62ea7e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbc100480a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc100480a%26sid%3Dliteratum%253Aachs%26aulast%3DKellogg%26aufirst%3DB.%2BA.%26aulast%3DGarrett%26aufirst%3DL.%26aulast%3DKovtun%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DK.%2BC.%26aulast%3DLeece%26aufirst%3DB.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DPayne%26aufirst%3DG.%26aulast%3DSteeves%26aufirst%3DR.%26aulast%3DWhiteman%26aufirst%3DK.%2BR.%26aulast%3DWiddison%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DChari%26aufirst%3DR.%2BV.%2BJ.%26aulast%3DLambert%26aufirst%3DJ.%2BM.%26aulast%3DLutz%26aufirst%3DR.%2BJ.%26atitle%3DDisulfide-Linked%2520Antibody-Maytansinoid%2520Conjugates%253A%2520Optimization%2520of%2520in%2520vivo%2520Activity%2520by%2520Varying%2520the%2520Steric%2520Hindrance%2520at%2520Carbon%2520Atoms%2520Adjacent%2520to%2520the%2520Disulfide%2520Linkage%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D717%26epage%3D727%26doi%3D10.1021%2Fbc100480a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">In this rat PK experiment, the plasma levels of cysteamine <b>12</b> and bis-geminal cysteamine <b>13</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) were not determined. However, in a separate PK experiment involving Sprague Dawley rats that have been surgically implanted with indwelling jugular vein cannula and portal vein cannula (similarly dosed orally at 30 mg/kg) only trace quantities of these two metabolites were detectable in the peripheral plasma. Niacin, nicotinuric acid <b>14</b>, and the thiol-nicotinamide metabolite <b>11</b> could not be detected in the peripheral plasma. A significant first pass metabolism of <b>11</b> had presumably taken place, since a significant quantity of it was detected in the portal circulation (metabolite <b>11</b>; portal <i>C</i><sub>max</sub> = 3129 ± 564 ng/mL, portal AUC<sub>last</sub> = 5888 ± 1297 h·ng/mL).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">Compound <b>5</b> has also been dosed orally (100 mg/kg b.i.d.) in a mouse PK/tissue distribution study over a 3.5 day period in order to assess autophagy activation in the various tissues. Both the parent compound and the biologically active metabolite <b>1</b> were detected in plasma and lung tissues. Compound <b>5</b> has also been administered to the Beagle dog orally with multiple doses over a 14 day period. The results from these studies will be discussed in more detail in a separate communication.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Levine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deretic, V.</span><span> </span><span class="NLM_article-title">Unveiling the Roles of Autophagy in Innate and Adaptive Immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span><span class="refDoi"> DOI: 10.1038/nri2161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fnri2161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=17767194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOrtbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=767-777&author=B.+Levineauthor=V.+Deretic&title=Unveiling+the+Roles+of+Autophagy+in+Innate+and+Adaptive+Immunity&doi=10.1038%2Fnri2161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Unveiling the roles of autophagy in innate and adaptive immunity</span></div><div class="casAuthors">Levine, Beth; Deretic, Vojo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">767-777</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells digest portions of their interiors in a process known as autophagy to recycle nutrients, remodel, and dispose of unwanted cytoplasmic constituents.  This ancient pathway, conserved from yeast to humans, is now emerging as a central player in the immunol. control of bacterial, parasitic, and viral infections.  The process of autophagy may degrade intracellular pathogens, deliver endogenous antigens to MHC class II-loading compartments, direct viral nucleic acids to Toll-like receptors, and regulate T-cell homeostasis.  This review describes the mechanisms of autophagy and highlights recent advances relevant to the role of autophagy in innate and adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmlHAwhNEYdrVg90H21EOLACvtfcHk0lj-2SSy_MRQJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOrtbnM&md5=925371512ee525495f2ae6028c7597ae</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnri2161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2161%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DDeretic%26aufirst%3DV.%26atitle%3DUnveiling%2520the%2520Roles%2520of%2520Autophagy%2520in%2520Innate%2520and%2520Adaptive%2520Immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26spage%3D767%26epage%3D777%26doi%3D10.1038%2Fnri2161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Amano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakagawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimori, T.</span><span> </span><span class="NLM_article-title">Autophagy in Innate Immunity against Intracellular Bacteria</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1093/jb/mvj162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1093%2Fjb%2Fmvj162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=16954534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKns7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2006&pages=161-166&author=A.+Amanoauthor=I.+Kakagawaauthor=T.+Yoshimori&title=Autophagy+in+Innate+Immunity+against+Intracellular+Bacteria&doi=10.1093%2Fjb%2Fmvj162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy in innate immunity against intracellular bacteria</span></div><div class="casAuthors">Amano, Atsuo; Nakagawa, Ichiro; Yoshimori, Tamotsu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-166</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Many pathogenic bacteria can invade phagocytic and non-phagocytic cells and colonize them intracellularly, then become disseminated to other cells.  The endocytic degrdn. pathway is thought to be the only prevention against such intracellular pathogens.  Autophagy, a fundamental cellular homeostasis pathway that operates with the intracellular degrdn./recycling system, causes the turnover of cellular components by delivering portions of the cytoplasm and organelles to lysosomes.  Recently, we reported that autophagic degrdn. is a previously unrecognized effector of host innate immunity.  Streptococcus pyogenes (Group A Streptococcus; GAS) successfully enters human epithelial cells via endocytosis.  GAS immediately escapes from the endosomes to the cytoplasm and gains a replicative niche, after which GAS in the cytoplasm is trapped in autophagosome-like compartments and degraded upon fusion with lysosomes.  This process indicates that autophagy plays a protective role in infectious diseases.  We also found that autophagic degrdn. was induced against Staphylococcus aureus, while methicillin-resistant S. aureus were resistant to autophagic degrdn.  The present review focuses on the protective function of autophagy against bacterial invasion of cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPV5-XOHa4lrVg90H21EOLACvtfcHk0ljEhWW_dlaiFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKns7jN&md5=0c7cf9ec5c298dd71626a4fb4bd5cc0e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvj162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvj162%26sid%3Dliteratum%253Aachs%26aulast%3DAmano%26aufirst%3DA.%26aulast%3DKakagawa%26aufirst%3DI.%26aulast%3DYoshimori%26aufirst%3DT.%26atitle%3DAutophagy%2520in%2520Innate%2520Immunity%2520against%2520Intracellular%2520Bacteria%26jtitle%3DJ.%2520Biochem.%26date%3D2006%26volume%3D140%26spage%3D161%26epage%3D166%26doi%3D10.1093%2Fjb%2Fmvj162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Cripps, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clancy, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyd, J.</span><span> </span><span class="NLM_article-title">Pulmonary Immunity to <i>Pseudomonas aeruginosa</i></span> <span class="citation_source-journal">Immunol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span><span class="refDoi"> DOI: 10.1038/icb.1995.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Ficb.1995.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=8595919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A280%3ADyaK287mslSgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1995&pages=418-424&author=A.+W.+Crippsauthor=M.+L.+Dunkleyauthor=R.+L.+Clancyauthor=J.+Kyd&title=Pulmonary+Immunity+to+Pseudomonas+aeruginosa&doi=10.1038%2Ficb.1995.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary immunity to Pseudomonas aeruginosa</span></div><div class="casAuthors">Cripps A W; Dunkley M L; Clancy R L; Kyd J</div><div class="citationInfo"><span class="NLM_cas:title">Immunology and cell biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">418-24</span>
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    </div><div class="casAbstract">Pseudomonas aeruginosa, an opportunistic bacterial pathogen, is a major course of morbidity and mortality in subjects with compromised respiratory function despite the significant advances in therapeutic practices.  The bacteria produces an armoury of products which modify its infective niche to ensure bacterial survival.  The role of antibody in protection against pulmonary infection remains poorly defined.  Protection appears to be associated with opsonizing antibody whilst some other antibody responses may be deleterious and promote further lung damage.  Cell mediated responses are clearly important in protection against infection.  This review proposes a vaccine strategy aimed at enhancing specific T cell responses in the lung which, though T cell-derived cytokines, drive the recruitment of neutrophils to the lung and the subsequent activation of these cells results in the clearance of bacteria from the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPPrY_q8l_CEcLvDNbOD4DfW6udTcc2eYWAforQ9Rle7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287mslSgsA%253D%253D&md5=129ac594e610e59f697fcae44ddb96b4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Ficb.1995.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ficb.1995.65%26sid%3Dliteratum%253Aachs%26aulast%3DCripps%26aufirst%3DA.%2BW.%26aulast%3DDunkley%26aufirst%3DM.%2BL.%26aulast%3DClancy%26aufirst%3DR.%2BL.%26aulast%3DKyd%26aufirst%3DJ.%26atitle%3DPulmonary%2520Immunity%2520to%2520Pseudomonas%2520aeruginosa%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D1995%26volume%3D73%26spage%3D418%26epage%3D424%26doi%3D10.1038%2Ficb.1995.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Hauser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Meir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColley, S. A.</span><span> </span><span class="NLM_article-title">Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1128/CMR.00036-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1128%2FCMR.00036-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=21233507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=29-70&author=A.+R.+Hauserauthor=M.+Jainauthor=M.+Bar-Meirauthor=S.+A.+McColley&title=Clinical+Significance+of+Microbial+Infection+and+Adaptation+in+Cystic+Fibrosis&doi=10.1128%2FCMR.00036-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical significance of microbial infection and adaptation in cystic fibrosis</span></div><div class="casAuthors">Hauser, Alan R.; Jain, Manu; Bar-Meir, Maskit; McColley, Susanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-70</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  A select group of microorganisms inhabit the airways of individuals with cystic fibrosis.  Once established within the pulmonary environment in these patients, many of these microbes adapt by altering aspects of their structure and physiol.  Some of these microbes and adaptations are assocd. with more rapid deterioration in lung function and overall clin. status, whereas others appear to have little effect.  Here we review current evidence supporting or refuting a role for the different microbes and their adaptations in contributing to poor clin. outcomes in cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaDbwWkf1qarVg90H21EOLACvtfcHk0ljEhWW_dlaiFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSgu70%253D&md5=591006729c2c2b1962828510af021b34</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FCMR.00036-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00036-10%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DA.%2BR.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DBar-Meir%26aufirst%3DM.%26aulast%3DMcColley%26aufirst%3DS.%2BA.%26atitle%3DClinical%2520Significance%2520of%2520Microbial%2520Infection%2520and%2520Adaptation%2520in%2520Cystic%2520Fibrosis%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2011%26volume%3D24%26spage%3D29%26epage%3D70%26doi%3D10.1128%2FCMR.00036-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Buchanan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elborn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schock, B.</span><span> </span><span class="NLM_article-title">Role of CFTR, <i>Pseudomonas aeruginosa</i> and Toll-like Receptors in Cystic Fibrosis lung inflammation</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.1042/BST0370863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1042%2FBST0370863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=19614608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVOju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=863-867&author=P.+J.+Buchananauthor=R.+K.+Ernstauthor=J.+S.+Elbornauthor=B.+Schock&title=Role+of+CFTR%2C+Pseudomonas+aeruginosa+and+Toll-like+Receptors+in+Cystic+Fibrosis+lung+inflammation&doi=10.1042%2FBST0370863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation</span></div><div class="casAuthors">Buchanan, Paul J.; Ernst, Robert K.; Elborn, J. Stuart; Schock, Bettina</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">863-867</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  CF (cystic fibrosis) is a severe autosomal recessive disease most common in Northwest European populations.  Underlying mutations in the CFTR (CF transmembrane conductance regulator) gene cause deregulation of ion transport and subsequent dehydration of the airway surface liq., producing a viscous mucus layer on the airway surface of CF patients.  This layer is readily colonized by bacteria such as Pseudomonas aeruginosa.  Owing to the resulting environment and treatment strategies, the bacteria acquire genetic modifications such as antibiotic resistance, biofilm formation, antimicrobial peptide resistance and pro-inflammatory lipid A structures.  Lipid A is a component of the lipopolysaccharide cell wall present on bacteria and is recognized by TLR4 (Toll-like receptor 4).  Its detection elicits a pro-inflammatory response that is heightened over time due to the addn. of fatty acids to the lipid A structure.  Eradication of bacteria from the lungs of CF patients becomes increasingly difficult and eventually leads to mortality.  In the present review, we describe the role of lipid A as a virulent factor of Ps. aeruginosa; however, it appears that further work is needed to investigate the role of CFTR in the innate immune response and in modifying the pathogen-host interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq6Z-YJvo4s7Vg90H21EOLACvtfcHk0liTUNPnc-UT_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVOju7o%253D&md5=dea5bc3ddc7c5c4916ec1e429d619a44</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1042%2FBST0370863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0370863%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DP.%2BJ.%26aulast%3DErnst%26aufirst%3DR.%2BK.%26aulast%3DElborn%26aufirst%3DJ.%2BS.%26aulast%3DSchock%26aufirst%3DB.%26atitle%3DRole%2520of%2520CFTR%252C%2520Pseudomonas%2520aeruginosa%2520and%2520Toll-like%2520Receptors%2520in%2520Cystic%2520Fibrosis%2520lung%2520inflammation%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2009%26volume%3D37%26spage%3D863%26epage%3D867%26doi%3D10.1042%2FBST0370863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Garcia-Medina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brody, S. L.</span><span> </span><span class="NLM_article-title"><i>Pseudomonas aeruginosa</i> Acquires Biofilm-like Properties within Airway Epithelial Cells</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">8298</span><span class="NLM_x">–</span> <span class="NLM_lpage">8305</span><span class="refDoi"> DOI: 10.1128/IAI.73.12.8298-8305.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1128%2FIAI.73.12.8298-8305.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=16299327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlertrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=8298-8305&author=R.+Garcia-Medinaauthor=W.+M.+Dunneauthor=P.+K.+Singhauthor=S.+L.+Brody&title=Pseudomonas+aeruginosa+Acquires+Biofilm-like+Properties+within+Airway+Epithelial+Cells&doi=10.1128%2FIAI.73.12.8298-8305.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells</span></div><div class="casAuthors">Garcia-Medina, Raquel; Dunne, W. Michael; Singh, Pradeep K.; Brody, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8298-8305</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa can notably cause both acute and chronic infection.  While several virulence factors are implicated in the acute phase of infection, advances in understanding bacterial pathogenesis suggest that chronic P. aeruginosa infection is related to biofilm formation.  However, the relationship between these two forms of disease is not well understood.  Accumulating evidence indicates that, during acute infection, P. aeruginosa enters epithelial cells, a process viewed as either a host-mediated defense response or a pathogenic mechanism to avoid host-mediated killing.  We investigated the possibility that epithelial cell entry during early P. aeruginosa-epithelial cell contact favors bacterial survival and is linked to chronic infection.  Using electron microscopy and confocal microscopy to analyze primary culture airway epithelial cells infected with P. aeruginosa, we found that epithelial cells developed pod-like clusters of intracellular bacteria with regional variation in protein expression.  Extracellular gentamicin added to the medium after acute infection led to the persistence of intracellular P. aeruginosa for at least 3 days.  Importantly, compared to bacterial culture under planktonic conditions, the intracellular bacteria were insensitive to growth inhibition or killing by antibiotics that were capable of intraepithelial cell penetration.  These findings suggest that P. aeruginosa can use airway epithelial cells as a sanctuary for persistence and develop a reversible antibiotic resistance phenotype characteristic of biofilm physiol. that can contribute to development of chronic infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq4GrLZ5VIcbVg90H21EOLACvtfcHk0liTUNPnc-UT_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlertrzN&md5=4fe1bebcdf98f4699559d898ab06de43</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FIAI.73.12.8298-8305.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.73.12.8298-8305.2005%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Medina%26aufirst%3DR.%26aulast%3DDunne%26aufirst%3DW.%2BM.%26aulast%3DSingh%26aufirst%3DP.%2BK.%26aulast%3DBrody%26aufirst%3DS.%2BL.%26atitle%3DPseudomonas%2520aeruginosa%2520Acquires%2520Biofilm-like%2520Properties%2520within%2520Airway%2520Epithelial%2520Cells%26jtitle%3DInfect.%2520Immun.%26date%3D2005%26volume%3D73%26spage%3D8298%26epage%3D8305%26doi%3D10.1128%2FIAI.73.12.8298-8305.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yuan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laturnus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span> </span><span class="NLM_article-title">Autophagy Plays an Essential Role in the Clearance of <i>Pseudomonas aeruginosa</i> by Alveolar Macrophages</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1242/jcs.094573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1242%2Fjcs.094573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=22302984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFShsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=507-515&author=K.+Yuanauthor=C.+Huangauthor=J.+Foxauthor=D.+Laturnusauthor=E.+Carlsonauthor=B.+Zhangauthor=Q.+Yinauthor=H.+Gaoauthor=M.+Wu&title=Autophagy+Plays+an+Essential+Role+in+the+Clearance+of+Pseudomonas+aeruginosa+by+Alveolar+Macrophages&doi=10.1242%2Fjcs.094573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy plays an essential role in the clearance of Pseudomonas aeruginosa by alveolar macrophages</span></div><div class="casAuthors">Yuan, Kefei; Huang, Canhua; Fox, John; Laturnus, Donna; Carlson, Edward; Zhang, Binjie; Yin, Qi; Gao, Hongwei; Wu, Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">507-515</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Intracellular bacteria have been shown to cause autophagy, which impacts infectious outcomes, whereas extracellular bacteria have not been reported to activate autophagy.  Here, we demonstrate that Pseudomonas aeruginosa, a Gram-neg. extracellular bacterium, activates autophagy with considerably increased LC3 punctation in both an alveolar macrophage cell line (MH-S) and primary alveolar macrophages.  Using the LC3 Gly120 mutant, we successfully demonstrated a hallmark of autophagy, conjugation of LC3 to phosphatidylethanolamine (PE).  The accumulation of typical autophagosomes with double membranes was identified morphol. by transmission electron microscopy (TEM).  Furthermore, the increase of PE-conjugated LC3 was indeed induced by infection rather than inhibition of lysosome degrdn.  P. aeruginosa induced autophagy through the classical beclin-1-Atg7-Atg5 pathway as detd. by specific siRNA anal.  Rapamycin and IFN-γ (autophagy inducers) augmented bacterial clearance, whereas beclin-1 and Atg5 knockdown reduced intracellular bacteria.  Thus, P. aeruginosa-induced autophagy represents a host protective mechanism, providing new insight into the pathogenesis of this infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobyePGYZQZ9bVg90H21EOLACvtfcHk0liTUNPnc-UT_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFShsbk%253D&md5=3815a9f0189c8693a3132ae79b5fcac8</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1242%2Fjcs.094573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.094573%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DLaturnus%26aufirst%3DD.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DM.%26atitle%3DAutophagy%2520Plays%2520an%2520Essential%2520Role%2520in%2520the%2520Clearance%2520of%2520Pseudomonas%2520aeruginosa%2520by%2520Alveolar%2520Macrophages%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2012%26volume%3D125%26spage%3D507%26epage%3D515%26doi%3D10.1242%2Fjcs.094573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Junkins, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-J.</span><span> </span><span class="NLM_article-title">Autophagy Enhances Bacterial Clearance during <i>P. aeruginosa</i> Lung Infection</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e72263</span><span class="refDoi"> DOI: 10.1371/journal.pone.0072263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1371%2Fjournal.pone.0072263" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e72263&author=R.+D.+Junkinsauthor=A.+Shenauthor=K.+Rosenauthor=C.+McCormickauthor=T.-J.+Lin&title=Autophagy+Enhances+Bacterial+Clearance+during+P.+aeruginosa+Lung+Infection&doi=10.1371%2Fjournal.pone.0072263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0072263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0072263%26sid%3Dliteratum%253Aachs%26aulast%3DJunkins%26aufirst%3DR.%2BD.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DRosen%26aufirst%3DK.%26aulast%3DMcCormick%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DT.-J.%26atitle%3DAutophagy%2520Enhances%2520Bacterial%2520Clearance%2520during%2520P.%2520aeruginosa%2520Lung%2520Infection%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De72263%26doi%3D10.1371%2Fjournal.pone.0072263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Abdulrahman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khweek, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caution, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotrange, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelaziz, D. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosales-Reyes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montione, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlesinger, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wewers, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valvano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amer, A. O.</span><span> </span><span class="NLM_article-title">Autophagy Stimulation by Rapamycin Suppresses Lung Inflammation and Infection by <i>Burkholderia cenocepacia</i> in a Model of Cystic Fibrosis</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span><span class="refDoi"> DOI: 10.4161/auto.7.11.17660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.7.11.17660" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=1359-1370&author=B.+Abdulrahmanauthor=A.+A.+Khweekauthor=A.+Akhterauthor=K.+Cautionauthor=S.+Kotrangeauthor=D.+H.+A.+Abdelazizauthor=C.+Newlandauthor=R.+Rosales-Reyesauthor=B.+Koppauthor=K.+McCoyauthor=R.+Montioneauthor=L.+S.+Schlesingerauthor=M.+A.+Gavrilinauthor=M.+D.+Wewersauthor=M.+Valvanoauthor=A.+O.+Amer&title=Autophagy+Stimulation+by+Rapamycin+Suppresses+Lung+Inflammation+and+Infection+by+Burkholderia+cenocepacia+in+a+Model+of+Cystic+Fibrosis&doi=10.4161%2Fauto.7.11.17660"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42c&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.11.17660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.11.17660%26sid%3Dliteratum%253Aachs%26aulast%3DAbdulrahman%26aufirst%3DB.%26aulast%3DKhweek%26aufirst%3DA.%2BA.%26aulast%3DAkhter%26aufirst%3DA.%26aulast%3DCaution%26aufirst%3DK.%26aulast%3DKotrange%26aufirst%3DS.%26aulast%3DAbdelaziz%26aufirst%3DD.%2BH.%2BA.%26aulast%3DNewland%26aufirst%3DC.%26aulast%3DRosales-Reyes%26aufirst%3DR.%26aulast%3DKopp%26aufirst%3DB.%26aulast%3DMcCoy%26aufirst%3DK.%26aulast%3DMontione%26aufirst%3DR.%26aulast%3DSchlesinger%26aufirst%3DL.%2BS.%26aulast%3DGavrilin%26aufirst%3DM.%2BA.%26aulast%3DWewers%26aufirst%3DM.%2BD.%26aulast%3DValvano%26aufirst%3DM.%26aulast%3DAmer%26aufirst%3DA.%2BO.%26atitle%3DAutophagy%2520Stimulation%2520by%2520Rapamycin%2520Suppresses%2520Lung%2520Inflammation%2520and%2520Infection%2520by%2520Burkholderia%2520cenocepacia%2520in%2520a%2520Model%2520of%2520Cystic%2520Fibrosis%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26spage%3D1359%26epage%3D1370%26doi%3D10.4161%2Fauto.7.11.17660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Bonfield, T.; Liu, F.; Chandran, S.; Fahrner, R.; Lee, D.; Nichols, A.; Picarella, D.; Ting, A.; Webb, S.; Wensley, A.; Yeager, M.; Vu, C. B.</span><span> </span><span class="NLM_article-title">CAT-5571 as a Novel Autophagy Activator that Enhances the Clearance of <i>Pseudomonas aeruginosa</i></span>. Presented at the 30th Annual North America Cystic Fibrosis Conferences, Orange County, FL, Oct 27–29,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span>Poster 223.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+Bonfield&author=F.+Liu&author=S.+Chandran&author=R.+Fahrner&author=D.+Lee&author=A.+Nichols&author=D.+Picarella&author=A.+Ting&author=S.+Webb&author=A.+Wensley&author=M.+Yeager&author=C.+B.+Vu&title=CAT-5571+as+a+Novel+Autophagy+Activator+that+Enhances+the+Clearance+of+Pseudomonas+aeruginosa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBonfield%26aufirst%3DT.%26atitle%3DCAT-5571%2520as%2520a%2520Novel%2520Autophagy%2520Activator%2520that%2520Enhances%2520the%2520Clearance%2520of%2520Pseudomonas%2520aeruginosa%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Milne, J. C.; Jirousek, M. R.; Bemis, J. E.; Vu, C. B.; Ting, A.</span><span> </span><span class="NLM_article-title">Bis-Fatty Acid Conjugates and Their Uses Thereof</span>. WO 2012115695,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+C.+Milne&author=M.+R.+Jirousek&author=J.+E.+Bemis&author=C.+B.+Vu&author=A.+Ting&title=Bis-Fatty+Acid+Conjugates+and+Their+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMilne%26aufirst%3DJ.%2BC.%26atitle%3DBis-Fatty%2520Acid%2520Conjugates%2520and%2520Their%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dohil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic Studies of Cysteamine Bitartrate Delayed-Release</span> <span class="citation_source-journal">Clin. Pharm. Drug Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1002/cpdd.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1002%2Fcpdd.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=27121672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ymsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=178-185&author=R.+Dohilauthor=P.+Rioux&title=Pharmacokinetic+Studies+of+Cysteamine+Bitartrate+Delayed-Release&doi=10.1002%2Fcpdd.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic studies of cysteamine bitartrate delayed-release</span></div><div class="casAuthors">Dohil, Ranjan; Rioux, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-185</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A twice-daily microsphere formulation of cysteamine bitartrate has been developed for cystinosis and other potential applications.  To date, there are no published pharmacokinetic data for cysteamine bitartrate delayed-release in healthy adults.  Three randomized open-label, crossover studies to det. the effects of fasting, high fat, and carbohydrate meals on the bioavailability of cysteamine bitartrate delayed-release (600 mg) administered in capsule or sprinkle form to healthy adults.  Adverse events were monitored.  Fifty-eight adults were studied.  Cysteamine absorption (AUC0-24 h) was the same for capsule and sprinkle forms during all meal/fasting states.  The AUC0-24 h for capsules while fasted, 30 and 120 min before a carbohydrate meal and during a high fat meal were 6,313 ± 329, 4,616 ± 878, 6,691 ± 669, 2,572 ± 295 min × μM, resp., and the mean Cmax values were 29.4 ± 1.7, 20.7 ± 4.9, 31.6 ± 3.0, and 10.9 ± 1.7 μM, resp.  The mean Tmax following fasting and high fat meal were about 3 and 6 h, resp.  Minor transient GI adverse events occurred.  Cysteamine bitartrate delayed-release capsule and sprinkle forms are bioequivalent and optimal absorption occurs during fasting state.  High fat diet reduces drug absorption, increases the Tmax and should be avoided at the time of drug ingestion.  Cysteamine bitartrate delayed-release (RP103) is best ingested >30 min before a carbohydrate-rich meal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOe1va0KVDWLVg90H21EOLACvtfcHk0lgP9TTDkDN5TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ymsrbM&md5=eaca9b3a8139c4037d208830d3e684d6</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.12%26sid%3Dliteratum%253Aachs%26aulast%3DDohil%26aufirst%3DR.%26aulast%3DRioux%26aufirst%3DP.%26atitle%3DPharmacokinetic%2520Studies%2520of%2520Cysteamine%2520Bitartrate%2520Delayed-Release%26jtitle%3DClin.%2520Pharm.%2520Drug%2520Dev.%26date%3D2013%26volume%3D2%26spage%3D178%26epage%3D185%26doi%3D10.1002%2Fcpdd.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blattler, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinson, A. R.</span><span> </span><span class="NLM_article-title">An Amplified Assay for Thiols based on Reactivation of Papain</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1006/abio.1993.1384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1006%2Fabio.1993.1384" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=1993&pages=49-56&author=R.+Singhauthor=W.+A.+Blattlerauthor=A.+R.+Collinson&title=An+Amplified+Assay+for+Thiols+based+on+Reactivation+of+Papain&doi=10.1006%2Fabio.1993.1384"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1006%2Fabio.1993.1384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1993.1384%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DBlattler%26aufirst%3DW.%2BA.%26aulast%3DCollinson%26aufirst%3DA.%2BR.%26atitle%3DAn%2520Amplified%2520Assay%2520for%2520Thiols%2520based%2520on%2520Reactivation%2520of%2520Papain%26jtitle%3DAnal.%2520Biochem.%26date%3D1993%26volume%3D213%26spage%3D49%26epage%3D56%26doi%3D10.1006%2Fabio.1993.1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c','cit11d'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':[],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':[],'ref29':[],'ref30':[],'ref31':[],'ref32':['cit32'],'ref33':['cit33'],'ref34':[],'ref35':[],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42a','cit42b','cit42c'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45a','cit45b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 27 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Michele Rossi, Sabrina Petralla, Michele Protti, Monica Baiula, Tereza Kobrlova, Ondrej Soukup, Santi Mario Spampinato, Laura Mercolini, Barbara Monti, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">α-Linolenic Acid–Valproic Acid Conjugates: Toward Single-Molecule Polypharmacology for Multiple Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 2406-2413. <a href="https://doi.org/10.1021/acsmedchemlett.0c00375" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00375%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%2525CE%2525B1-Linolenic%252BAcid%2525E2%252580%252593Valproic%252BAcid%252BConjugates%25253A%252BToward%252BSingle-Molecule%252BPolypharmacology%252Bfor%252BMultiple%252BSclerosis%26aulast%3DRossi%26aufirst%3DMichele%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D23102020%26date%3D27102020%26volume%3D11%26issue%3D12%26spage%3D2406%26epage%3D2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Skylar J. Ferrara, <span class="NLM_string-name hlFld-ContribAuthor">Thomas S. Scanlan</span>. </span><span class="cited-content_cbyCitation_article-title">A CNS-Targeting Prodrug Strategy for Nuclear Receptor Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9742-9751. <a href="https://doi.org/10.1021/acs.jmedchem.0c00868" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00868%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BCNS-Targeting%252BProdrug%252BStrategy%252Bfor%252BNuclear%252BReceptor%252BModulators%26aulast%3DFerrara%26aufirst%3DSkylar%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21052020%26date%3D20082020%26date%3D05082020%26volume%3D63%26issue%3D17%26spage%3D9742%26epage%3D9751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marc J. C. Scanio, Xenia B. Searle, Bo Liu, John R. Koenig, Robert Altenbach, Gregory A. Gfesser, Andrew Bogdan, Stephen Greszler, Gang Zhao, Ashvani Singh, Yihong Fan, Andrew M. Swensen, Timothy Vortherms, Arlene Manelli, Corina Balut, Ying Jia, Wenqing Gao, Hong Yong, Michael Schrimpf, Chris Tse, Philip Kym, <span class="NLM_string-name hlFld-ContribAuthor">Xueqing Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (11)
                                     , 1543-1548. <a href="https://doi.org/10.1021/acsmedchemlett.9b00377" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00377</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00377%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BABBV%25252FGLPG-3221%25252C%252Ba%252BPotent%252BCorrector%252Bof%252BCFTR%252Bfor%252Bthe%252BTreatment%252Bof%252BCystic%252BFibrosis%26aulast%3DScanio%26aufirst%3DMarc%2BJ.%2BC.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12082019%26date%3D28102019%26date%3D31102019%26volume%3D10%26issue%3D11%26spage%3D1543%26epage%3D1548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Justin
T. Marinko, Hui Huang, Wesley D. Penn, John A. Capra, Jonathan P. Schlebach, <span class="NLM_string-name hlFld-ContribAuthor">Charles R. Sanders</span>. </span><span class="cited-content_cbyCitation_article-title">Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (9)
                                     , 5537-5606. <a href="https://doi.org/10.1021/acs.chemrev.8b00532" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00532%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DFolding%252Band%252BMisfolding%252Bof%252BHuman%252BMembrane%252BProteins%252Bin%252BHealth%252Band%252BDisease%25253A%252BFrom%252BSingle%252BMolecules%252Bto%252BCellular%252BProteostasis%26aulast%3DMarinko%26aufirst%3DJustin%2BT.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D25082018%26date%3D04012019%26volume%3D119%26issue%3D9%26spage%3D5537%26epage%3D5606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueqing  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Xenia  Searle</span>, <span class="hlFld-ContribAuthor ">Clinton  Yeung</span>, <span class="hlFld-ContribAuthor ">Andrew  Bogdan</span>, <span class="hlFld-ContribAuthor ">Stephen  Greszler</span>, <span class="hlFld-ContribAuthor ">Ashvani  Singh</span>, <span class="hlFld-ContribAuthor ">Yihong  Fan</span>, <span class="hlFld-ContribAuthor ">Andrew M  Swensen</span>, <span class="hlFld-ContribAuthor ">Timothy  Vortherms</span>, <span class="hlFld-ContribAuthor ">Corina  Balut</span>, <span class="hlFld-ContribAuthor ">Ying  Jia</span>, <span class="hlFld-ContribAuthor ">Kelly  Desino</span>, <span class="hlFld-ContribAuthor ">Wenqing  Gao</span>, <span class="hlFld-ContribAuthor ">Hong  Yong</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>, and <span class="hlFld-ContribAuthor ">Philip  Kym</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for the Treatment of Cystic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1436-1449. <a href="https://doi.org/10.1021/acs.jmedchem.7b01339" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01339%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%25255B%2525282R%25252C4R%252529-4-%252528%25257B%25255B1-%2525282%25252C2-Difluoro-1%25252C3-benzodioxol-5-yl%252529cyclopropyl%25255Dcarbonyl%25257Damino%252529-7-%252528difluoromethoxy%252529-3%25252C4-dihydro-2H-chromen-2-yl%25255Dbenzoic%252BAcid%252B%252528ABBV%25252FGLPG-2222%252529%25252C%252Ba%252BPotent%252BCystic%252BFibrosis%252BTransmembrane%252BConductance%252BRegulator%252B%252528CFTR%252529%252BCorrector%252Bfor%252Bthe%252BTreatment%252Bof%252BCystic%252BFibrosis%26aulast%3DWang%26aufirst%3DXueqing%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D11092017%26date%3D05012018%26date%3D22022018%26date%3D18122017%26volume%3D61%26issue%3D4%26spage%3D1436%26epage%3D1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wren E  Michaels</span>, <span class="hlFld-ContribAuthor ">Robert J  Bridges</span>, <span class="hlFld-ContribAuthor ">Michelle L  Hastings</span>. </span><span class="cited-content_cbyCitation_article-title">Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2020,</strong> <em>245 </em><a href="https://doi.org/10.1093/nar/gkaa490" title="DOI URL">https://doi.org/10.1093/nar/gkaa490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkaa490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkaa490%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DAntisense%252Boligonucleotide-mediated%252Bcorrection%252Bof%252BCFTR%252Bsplicing%252Bimproves%252Bchloride%252Bsecretion%252Bin%252Bcystic%252Bfibrosis%252Bpatient-derived%252Bbronchial%252Bepithelial%252Bcells%26aulast%3DMichaels%26aufirst%3DWren%2BE%26date%3D2020%26date%3D2020%26volume%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changyu  Shan</span>, <span class="hlFld-ContribAuthor ">Wenqi  Hui</span>, <span class="hlFld-ContribAuthor ">Hongwei  Li</span>, <span class="hlFld-ContribAuthor ">Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Chunling  Guo</span>, <span class="hlFld-ContribAuthor ">Ruikun  Peng</span>, <span class="hlFld-ContribAuthor ">Jing  Gu</span>, <span class="hlFld-ContribAuthor ">Yingchun  Chen</span>, <span class="hlFld-ContribAuthor ">Qin  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Autophagy Inhibitors and Their Sensitization Abilities for Vincristine‐Resistant Esophageal Cancer Cell Line Eca109/VCR. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (11)
                                     , 970-981. <a href="https://doi.org/10.1002/cmdc.202000004" title="DOI URL">https://doi.org/10.1002/cmdc.202000004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000004%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252BNovel%252BAutophagy%252BInhibitors%252Band%252BTheir%252BSensitization%252BAbilities%252Bfor%252BVincristine%2525E2%252580%252590Resistant%252BEsophageal%252BCancer%252BCell%252BLine%252BEca109%25252FVCR%26aulast%3DShan%26aufirst%3DChangyu%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D11%26spage%3D970%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viola C.  Scoffone</span>, <span class="hlFld-ContribAuthor ">Giulia  Barbieri</span>, <span class="hlFld-ContribAuthor ">Silvia  Buroni</span>, <span class="hlFld-ContribAuthor ">Maria  Scarselli</span>, <span class="hlFld-ContribAuthor ">Mariagrazia  Pizza</span>, <span class="hlFld-ContribAuthor ">Rino  Rappuoli</span>, <span class="hlFld-ContribAuthor ">Giovanna  Riccardi</span>. </span><span class="cited-content_cbyCitation_article-title">Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia. </span><span class="cited-content_cbyCitation_journal-name">Trends in Microbiology</span><span> <strong>2020,</strong> <em>28 </em>
                                    (4)
                                     , 315-326. <a href="https://doi.org/10.1016/j.tim.2019.12.005" title="DOI URL">https://doi.org/10.1016/j.tim.2019.12.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tim.2019.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tim.2019.12.005%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Microbiology%26atitle%3DVaccines%252Bto%252BOvercome%252BAntibiotic%252BResistance%25253A%252BThe%252BChallenge%252Bof%252BBurkholderia%252Bcenocepacia%26aulast%3DScoffone%26aufirst%3DViola%2BC.%26date%3D2020%26volume%3D28%26issue%3D4%26spage%3D315%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanlan  Liu</span>, <span class="hlFld-ContribAuthor ">Jayaprakasam  Bolleddula</span>, <span class="hlFld-ContribAuthor ">Andrew  Nichols</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Zhiyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Chandra  Prakash</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism of bioconjugate therapeutics: why, when, and how?. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2020,</strong> <em>52 </em>
                                    (1)
                                     , 66-124. <a href="https://doi.org/10.1080/03602532.2020.1716784" title="DOI URL">https://doi.org/10.1080/03602532.2020.1716784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03602532.2020.1716784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03602532.2020.1716784%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DMetabolism%252Bof%252Bbioconjugate%252Btherapeutics%25253A%252Bwhy%25252C%252Bwhen%25252C%252Band%252Bhow%25253F%26aulast%3DLiu%26aufirst%3DHanlan%26date%3D2020%26date%3D2020%26volume%3D52%26issue%3D1%26spage%3D66%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashvani K.  Singh</span>, <span class="hlFld-ContribAuthor ">Yihong  Fan</span>, <span class="hlFld-ContribAuthor ">Corina  Balut</span>, <span class="hlFld-ContribAuthor ">Sara  Alani</span>, <span class="hlFld-ContribAuthor ">Arlene M.  Manelli</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Swensen</span>, <span class="hlFld-ContribAuthor ">Ying  Jia</span>, <span class="hlFld-ContribAuthor ">Torben R.  Neelands</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Vortherms</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Xenia B.  Searle</span>, <span class="hlFld-ContribAuthor ">Xueqing  Wang</span>, <span class="hlFld-ContribAuthor ">Wenqing  Gao</span>, <span class="hlFld-ContribAuthor ">Tzyh-Chang  Hwang</span>, <span class="hlFld-ContribAuthor ">Hong Y.  Ren</span>, <span class="hlFld-ContribAuthor ">Douglas  Cyr</span>, <span class="hlFld-ContribAuthor ">Philip R.  Kym</span>, <span class="hlFld-ContribAuthor ">Katja  Conrath</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2020,</strong> <em>372 </em>
                                    (1)
                                     , 107-118. <a href="https://doi.org/10.1124/jpet.119.261800" title="DOI URL">https://doi.org/10.1124/jpet.119.261800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.119.261800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.119.261800%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DBiological%252BCharacterization%252Bof%252BF508delCFTR%252BProtein%252BProcessing%252Bby%252Bthe%252BCFTR%252BCorrector%252BABBV-2222%25252FGLPG2222%26aulast%3DSingh%26aufirst%3DAshvani%2BK.%26date%3D2020%26date%3D2019%26volume%3D372%26issue%3D1%26spage%3D107%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John W.  Hanrahan</span>, <span class="hlFld-ContribAuthor ">Yukiko  Sato</span>, <span class="hlFld-ContribAuthor ">Graeme W.  Carlile</span>, <span class="hlFld-ContribAuthor ">Gregor  Jansen</span>, <span class="hlFld-ContribAuthor ">Jason C.  Young</span>, <span class="hlFld-ContribAuthor ">David Y.  Thomas</span>. </span><span class="cited-content_cbyCitation_article-title">Cystic Fibrosis: Proteostatic correctors of CFTR trafficking and alternative therapeutic targets.. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2019,</strong> <em>23 </em>
                                    (8)
                                     , 711-724. <a href="https://doi.org/10.1080/14728222.2019.1628948" title="DOI URL">https://doi.org/10.1080/14728222.2019.1628948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2019.1628948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2019.1628948%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DCystic%252BFibrosis%25253A%252BProteostatic%252Bcorrectors%252Bof%252BCFTR%252Btrafficking%252Band%252Balternative%252Btherapeutic%252Btargets.%26aulast%3DHanrahan%26aufirst%3DJohn%2BW.%26date%3D2019%26date%3D2019%26volume%3D23%26issue%3D8%26spage%3D711%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobias  Schwalbe</span>, <span class="hlFld-ContribAuthor ">Harald  Huebner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>. </span><span class="cited-content_cbyCitation_article-title">Development of covalent antagonists for β1- and β2-adrenergic receptors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (13)
                                     , 2959-2971. <a href="https://doi.org/10.1016/j.bmc.2019.05.034" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.05.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.05.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.05.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bcovalent%252Bantagonists%252Bfor%252B%2525CE%2525B21-%252Band%252B%2525CE%2525B22-adrenergic%252Breceptors%26aulast%3DSchwalbe%26aufirst%3DTobias%26date%3D2019%26volume%3D27%26issue%3D13%26spage%3D2959%26epage%3D2971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gert  de Wilde</span>, <span class="hlFld-ContribAuthor ">Maarten  Gees</span>, <span class="hlFld-ContribAuthor ">Sara  Musch</span>, <span class="hlFld-ContribAuthor ">Katleen  Verdonck</span>, <span class="hlFld-ContribAuthor ">Mia  Jans</span>, <span class="hlFld-ContribAuthor ">Anne-Sophie  Wesse</span>, <span class="hlFld-ContribAuthor ">Ashvani K.  Singh</span>, <span class="hlFld-ContribAuthor ">Tzyh-Chang  Hwang</span>, <span class="hlFld-ContribAuthor ">Thierry  Christophe</span>, <span class="hlFld-ContribAuthor ">Mathieu  Pizzonero</span>, <span class="hlFld-ContribAuthor ">Steven  Van der Plas</span>, <span class="hlFld-ContribAuthor ">Nicolas  Desroy</span>, <span class="hlFld-ContribAuthor ">Marlon  Cowart</span>, <span class="hlFld-ContribAuthor ">Pieter  Stouten</span>, <span class="hlFld-ContribAuthor ">Luc  Nelles</span>, <span class="hlFld-ContribAuthor ">Katja  Conrath</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00514" title="DOI URL">https://doi.org/10.3389/fphar.2019.00514</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00514%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DIdentification%252Bof%252BGLPG%25252FABBV-2737%25252C%252Ba%252BNovel%252BClass%252Bof%252BCorrector%25252C%252BWhich%252BExerts%252BFunctional%252BSynergy%252BWith%252BOther%252BCFTR%252BModulators%26aulast%3Dde%2BWilde%26aufirst%3DGert%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janine  Faraj</span>, <span class="hlFld-ContribAuthor ">Manish  Bodas</span>, <span class="hlFld-ContribAuthor ">Garrett  Pehote</span>, <span class="hlFld-ContribAuthor ">Doug  Swanson</span>, <span class="hlFld-ContribAuthor ">Ajit  Sharma</span>, <span class="hlFld-ContribAuthor ">Neeraj  Vij</span>. </span><span class="cited-content_cbyCitation_article-title">Novel cystamine-core dendrimer-formulation rescues ΔF508-CFTR and inhibits
              Pseudomonas aeruginosa
              infection by augmenting autophagy. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Delivery</span><span> <strong>2019,</strong> <em>16 </em>
                                    (2)
                                     , 177-186. <a href="https://doi.org/10.1080/17425247.2019.1575807" title="DOI URL">https://doi.org/10.1080/17425247.2019.1575807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425247.2019.1575807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425247.2019.1575807%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Delivery%26atitle%3DNovel%252Bcystamine-core%252Bdendrimer-formulation%252Brescues%252B%2525CE%252594F508-CFTR%252Band%252Binhibits%252BPseudomonas%252Baeruginosa%252Binfection%252Bby%252Baugmenting%252Bautophagy%26aulast%3DFaraj%26aufirst%3DJanine%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D2%26spage%3D177%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Bodas</span>, <span class="hlFld-ContribAuthor ">Neeraj  Vij</span>. </span><span class="cited-content_cbyCitation_article-title">Adapting Proteostasis and Autophagy for Controlling the Pathogenesis of Cystic Fibrosis Lung Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00020" title="DOI URL">https://doi.org/10.3389/fphar.2019.00020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00020%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DAdapting%252BProteostasis%252Band%252BAutophagy%252Bfor%252BControlling%252Bthe%252BPathogenesis%252Bof%252BCystic%252BFibrosis%252BLung%252BDisease%26aulast%3DBodas%26aufirst%3DManish%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ángel Gabriel  Valdivieso</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondrial Alterations and Oxidative Stress in Cystic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 355-371. <a href="https://doi.org/10.1007/978-981-13-8413-4_18" title="DOI URL">https://doi.org/10.1007/978-981-13-8413-4_18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-8413-4_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-8413-4_18%26sid%3Dliteratum%253Aachs%26atitle%3DMitochondrial%252BAlterations%252Band%252BOxidative%252BStress%252Bin%252BCystic%252BFibrosis%26aulast%3DValdivieso%26aufirst%3D%25C3%2581ngel%2BGabriel%26date%3D2019%26date%3D2019%26spage%3D355%26epage%3D371%26pub%3DSpringer%2520Singapore%26atitle%3DOxidative%252BStress%252Bin%252BLung%252BDiseases%26aulast%3DChakraborti%26aufirst%3DSajal%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Bodas</span>, <span class="hlFld-ContribAuthor ">Neeraj  Vij</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative Stress-Induced Autophagy Impairment and Pathogenesis of Chronic Obstructive Lung Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 389-425. <a href="https://doi.org/10.1007/978-981-13-8413-4_20" title="DOI URL">https://doi.org/10.1007/978-981-13-8413-4_20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-13-8413-4_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-13-8413-4_20%26sid%3Dliteratum%253Aachs%26atitle%3DOxidative%252BStress-Induced%252BAutophagy%252BImpairment%252Band%252BPathogenesis%252Bof%252BChronic%252BObstructive%252BLung%252BDiseases%26aulast%3DBodas%26aufirst%3DManish%26date%3D2019%26date%3D2019%26spage%3D389%26epage%3D425%26pub%3DSpringer%2520Singapore%26atitle%3DOxidative%252BStress%252Bin%252BLung%252BDiseases%26aulast%3DChakraborti%26aufirst%3DSajal%26date%3D2019%26volume%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott M.  O’Grady</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative stress, autophagy and airway ion transport. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Cell Physiology</span><span> <strong>2019,</strong> <em>316 </em>
                                    (1)
                                     , C16-C32. <a href="https://doi.org/10.1152/ajpcell.00341.2018" title="DOI URL">https://doi.org/10.1152/ajpcell.00341.2018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajpcell.00341.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajpcell.00341.2018%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Cell%2520Physiology%26atitle%3DOxidative%252Bstress%25252C%252Bautophagy%252Band%252Bairway%252Bion%252Btransport%26aulast%3DO%25E2%2580%2599Grady%26aufirst%3DScott%2BM.%26date%3D2019%26volume%3D316%26issue%3D1%26spage%3DC16%26epage%3DC32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer R.  Peters-Hall</span>, <span class="hlFld-ContribAuthor ">Melissa L.  Coquelin</span>, <span class="hlFld-ContribAuthor ">Michael J.  Torres</span>, <span class="hlFld-ContribAuthor ">Ryan  LaRanger</span>, <span class="hlFld-ContribAuthor ">Busola R.  Alabi</span>, <span class="hlFld-ContribAuthor ">Sei  Sho</span>, <span class="hlFld-ContribAuthor ">Jose F.  Calva-Moreno</span>, <span class="hlFld-ContribAuthor ">Philip J.  Thomas</span>, <span class="hlFld-ContribAuthor ">Jerry W.  Shay</span>. </span><span class="cited-content_cbyCitation_article-title">Long-term culture and cloning of primary human bronchial basal cells that maintain multipotent differentiation capacity and CFTR channel function. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Lung Cellular and Molecular Physiology</span><span> <strong>2018,</strong> <em>315 </em>
                                    (2)
                                     , L313-L327. <a href="https://doi.org/10.1152/ajplung.00355.2017" title="DOI URL">https://doi.org/10.1152/ajplung.00355.2017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajplung.00355.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajplung.00355.2017%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Lung%2520Cellular%2520and%2520Molecular%2520Physiology%26atitle%3DLong-term%252Bculture%252Band%252Bcloning%252Bof%252Bprimary%252Bhuman%252Bbronchial%252Bbasal%252Bcells%252Bthat%252Bmaintain%252Bmultipotent%252Bdifferentiation%252Bcapacity%252Band%252BCFTR%252Bchannel%252Bfunction%26aulast%3DPeters-Hall%26aufirst%3DJennifer%2BR.%26date%3D2018%26volume%3D315%26issue%3D2%26spage%3DL313%26epage%3DL327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Domenique D.  Zomer-van Ommen</span>, <span class="hlFld-ContribAuthor ">Eyleen  de Poel</span>, <span class="hlFld-ContribAuthor ">Evelien  Kruisselbrink</span>, <span class="hlFld-ContribAuthor ">Hugo  Oppelaar</span>, <span class="hlFld-ContribAuthor ">Annelotte M.  Vonk</span>, <span class="hlFld-ContribAuthor ">Hettie M.  Janssens</span>, <span class="hlFld-ContribAuthor ">Cornelis K.  van der Ent</span>, <span class="hlFld-ContribAuthor ">Marne C.  Hagemeijer</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Beekman</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cystic Fibrosis</span><span> <strong>2018,</strong> <em>17 </em>
                                    (3)
                                     , 316-324. <a href="https://doi.org/10.1016/j.jcf.2018.02.007" title="DOI URL">https://doi.org/10.1016/j.jcf.2018.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jcf.2018.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jcf.2018.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cystic%2520Fibrosis%26atitle%3DComparison%252Bof%252Bex%252Bvivo%252Band%252Bin%252Bvitro%252Bintestinal%252Bcystic%252Bfibrosis%252Bmodels%252Bto%252Bmeasure%252BCFTR-dependent%252Bion%252Bchannel%252Bactivity%26aulast%3DZomer-van%2BOmmen%26aufirst%3DDomenique%2BD.%26date%3D2018%26volume%3D17%26issue%3D3%26spage%3D316%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phil R.  Kym</span>, <span class="hlFld-ContribAuthor ">Xueqing  Wang</span>, <span class="hlFld-ContribAuthor ">Mathieu  Pizzonero</span>, <span class="hlFld-ContribAuthor ">Steven E.  Van der Plas</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Discovery and Development of Small-Molecule Modulators of CFTR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 235-276. <a href="https://doi.org/10.1016/bs.pmch.2018.01.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2018.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2018.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2018.01.001%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDiscovery%252Band%252BDevelopment%252Bof%252BSmall-Molecule%252BModulators%252Bof%252BCFTR%26aulast%3DKym%26aufirst%3DPhil%2BR.%26date%3D2018%26spage%3D235%26epage%3D276%26pub%3DElsevier%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saumel  Ahmadi</span>, <span class="hlFld-ContribAuthor ">Zoltan  Bozoky</span>, <span class="hlFld-ContribAuthor ">Michelle  Di Paola</span>, <span class="hlFld-ContribAuthor ">Sunny  Xia</span>, <span class="hlFld-ContribAuthor ">Canhui  Li</span>, <span class="hlFld-ContribAuthor ">Amy P.  Wong</span>, <span class="hlFld-ContribAuthor ">Leigh  Wellhauser</span>, <span class="hlFld-ContribAuthor ">Steven V.  Molinski</span>, <span class="hlFld-ContribAuthor ">Wan  Ip</span>, <span class="hlFld-ContribAuthor ">Hong  Ouyang</span>, <span class="hlFld-ContribAuthor ">Julie  Avolio</span>, <span class="hlFld-ContribAuthor ">Julie D.  Forman-Kay</span>, <span class="hlFld-ContribAuthor ">Felix  Ratjen</span>, <span class="hlFld-ContribAuthor ">Jeremy A.  Hirota</span>, <span class="hlFld-ContribAuthor ">Johanna  Rommens</span>, <span class="hlFld-ContribAuthor ">Janet  Rossant</span>, <span class="hlFld-ContribAuthor ">Tanja  Gonska</span>, <span class="hlFld-ContribAuthor ">Theo J.  Moraes</span>, <span class="hlFld-ContribAuthor ">Christine E.  Bear</span>. </span><span class="cited-content_cbyCitation_article-title">Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia. </span><span class="cited-content_cbyCitation_journal-name">npj Genomic Medicine</span><span> <strong>2017,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41525-017-0015-6" title="DOI URL">https://doi.org/10.1038/s41525-017-0015-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41525-017-0015-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41525-017-0015-6%26sid%3Dliteratum%253Aachs%26jtitle%3Dnpj%2520Genomic%2520Medicine%26atitle%3DPhenotypic%252Bprofiling%252Bof%252BCFTR%252Bmodulators%252Bin%252Bpatient-derived%252Brespiratory%252Bepithelia%26aulast%3DAhmadi%26aufirst%3DSaumel%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Bodas</span>, <span class="hlFld-ContribAuthor ">Neeraj  Vij</span>. </span><span class="cited-content_cbyCitation_article-title">Augmenting autophagy for prognosis based intervention of COPD-pathophysiology. </span><span class="cited-content_cbyCitation_journal-name">Respiratory Research</span><span> <strong>2017,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12931-017-0560-7" title="DOI URL">https://doi.org/10.1186/s12931-017-0560-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12931-017-0560-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12931-017-0560-7%26sid%3Dliteratum%253Aachs%26jtitle%3DRespiratory%2520Research%26atitle%3DAugmenting%252Bautophagy%252Bfor%252Bprognosis%252Bbased%252Bintervention%252Bof%252BCOPD-pathophysiology%26aulast%3DBodas%26aufirst%3DManish%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer  Guimbellot</span>, <span class="hlFld-ContribAuthor ">Jyoti  Sharma</span>, <span class="hlFld-ContribAuthor ">Steven M.  Rowe</span>. </span><span class="cited-content_cbyCitation_article-title">Toward inclusive therapy with CFTR modulators: Progress and challenges. </span><span class="cited-content_cbyCitation_journal-name">Pediatric Pulmonology</span><span> <strong>2017,</strong> <em>52 </em>
                                    (S48)
                                     , S4-S14. <a href="https://doi.org/10.1002/ppul.23773" title="DOI URL">https://doi.org/10.1002/ppul.23773</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ppul.23773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fppul.23773%26sid%3Dliteratum%253Aachs%26jtitle%3DPediatric%2520Pulmonology%26atitle%3DToward%252Binclusive%252Btherapy%252Bwith%252BCFTR%252Bmodulators%25253A%252BProgress%252Band%252Bchallenges%26aulast%3DGuimbellot%26aufirst%3DJennifer%26date%3D2017%26date%3D2017%26volume%3D52%26issue%3DS48%26spage%3DS4%26epage%3DS14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiali  Yuan</span>, <span class="hlFld-ContribAuthor ">Ruhui  Han</span>, <span class="hlFld-ContribAuthor ">Ayaaba  Esther</span>, <span class="hlFld-ContribAuthor ">Qiuyun  Wu</span>, <span class="hlFld-ContribAuthor ">Jingjin  Yang</span>, <span class="hlFld-ContribAuthor ">Weiwen  Yan</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Ji</span>, <span class="hlFld-ContribAuthor ">Yi  Liu</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Wenxi  Yao</span>, <span class="hlFld-ContribAuthor ">Chunhui  Ni</span>. </span><span class="cited-content_cbyCitation_article-title">Polymorphisms in autophagy related genes and the coal workers' pneumoconiosis in a Chinese population. </span><span class="cited-content_cbyCitation_journal-name">Gene</span><span> <strong>2017,</strong> <em>632 </em>, 36-42. <a href="https://doi.org/10.1016/j.gene.2017.08.017" title="DOI URL">https://doi.org/10.1016/j.gene.2017.08.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gene.2017.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gene.2017.08.017%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%26atitle%3DPolymorphisms%252Bin%252Bautophagy%252Brelated%252Bgenes%252Band%252Bthe%252Bcoal%252Bworkers%252527%252Bpneumoconiosis%252Bin%252Ba%252BChinese%252Bpopulation%26aulast%3DYuan%26aufirst%3DJiali%26date%3D2017%26volume%3D632%26spage%3D36%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott Mackenzie  Brockman</span>, <span class="hlFld-ContribAuthor ">Manish  Bodas</span>, <span class="hlFld-ContribAuthor ">David  Silverberg</span>, <span class="hlFld-ContribAuthor ">Ajit  Sharma</span>, <span class="hlFld-ContribAuthor ">Neeraj  Vij</span>, . </span><span class="cited-content_cbyCitation_article-title">Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2017,</strong> <em>12 </em>
                                    (9)
                                     , e0184793. <a href="https://doi.org/10.1371/journal.pone.0184793" title="DOI URL">https://doi.org/10.1371/journal.pone.0184793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0184793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0184793%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DDendrimer-based%252Bselective%252Bautophagy-induction%252Brescues%252B%2525CE%252594F508-CFTR%252Band%252Binhibits%252BPseudomonas%252Baeruginosa%252Binfection%252Bin%252Bcystic%252Bfibrosis%26aulast%3DBrockman%26aufirst%3DScott%2BMackenzie%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D9%26spage%3De0184793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viola C.  Scoffone</span>, <span class="hlFld-ContribAuthor ">Laurent R.  Chiarelli</span>, <span class="hlFld-ContribAuthor ">Gabriele  Trespidi</span>, <span class="hlFld-ContribAuthor ">Massimo  Mentasti</span>, <span class="hlFld-ContribAuthor ">Giovanna  Riccardi</span>, <span class="hlFld-ContribAuthor ">Silvia  Buroni</span>. </span><span class="cited-content_cbyCitation_article-title">Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2017,</strong> <em>8 </em><a href="https://doi.org/10.3389/fmicb.2017.01592" title="DOI URL">https://doi.org/10.3389/fmicb.2017.01592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2017.01592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2017.01592%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DBurkholderia%252Bcenocepacia%252BInfections%252Bin%252BCystic%252BFibrosis%252BPatients%25253A%252BDrug%252BResistance%252Band%252BTherapeutic%252BApproaches%26aulast%3DScoffone%26aufirst%3DViola%2BC.%26date%3D2017%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0015.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative CFTR modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0016.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In CF, the defective CFTR induces an upregulation of TG2, which causes the cross-linking of beclin-1 and the subsequent impairment of autophagy. This results in an increase in the p62 aggresomes, which can further trap the F508del-CFTR for the eventual degradation by the proteasome. A successful activation of autophagy would reverse these steps to allow more of the F508del-CFTR to reach the cell membrane. The fatty acid cysteamine conjugate <b>1</b> allows the simultaneous inhibition of TG2 and upregulation of AMPK to take place in order to activate autophagy more effectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. List of covalent fatty acid conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hydrolysis of the fatty acid cysteamine conjugate <b>1</b> using purified recombinant FAAH-1. Shown are measurements of DHA that was released upon hydrolysis of <b>1</b> using recombinant FAAH-1. Measurements were taken in the presence or absence of the recombinant enzyme FAAH-1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Representative immunoblots of primary homozygous F508del-CFTR hBE cells (patient code KKCFFT004I) that were treated for 24 h at 37 °C with the following: (lane a) vehicle; (lane b) cysteamine (250 μM); (lane c) DHA (250 μM); (lane d) combination of cysteamine (250 μM) + DHA (250 μM); (lane e) fatty acid cysteamine conjugate <b>1</b> (3 μM). (B) Quantification of the immunoblots shown in (A) for beclin-1 levels. (C) Quantification of the immunoblots shown in (A) for the ratio of LC3-II to LC3-I. (D) Quantification of the immunoblots shown in (A) for the p62 levels. Error bars represent standard error of the mean (SEM, <i>n</i> = 3): (∗) <i>p</i> < 0.05, compared to the vehicle with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Determination of CFTR band B and band C. (A) Immunoblots of primary homozygous F508del-CFTR hBE cells (patient code KKCFFT006F) when treated for 24 h with the following: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) <b>1</b> (3 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). (B) Quantification of the immunoblots shown in (A) for the corresponding CFTR band B, the CFTR band C, and the ratio of band C to band B. (C) Quantification of the corresponding immunoblots for beclin-1, the ratio of LC3-II/LC3-I and p62, expressed as a % of the lumacaftor/ivacaftor control group. Error bars represent standard deviation (SD): (∗) <i>p</i> < 0.05, SD, <i>n</i> = 3, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. TECC-24 assay, Rosalind Franklin University, patient code CFFT018I: chronic ivacaftor preincubation protocol. Primary homozygous F508del-CFTR hBE cells were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) compound <b>1</b> (0.075 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). The medium was then switched to Coon’s F12, with test compounds added back. Plate was incubated at 37 °C for 4 h prior to <i>I</i><sub>EQ</sub> measurements. (A) Representative <i>I</i><sub>EQ</sub> traces following the addition of benzamil (3 μM) to first block currents deriving from ENaC. Forskolin (10 μM) was added, and the <i>I</i><sub>EQ</sub> was recorded over a 27 min period at 37 °C. Bumetanide (20 μM) was added to block the chloride secretion from the CFTR. (B) Quantification of the bumetanide-inhibited CFTR chloride current for the three indicated treatment groups, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (C) Quantification of the AUC (computed for the time period that spans the <i>I</i><sub>EQ</sub> value at the time of forskolin addition up to the <i>I</i><sub>EQ</sub> value at the time of bumetanide addition): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 3, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. TECC-24 assay, Charles River Laboratories, patient code KKCFFT006F: chronic ivacaftor preincubation protocol. Primary homozygous F508del-CFTR hBE cells were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) compound <b>1</b> (0.15 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). The medium was then switched to Coon’s F12, with the test compounds added back. Plate was incubated at 37 °C for 4 h prior to <i>I</i><sub>EQ</sub> measurements. (A) Average <i>I</i><sub>EQ</sub> traces for the three treatment groups following the addition of benzamil (10 μM) to first block currents deriving from ENaC. Forskolin (10 μM) was then added, and the <i>I</i><sub>EQ</sub> was recorded over a 60 min period at 37 °C. CFTR<sub>inh</sub>-172 (20 μM) was added to block the chloride secretion from the CFTR. (B) Quantification of the peak forskolin-activated chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (C) Quantification of the CFTR<sub>inh</sub>-172 inhibited chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (D) Quantification of the AUC (computed for the time period that spans the <i>I</i><sub>EQ</sub> value at the time of forskolin addition up to the <i>I</i><sub>EQ</sub> value at the time of CFTR<sub>inh</sub>-172 addition): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 4, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. TECC-24 assay, Charles River Laboratories, patient code KKCFFT004I: chronic ivacaftor preincubation protocol. Primary homozygous F508del-CFTR hBE cells were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle + ivacaftor (0.10 μM); (2) lumacaftor (3 μM) + ivacaftor (0.10 μM); (3) compound <b>1</b> (0.30 μM) + lumacaftor (3 μM) + ivacaftor (0.10 μM). Protocols are the same as detailed in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>. (A) Average <i>I</i><sub>EQ</sub> traces for the three treatment groups. (B) Quantification of the peak forskolin-activated chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 6, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) cysteamine, MeOH, rt; (b) DHA, HATU, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 1-amino-2-methylpropane-2-thiol, MeOH/DMF (1:1), rt; (d) nicotinoyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Plasma stability for the fatty acid cysteamine conjugate <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Plasma concentrations of the parent compound <b>5</b> and the biologically active metabolite <b>1</b> upon oral dosing to Sprague Dawley rats (30 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0010.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Potential metabolites obtained from oral dosing with <b>5</b> to Sprague Dawley rats. Compound <b>15</b> represents the corresponding Ellman’s adduct of conjugate <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0011.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. TECC-24 assay, Rosalind Franklin University, patient code CFFT028H: acute ivacaftor protocol. Primary homozygous F508del-CFTR hBE cells were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle; (2) lumacaftor (3 μM); (3) compound <b>5</b> (0.0375 μM) + lumacaftor (3 μM). The medium was then switched to Coon’s F12, with test compounds added back. Plate was incubated at 37 °C for 30 min prior to <i>I</i><sub>EQ</sub> measurements. (A) Representative <i>I</i><sub>EQ</sub> traces following the addition of benzamil (3 μM) to first block the epithelial Na channel. Forskolin (10 μM) was then added, followed by ivacaftor (0.10 μM). <i>I</i><sub>EQ</sub> was recorded over a 45 min period at 37 °C. Bumetanide (20 μM) was added to block the chloride secretion from the CFTR. (B) Quantification of the bumetanide-inhibited CFTR chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (C) Quantification of the AUC (computed for the time period that spans the <i>I</i><sub>EQ</sub> value at the time of forskolin addition up to the <i>I</i><sub>EQ</sub> value at the time of bumetanide addition): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 3, statistically significant relative to the lumacaftor/ivacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/medium/jm-2016-01539j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0012.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. TECC-24 assay, Charles River Laboratories, patient code KKCFFT0012I: acute ivacaftor protocol. Primary homozygous F508del-CFTR hBE cells (<i>n</i> = 4) were incubated in differentiation medium at 37 °C for 24 h with the following: (1) vehicle; (2) lumacaftor (3 μM); (3) compound <b>5</b> (0.018 μM) + lumacaftor (3 μM). The medium was then switched to Coon’s F12, with the test compounds added back. Plate was incubated at 37 °C for 30 min prior to <i>I</i><sub>EQ</sub> measurements. (A) Average <i>I</i><sub>EQ</sub> traces for the indicated treatment groups following the addition of benzamil (10 μM) to first block currents deriving from ENaC. Forskolin (10 μM) and ivacaftor (0.10 μM) were then added, and the <i>I</i><sub>EQ</sub> was recorded over a 60 min period at 37 °C. CFTR<sub>inh</sub>-172 (20 μM) was added to block the chloride secretion from the CFTR. (B) Quantification of the CFTR<sub>inh</sub>-172 inhibited chloride current, Δ<i>I</i><sub>EQ</sub> (μA/cm<sup>2</sup>). (C) Quantification of the AUC (computed for the time period that spans the <i>I</i><sub>EQ</sub> value at the time of forskolin addition up to the <i>I</i><sub>EQ</sub> value at the time of CFTR<sub>inh</sub>-172 addition): (∗) <i>p</i> < 0.05, SEM, <i>n</i> = 4, statistically significant relative to the lumacaftor treatment group with ANOVA followed by Dunnett’s multiple comparison test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b01539/20170106/images/large/jm-2016-01539j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01539&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Drug Discovery: Predicting Promiscuity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1038/462167a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2F462167a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=19907483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSjsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=167-168&author=A.+L.+Hopkins&title=Drug+Discovery%3A+Predicting+Promiscuity&doi=10.1038%2F462167a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery: Predicting promiscuity</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7270</span>),
    <span class="NLM_cas:pages">167-168</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Computational methods that reliably predict the biol. activities of compds. have long been sought.  The validation of one such method suggests that in silico predictions for drug discovery have come of age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQeKOdE7MUxLVg90H21EOLACvtfcHk0ljPSCobwPuebw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSjsrnI&md5=d7a2f49900632ba698ed3790f3b3c4d5</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2F462167a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F462167a%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DDrug%2520Discovery%253A%2520Predicting%2520Promiscuity%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D167%26epage%3D168%26doi%3D10.1038%2F462167a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span> </span><span class="NLM_article-title">Network Pharmacology: The Next Paradigm in Drug Discovery</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span><span class="refDoi"> DOI: 10.1038/nchembio.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fnchembio.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=18936753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=682-690&author=A.+L.+Hopkins&title=Network+Pharmacology%3A+The+Next+Paradigm+in+Drug+Discovery&doi=10.1038%2Fnchembio.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology: the next paradigm in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">682-690</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The dominant paradigm in drug discovery is the concept of designing maximally selective ligands to act on individual drug targets.  However, many effective drugs act via modulation of multiple proteins rather than single targets.  Advances in systems biol. are revealing a phenotypic robustness and a network structure that strongly suggests that exquisitely selective compds., compared with multi-target drugs, may exhibit lower than desired clin. efficacy.  This new appreciation of the role of polypharmacol. has significant implications for tackling the two major sources of attrition in drug development, efficacy and toxicity.  Integrating network biol. and polypharmacol. holds the promise of expanding the current opportunity space for druggable targets.  However, the rational design of polypharmacol. faces considerable challenges in the need for new methods to validate target combinations and optimize multiple structure-activity relationships while maintaining drug-like properties.  Advances in these areas are creating the foundation of the next paradigm in drug discovery: network pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqHy4FqkK-h7Vg90H21EOLACvtfcHk0lhOxBREdGZ-BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK&md5=03b8be3ddbcab7dc65afd17df7ee8395</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.118%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DNetwork%2520Pharmacology%253A%2520The%2520Next%2520Paradigm%2520in%2520Drug%2520Discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D682%26epage%3D690%26doi%3D10.1038%2Fnchembio.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zimmermann, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, C. T.</span><span> </span><span class="NLM_article-title">Multi-target Therapeutics: When the Whole is Greater than the Sum of the Parts</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1016/j.drudis.2006.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leharauthor=C.+T.+Keith&title=Multi-target+Therapeutics%3A+When+the+Whole+is+Greater+than+the+Sum+of+the+Parts&doi=10.1016%2Fj.drudis.2006.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2eYneh8FAHiQuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520Therapeutics%253A%2520When%2520the%2520Whole%2520is%2520Greater%2520than%2520the%2520Sum%2520of%2520the%2520Parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42%26doi%3D10.1016%2Fj.drudis.2006.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span> </span><span class="NLM_article-title">Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5906</span><span class="NLM_x">–</span> <span class="NLM_lpage">5914</span><span class="refDoi"> DOI: 10.1021/jm100293f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100293f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5906-5914&author=C.+Melchiorreauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiatti&title=Polyamines+in+Drug+Discovery%3A+From+the+Universal+Template+Approach+to+the+Multitarget-Directed+Ligand+Design+Strategy&doi=10.1021%2Fjm100293f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1021%2Fjm100293f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100293f%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26atitle%3DPolyamines%2520in%2520Drug%2520Discovery%253A%2520From%2520the%2520Universal%2520Template%2520Approach%2520to%2520the%2520Multitarget-Directed%2520Ligand%2520Design%2520Strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5906%26epage%3D5914%26doi%3D10.1021%2Fjm100293f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Peters, J.-U.</span><span> </span><span class="NLM_article-title">Polypharmacology-Foe or Friend?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8955</span><span class="NLM_x">–</span> <span class="NLM_lpage">8971</span><span class="refDoi"> DOI: 10.1021/jm400856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8955-8971&author=J.-U.+Peters&title=Polypharmacology-Foe+or+Friend%3F&doi=10.1021%2Fjm400856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology - Foe or Friend?</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8955-8971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Polypharmacol. describes the activity of compds. at multiple targets.  Current research focuses on two aspects of polypharmacol.: (1) unintended polypharmacol. can lead to adverse effects; (2) polypharmacol. across several disease-relevant targets can improve therapeutic efficacy, prevent drug resistance, or reduce therapeutic-target-related adverse effects.  This perspective reviews these interconnected aspects of polypharmacol.  The first part discusses the relevance of polypharmacol. for the safety of drugs, the mitigation of safety risks, and methods to identify polypharmacol. compds. early in the drug discovery process.  The second part discusses the advantages of polypharmacol. in the treatment of multigenic diseases and infections, and opportunities for drug discovery and drug repurposing.  This perspective aims to provide a balanced view on polypharmacol., which can compromise the safety of drugs, but can also confer superior efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5vnFGPfTnGLVg90H21EOLACvtfcHk0lhjLa1sHMqI9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO&md5=f4aeb6efddd4bfdf4e94656303323cba</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400856t%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3DPolypharmacology-Foe%2520or%2520Friend%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8955%26epage%3D8971%26doi%3D10.1021%2Fjm400856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Azmi, A. S.</span><span> </span><span class="NLM_article-title">Network Pharmacology for Cancer Drug Discovery: Are We There Yet?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.4155/fmc.12.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4155%2Ffmc.12.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=22650234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVOrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=939-941&author=A.+S.+Azmi&title=Network+Pharmacology+for+Cancer+Drug+Discovery%3A+Are+We+There+Yet%3F&doi=10.4155%2Ffmc.12.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Network pharmacology for cancer drug discovery: are we there yet?</span></div><div class="casAuthors">Azmi, Asfar S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">939-941</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The emergence of network biol. has improved the knowledge of multi-pathway interactions in cancer and helped to make sense of drug-response signature datasets that collectively decode the complex mechanisms of drug action.  Network pharmacol. showed that promiscuity often engages a synergistic combination of appropriate high-value targets in cancer cells to develop treatment success.  In general, it holds promise to revolutionize the approach towards next-generation cancer drug design and development.  Thus, it certainly has the potential to modify the view of drug design and understanding mechanisms of action and, if used correctly, is predicted to significantly de-risk cancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-nEGlIwnic7Vg90H21EOLACvtfcHk0lhjLa1sHMqI9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVOrsrc%253D&md5=b545e162e850a4ada587a447bf9b82b6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.44%26sid%3Dliteratum%253Aachs%26aulast%3DAzmi%26aufirst%3DA.%2BS.%26atitle%3DNetwork%2520Pharmacology%2520for%2520Cancer%2520Drug%2520Discovery%253A%2520Are%2520We%2520There%2520Yet%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D939%26epage%3D941%26doi%3D10.4155%2Ffmc.12.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bista, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carney, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ting, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wensley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirousek, M. R.</span><span> </span><span class="NLM_article-title">Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC28XptlKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1217-1231&author=C.+B.+Vuauthor=J.+E.+Bemisauthor=E.+Bensonauthor=P.+Bistaauthor=D.+Carneyauthor=R.+Fahrnerauthor=D.+Leeauthor=F.+Liuauthor=P.+Lonkarauthor=J.+C.+Milneauthor=A.+J.+Nicholsauthor=D.+Picarellaauthor=A.+Shoelsonauthor=J.+Smithauthor=A.+Tingauthor=A.+Wensleyauthor=M.+Yeagerauthor=M.+Zimmerauthor=M.+R.+Jirousek&title=Synthesis+and+Characterization+of+Fatty+Acid+Conjugates+of+Niacin+and+Salicylic+Acid&doi=10.1021%2Facs.jmedchem.5b01961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid</span></div><div class="casAuthors">Vu, Chi B.; Bemis, Jean E.; Benson, Ericka; Bista, Pradeep; Carney, David; Fahrner, Richard; Lee, Diana; Liu, Feng; Lonkar, Pallavi; Milne, Jill C.; Nichols, Andrew J.; Picarella, Dominic; Shoelson, Adam; Smith, Jesse; Ting, Amal; Wensley, Allison; Yeager, Maisy; Zimmer, Michael; Jirousek, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1217-1231</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes the synthesis and preliminary biol. characterization of novel fatty acid niacin conjugates and fatty acid salicylate conjugates.  These mol. entities were created by covalently linking two bioactive mols., either niacin or salicylic acid, to an omega-3 fatty acid.  This methodol. allows the simultaneous intracellular delivery of two bioactives in order to elicit a pharmacol. response that could not be replicated by administering the bioactives individually or in combination.  The fatty acid niacin conjugate 5 has been shown to be an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metab. proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1.  On the other hand, the fatty acid salicylate conjugate 11 has been shown to have a unique anti-inflammatory profile based on its ability to modulate the NF-κB pathway through the intracellular release of the two bioactives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2DZ5fMPvPNLVg90H21EOLACvtfcHk0lhjLa1sHMqI9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptlKhuw%253D%253D&md5=937f6757357d8bef388b49f153ffa0a7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01961%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBenson%26aufirst%3DE.%26aulast%3DBista%26aufirst%3DP.%26aulast%3DCarney%26aufirst%3DD.%26aulast%3DFahrner%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DLonkar%26aufirst%3DP.%26aulast%3DMilne%26aufirst%3DJ.%2BC.%26aulast%3DNichols%26aufirst%3DA.%2BJ.%26aulast%3DPicarella%26aufirst%3DD.%26aulast%3DShoelson%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DTing%26aufirst%3DA.%26aulast%3DWensley%26aufirst%3DA.%26aulast%3DYeager%26aufirst%3DM.%26aulast%3DZimmer%26aufirst%3DM.%26aulast%3DJirousek%26aufirst%3DM.%2BR.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Fatty%2520Acid%2520Conjugates%2520of%2520Niacin%2520and%2520Salicylic%2520Acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1217%26epage%3D1231%26doi%3D10.1021%2Facs.jmedchem.5b01961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mizushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, M.</span><span> </span><span class="NLM_article-title">Autophagy: Renovation of Cells and Tissues</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span><span class="refDoi"> DOI: 10.1016/j.cell.2011.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1016%2Fj.cell.2011.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=22078875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKgsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=728-741&author=N.+Mizushimaauthor=M.+Komatsu&title=Autophagy%3A+Renovation+of+Cells+and+Tissues&doi=10.1016%2Fj.cell.2011.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy: Renovation of Cells and Tissues</span></div><div class="casAuthors">Mizushima, Noboru; Komatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">728-741</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Autophagy is the major intracellular degrdn. system by which cytoplasmic materials are delivered to and degraded in the lysosome.  However, the purpose of autophagy is not the simple elimination of materials, but instead, autophagy serves as a dynamic recycling system that produces new building blocks and energy for cellular renovation and homeostasis.  Here we provide a multidisciplinary review of our current understanding of autophagy's role in metabolic adaptation, intracellular quality control, and renovation during development and differentiation.  We also explore how recent mouse models in combination with advances in human genetics are providing key insights into how the impairment or activation of autophagy contributes to pathogenesis of diverse diseases, from neurodegenerative diseases such as Parkinson disease to inflammatory disorders such as Crohn disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphHJHJXZsr6bVg90H21EOLACvtfcHk0lg7vZFEoTKx2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKgsLnN&md5=c749750db767f05549db0b22ec5068c7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DKomatsu%26aufirst%3DM.%26atitle%3DAutophagy%253A%2520Renovation%2520of%2520Cells%2520and%2520Tissues%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D728%26epage%3D741%26doi%3D10.1016%2Fj.cell.2011.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><div class="note"><p class="first last">For a review, see the following:</p></div><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorscher, E. J.</span><span> </span><span class="NLM_article-title">Mechanisms of Disease: Cystic Fibrosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1992</span><span class="NLM_x">–</span> <span class="NLM_lpage">2001</span><span class="refDoi"> DOI: 10.1056/NEJMra043184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1056%2FNEJMra043184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=15888700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFyrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1992-2001&author=S.+M.+Roweauthor=S.+Millerauthor=E.+J.+Sorscher&title=Mechanisms+of+Disease%3A+Cystic+Fibrosis&doi=10.1056%2FNEJMra043184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cystic fibrosis</span></div><div class="casAuthors">Rowe, Steven M.; Miller, Stacey; Sorscher, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1992-2001</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  Important advances have improved our understanding of the role of the CFTR protein in the progression of suppurative pulmonary failure in cystic fibrosis.  These discoveries are ushering in a new era of translational research that incorporates specific therapeutic targets and new cellular pathways.  Progress in research on cystic fibrosis will continue to rely on an improved understanding of CFTR function and its relationship to mucociliary clearance, airway secretion, and other ion channels.  Clin. advances directed at the correction of CFTR function predict an optimistic future for patients with cystic fibrosis and their families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKiiafli4tp7Vg90H21EOLACvtfcHk0lg7vZFEoTKx2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFyrtLY%253D&md5=e6bc05b49d7b177d43dd7592ad63f0fb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMra043184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra043184%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DSorscher%26aufirst%3DE.%2BJ.%26atitle%3DMechanisms%2520of%2520Disease%253A%2520Cystic%2520Fibrosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1992%26epage%3D2001%26doi%3D10.1056%2FNEJMra043184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCartney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wine, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frizzell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashlock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P. A.</span><span> </span><span class="NLM_article-title">Correction of the F508del-CFTR Protein Processing Defect In Vitro by the Investigational Drug lumacaftor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">18843</span><span class="NLM_x">–</span> <span class="NLM_lpage">18848</span><span class="refDoi"> DOI: 10.1073/pnas.1105787108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1073%2Fpnas.1105787108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18843-18848&author=F.+Van+Goorauthor=S.+Hadidaauthor=P.+D.+Grootenhuisauthor=B.+Burtonauthor=J.+H.+Stackauthor=K.+S.+Straleyauthor=C.+J.+Deckerauthor=M.+Millerauthor=J.+McCartneyauthor=E.+R.+Olsonauthor=J.+J.+Wineauthor=R.+A.+Frizzellauthor=M.+Ashlockauthor=P.+A.+Negulescu&title=Correction+of+the+F508del-CFTR+Protein+Processing+Defect+In+Vitro+by+the+Investigational+Drug+lumacaftor&doi=10.1073%2Fpnas.1105787108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1105787108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1105787108%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DStack%26aufirst%3DJ.%2BH.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DMcCartney%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DE.%2BR.%26aulast%3DWine%26aufirst%3DJ.%2BJ.%26aulast%3DFrizzell%26aufirst%3DR.%2BA.%26aulast%3DAshlock%26aufirst%3DM.%26aulast%3DNegulescu%26aufirst%3DP.%2BA.%26atitle%3DCorrection%2520of%2520the%2520F508del-CFTR%2520Protein%2520Processing%2520Defect%2520In%2520Vitro%2520by%2520the%2520Investigational%2520Drug%2520lumacaftor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D18843%26epage%3D18848%26doi%3D10.1073%2Fpnas.1105787108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hadida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCartney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazlewood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negulescu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grootenhuis, P. D. J.</span><span> </span><span class="NLM_article-title">Discovery of <i>N-</i>(2,4-Di-<i>tert</i>-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9776</span><span class="NLM_x">–</span> <span class="NLM_lpage">9795</span><span class="refDoi"> DOI: 10.1021/jm5012808</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012808" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9776-9795&author=S.+Hadidaauthor=F.+Van+Goorauthor=J.+Zhouauthor=V.+Arumugamauthor=J.+McCartneyauthor=A.+Hazlewoodauthor=C.+Deckerauthor=P.+Negulescuauthor=P.+D.+J.+Grootenhuis&title=Discovery+of+N-%282%2C4-Di-tert-butyl-5-hydroxyphenyl%29-4-oxo-1%2C4-dihydroquinoline-3-carboxamide+%28VX-770%2C+Ivacaftor%29%2C+a+Potent+and+Orally+Bioavailable+CFTR+Potentiator&doi=10.1021%2Fjm5012808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator</span></div><div class="casAuthors">Hadida, Sabine; Van Goor, Fredrick; Zhou, Jinglan; Arumugam, Vijayalaksmi; McCartney, Jason; Hazlewood, Anna; Decker, Caroline; Negulescu, Paul; Grootenhuis, Peter D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9776-9795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing the F508del-CFTR mutation.  Extensive medicinal chem. and iterative structure-activity relationship (SAR) studies to evaluate potency, selectivity, and pharmacokinetic properties resulted in the identification of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, 48, ivacaftor), an investigational drug candidate approved by the FDA for the treatment of CF patients 6 years of age and older carrying the G551D mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCmDwR5g0hbVg90H21EOLACvtfcHk0lg7vZFEoTKx2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsb%252FO&md5=c4ed161be3b5d7752e7591d2c4847637</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm5012808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012808%26sid%3Dliteratum%253Aachs%26aulast%3DHadida%26aufirst%3DS.%26aulast%3DVan%2BGoor%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DArumugam%26aufirst%3DV.%26aulast%3DMcCartney%26aufirst%3DJ.%26aulast%3DHazlewood%26aufirst%3DA.%26aulast%3DDecker%26aufirst%3DC.%26aulast%3DNegulescu%26aufirst%3DP.%26aulast%3DGrootenhuis%26aufirst%3DP.%2BD.%2BJ.%26atitle%3DDiscovery%2520of%2520N-%25282%252C4-Di-tert-butyl-5-hydroxyphenyl%2529-4-oxo-1%252C4-dihydroquinoline-3-carboxamide%2520%2528VX-770%252C%2520Ivacaftor%2529%252C%2520a%2520Potent%2520and%2520Orally%2520Bioavailable%2520CFTR%2520Potentiator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9776%26epage%3D9795%26doi%3D10.1021%2Fjm5012808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wainwright, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elborn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marigowda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Boeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flume, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konstan, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKone, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratjen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. P.</span><span> </span><span class="NLM_article-title">Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del <i>CFTR</i>. <i>N. Eng</i></span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="refDoi"> DOI: 10.1056/NEJMoa1409547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1056%2FNEJMoa1409547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=25981758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKrtbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=220&author=C.+E.+Wainwrightauthor=J.+S.+Elbornauthor=B.+W.+Ramseyauthor=G.+Marigowdaauthor=X.+Huangauthor=M.+Cipolliauthor=C.+Colomboauthor=J.+C.+Daviesauthor=K.+De+Boeckauthor=P.+A.+Flumeauthor=M.+W.+Konstanauthor=S.+A.+McColleyauthor=K.+McCoyauthor=E.+F.+McKoneauthor=A.+Munckauthor=F.+Ratjenauthor=S.+M.+Roweauthor=D.+Waltzauthor=M.+P.+Boyle&title=Lumacaftor-Ivacaftor+in+Patients+with+Cystic+Fibrosis+Homozygous+for+Phe508del+CFTR.+N.+Eng&doi=10.1056%2FNEJMoa1409547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR</span></div><div class="casAuthors">Wainwright, C. E.; Elborn, J. S.; Ramsey, B. W.; Marigowda, G.; Huang, X.; Cipolli, M.; Colombo, C.; Davies, J. C.; De Boeck, K.; Flume, P. A.; Konstan, M. W.; McColley, S. A.; McCoy, K.; McKone, E. F.; Munck, A.; Ratjen, F.; Rowe, S. M.; Waltz, D.; Boyle, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-231</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Cystic fibrosis is a life-limiting disease that is caused by defective or deficient cystic fibrosis transmembrane conductance regulator (CFTR) protein activity.  Phe508del is the most common CFTR mutation.  We conducted two phase 3, randomized, double-blind, placebo-controlled studies that were designed to assess the effects of lumacaftor (VX-809), a CFTR corrector, in combination with ivacaftor (VX-770), a CFTR potentiator, in patients 12 years of age or older who had cystic fibrosis and were homozygous for the Phe508del CFTR mutation.  In both studies, patients were randomly assigned to receive either lumacaftor (600 mg once daily or 400 mg every 12 h) in combination with ivacaftor (250 mg every 12 h) or matched placebo for 24 wk.  The primary end point was the abs. change from baseline in the percentage of predicted forced expiratory vol. in 1 s (FEV1) at week 24.  A total of 1108 patients underwent randomization and received study drug.  The mean baseline FEV1 was 61% of the predicted value.  In both studies, there were significant improvements in the primary end point in both lumacaftor-ivacaftor dose groups; the difference between active treatment and placebo with respect to the mean abs. improvement in the percentage of predicted FEV1 ranged from 2.6 to 4.0 percentage points (P<0.001), which corresponded to a mean relative treatment difference of 4.3 to 6.7% (P<0.001).  Pooled analyses showed that the rate of pulmonary exacerbations was 30 to 39% lower in the lumacaftor-ivacaftor groups than in the placebo group; the rate of events leading to hospitalization or the use of i.v. antibiotics was lower in the lumacaftor-ivacaftor groups as well.  The incidence of adverse events was generally similar in the lumacaftor-ivacaftor and placebo groups.  The rate of discontinuation due to an adverse event was 4.2% among patients who received lumacaftor-ivacaftor vs. 1.6% among those who received placebo.  These data show that lumacaftor in combination with ivacaftor provided a benefit for patients with cystic fibrosis homozygous for the Phe508del CFTR mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZ6NBA6wsbbVg90H21EOLACvtfcHk0lh45rMBOrbUmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKrtbzJ&md5=223bb13c5c677a4db798be91ccedc665</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1409547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1409547%26sid%3Dliteratum%253Aachs%26aulast%3DWainwright%26aufirst%3DC.%2BE.%26aulast%3DElborn%26aufirst%3DJ.%2BS.%26aulast%3DRamsey%26aufirst%3DB.%2BW.%26aulast%3DMarigowda%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCipolli%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DJ.%2BC.%26aulast%3DDe%2BBoeck%26aufirst%3DK.%26aulast%3DFlume%26aufirst%3DP.%2BA.%26aulast%3DKonstan%26aufirst%3DM.%2BW.%26aulast%3DMcColley%26aufirst%3DS.%2BA.%26aulast%3DMcCoy%26aufirst%3DK.%26aulast%3DMcKone%26aufirst%3DE.%2BF.%26aulast%3DMunck%26aufirst%3DA.%26aulast%3DRatjen%26aufirst%3DF.%26aulast%3DRowe%26aufirst%3DS.%2BM.%26aulast%3DWaltz%26aufirst%3DD.%26aulast%3DBoyle%26aufirst%3DM.%2BP.%26atitle%3DLumacaftor-Ivacaftor%2520in%2520Patients%2520with%2520Cystic%2520Fibrosis%2520Homozygous%2520for%2520Phe508del%2520CFTR.%2520N.%2520Eng%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D220%26doi%3D10.1056%2FNEJMoa1409547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ruah, S. S. H.; Grootenhuis, P. D. J.; Van Goor, F.; Zhou, J.; Bear, B.; Miller, M. T.; McCartney, J.; Numa, M. M. D.</span><span> </span><span class="NLM_article-title">Indolyl Cycloalkylcarboxamide Compounds as Modulators of ATP-Binding Cassette Transporters and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Diseases</span>. US 7645789,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+S.+H.+Ruah&author=P.+D.+J.+Grootenhuis&author=F.+Van+Goor&author=J.+Zhou&author=B.+Bear&author=M.+T.+Miller&author=J.+McCartney&author=M.+M.+D.+Numa&title=Indolyl+Cycloalkylcarboxamide+Compounds+as+Modulators+of+ATP-Binding+Cassette+Transporters+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRuah%26aufirst%3DS.%2BS.%2BH.%26atitle%3DIndolyl%2520Cycloalkylcarboxamide%2520Compounds%2520as%2520Modulators%2520of%2520ATP-Binding%2520Cassette%2520Transporters%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Der Plas, S. E.; Mammoliti, O.; Menet, C.; Tricarico, G.; De Blieck, A.; Joanesse, C.; De Munck, T.; Kelgtermans, H.</span><span> </span><span class="NLM_article-title">Preparation of 5-Sulfonylthiophene-3-carboxamide Compounds and Pharmaceutical Compositions Thereof for the Treatment of Cystic Fibrosis</span>. US 20150005275,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+E.+Van+Der+Plas&author=O.+Mammoliti&author=C.+Menet&author=G.+Tricarico&author=A.+De+Blieck&author=C.+Joanesse&author=T.+De+Munck&author=H.+Kelgtermans&title=Preparation+of+5-Sulfonylthiophene-3-carboxamide+Compounds+and+Pharmaceutical+Compositions+Thereof+for+the+Treatment+of+Cystic+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BPlas%26aufirst%3DS.%2BE.%26atitle%3DPreparation%2520of%25205-Sulfonylthiophene-3-carboxamide%2520Compounds%2520and%2520Pharmaceutical%2520Compositions%2520Thereof%2520for%2520the%2520Treatment%2520of%2520Cystic%2520Fibrosis%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Van Der Plas, S. E.; Martina, S. L. X.; Dropsit-Montovert, S. J.-J. C.; Andrews, M. J. I.; Kelgtermans, H.</span><span> </span><span class="NLM_article-title">Thieno[2,3-c]pyrans as CFTR Modulators</span>. US 20150045327,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+E.+Van+Der+Plas&author=S.+L.+X.+Martina&author=S.+J.-J.+C.+Dropsit-Montovert&author=M.+J.+I.+Andrews&author=H.+Kelgtermans&title=Thieno%5B2%2C3-c%5Dpyrans+as+CFTR+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BPlas%26aufirst%3DS.%2BE.%26atitle%3DThieno%255B2%252C3-c%255Dpyrans%2520as%2520CFTR%2520Modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Miller, M. T.; Anderson, C.; Arumugam, V.; Bear, B. R.; Binch, H. M.; Clemens, J.; Cleveland, T.; Conroy, E.; Coon, T. R.; Frieman, B.A.; Grootenhuis, P. D. J.; Gross, R. S.; Hadida-Ruah, S. S.; Haripada, K.; Joshi, P. V.; Krenitsky, P. J.; Lin, C.-C.; Marelius, G. E.; Melilo, V.; McCartney, J.; Nicholls, G. M.; Pierre, F. J. D.; Silina, A.; Termin, A. P.; Uly, J.; Zhou, J.</span><span> </span><span class="NLM_article-title">Preparation of N-Aroylsulfonamide Derivatives as Cystic Fibrosis Transmembrane Conductance Regulator Modulators</span>. WO 2016057572,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+T.+Miller&author=C.+Anderson&author=V.+Arumugam&author=B.+R.+Bear&author=H.+M.+Binch&author=J.+Clemens&author=T.+Cleveland&author=E.+Conroy&author=T.+R.+Coon&author=B.A.+Frieman&author=P.+D.+J.+Grootenhuis&author=R.+S.+Gross&author=S.+S.+Hadida-Ruah&author=K.+Haripada&author=P.+V.+Joshi&author=P.+J.+Krenitsky&author=C.-C.+Lin&author=G.+E.+Marelius&author=V.+Melilo&author=J.+McCartney&author=G.+M.+Nicholls&author=F.+J.+D.+Pierre&author=A.+Silina&author=A.+P.+Termin&author=J.+Uly&author=J.+Zhou&title=Preparation+of+N-Aroylsulfonamide+Derivatives+as+Cystic+Fibrosis+Transmembrane+Conductance+Regulator+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DM.%2BT.%26atitle%3DPreparation%2520of%2520N-Aroylsulfonamide%2520Derivatives%2520as%2520Cystic%2520Fibrosis%2520Transmembrane%2520Conductance%2520Regulator%2520Modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tait, B.; Cullen, M.</span><span> </span><span class="NLM_article-title">Methods of Modulating CFTR Activity</span>. WO 2014210159 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Tait&author=M.+Cullen&title=Methods+of+Modulating+CFTR+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTait%26aufirst%3DB.%26atitle%3DMethods%2520of%2520Modulating%2520CFTR%2520Activity%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bastos, C. M.; Munoz, B.; Tait, B.</span><span> </span><span class="NLM_article-title">Compounds, Compositions, and Methods for Increasing CFTR Activity</span>. WO 2015138934 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+M.+Bastos&author=B.+Munoz&author=B.+Tait&title=Compounds%2C+Compositions%2C+and+Methods+for+Increasing+CFTR+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBastos%26aufirst%3DC.%2BM.%26atitle%3DCompounds%252C%2520Compositions%252C%2520and%2520Methods%2520for%2520Increasing%2520CFTR%2520Activity%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bastos, C. M.; Tait, B.; Munoz, B.</span><span> </span><span class="NLM_article-title">Compounds, Compositions, and Methods of Increasing CFTR Activity</span>. WO 2015196071 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+M.+Bastos&author=B.+Tait&author=B.+Munoz&title=Compounds%2C+Compositions%2C+and+Methods+of+Increasing+CFTR+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBastos%26aufirst%3DC.%2BM.%26atitle%3DCompounds%252C%2520Compositions%252C%2520and%2520Methods%2520of%2520Increasing%2520CFTR%2520Activity%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><div class="note"><p class="first last">For a review on autophagy see the following:</p></div><span class="NLM_contrib-group">Levine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Autophagy in the Pathogenesis of Disease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1016/j.cell.2007.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1016%2Fj.cell.2007.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=18191218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFehtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2008&pages=27-42&author=B.+Levineauthor=G.+Kroemer&title=Autophagy+in+the+Pathogenesis+of+Disease&doi=10.1016%2Fj.cell.2007.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy in the pathogenesis of disease</span></div><div class="casAuthors">Levine, Beth; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The role of mTOR kinase-related multiple pathways as regulators of autophagy in diseases is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJaHO5xPdGbVg90H21EOLACvtfcHk0lhvhZDDj58f-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFehtb8%253D&md5=330b3696429911990b51385919e2bd39</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DAutophagy%2520in%2520the%2520Pathogenesis%2520of%2520Disease%26jtitle%3DCell%26date%3D2008%26volume%3D132%26spage%3D27%26epage%3D42%26doi%3D10.1016%2Fj.cell.2007.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Luciani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villella, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettoello-Mantovani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnuccio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Matteis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, L.</span><span> </span><span class="NLM_article-title">Targeting Autophagy as a Novel Strategy for Facilitating the Therapeutic Action of Potentiators on ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1657</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span><span class="refDoi"> DOI: 10.4161/auto.21483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.21483" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=1657-1672&author=A.+Lucianiauthor=V.+R.+Villellaauthor=S.+Espositoauthor=M.+Gavinaauthor=I.+Russoauthor=M.+Silanoauthor=S.+Guidoauthor=M.+Pettoello-Mantovaniauthor=R.+Carnuccioauthor=B.+Scholteauthor=A.+De+Matteisauthor=M.+C.+Maiuriauthor=V.+Raiaauthor=A.+Luiniauthor=G.+Kroemerauthor=L.+Maiuri&title=Targeting+Autophagy+as+a+Novel+Strategy+for+Facilitating+the+Therapeutic+Action+of+Potentiators+on+%CE%94F508+Cystic+Fibrosis+Transmembrane+Conductance+Regulator&doi=10.4161%2Fauto.21483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.4161%2Fauto.21483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.21483%26sid%3Dliteratum%253Aachs%26aulast%3DLuciani%26aufirst%3DA.%26aulast%3DVillella%26aufirst%3DV.%2BR.%26aulast%3DEsposito%26aufirst%3DS.%26aulast%3DGavina%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DI.%26aulast%3DSilano%26aufirst%3DM.%26aulast%3DGuido%26aufirst%3DS.%26aulast%3DPettoello-Mantovani%26aufirst%3DM.%26aulast%3DCarnuccio%26aufirst%3DR.%26aulast%3DScholte%26aufirst%3DB.%26aulast%3DDe%2BMatteis%26aufirst%3DA.%26aulast%3DMaiuri%26aufirst%3DM.%2BC.%26aulast%3DRaia%26aufirst%3DV.%26aulast%3DLuini%26aufirst%3DA.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DL.%26atitle%3DTargeting%2520Autophagy%2520as%2520a%2520Novel%2520Strategy%2520for%2520Facilitating%2520the%2520Therapeutic%2520Action%2520of%2520Potentiators%2520on%2520%25CE%2594F508%2520Cystic%2520Fibrosis%2520Transmembrane%2520Conductance%2520Regulator%26jtitle%3DAutophagy%26date%3D2012%26volume%3D8%26spage%3D1657%26epage%3D1672%26doi%3D10.4161%2Fauto.21483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Luciani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villella, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetti-Pierri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settembre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulze, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardino, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettoello-Mantovani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Apolito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quaratino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballabio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, L.</span><span> </span><span class="NLM_article-title">Defective CFTR Induces Aggresome Formation and Lung Inflammation in Cystic Fibrosis through ROS-Mediated Autophagy Inhibition</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span><span class="refDoi"> DOI: 10.1038/ncb2090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fncb2090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=20711182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSju7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=863-875&author=A.+Lucianiauthor=V.+R.+Villellaauthor=S.+Espositoauthor=N.+Brunetti-Pierriauthor=D.+Medinaauthor=C.+Settembreauthor=M.+Gavinaauthor=L.+Pulzeauthor=I.+Giardinoauthor=M.+Pettoello-Mantovaniauthor=M.+D%E2%80%99Apolitoauthor=S.+Guidoauthor=E.+Masliahauthor=B.+Spencerauthor=S.+Quaratinoauthor=V.+Raiaauthor=A.+Ballabioauthor=L.+Maiuri&title=Defective+CFTR+Induces+Aggresome+Formation+and+Lung+Inflammation+in+Cystic+Fibrosis+through+ROS-Mediated+Autophagy+Inhibition&doi=10.1038%2Fncb2090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition</span></div><div class="casAuthors">Luciani, Alessandro; Villella, Valeria Rachela; Esposito, Speranza; Brunetti-Pierri, Nicola; Medina, Diego; Settembre, Carmine; Gavina, Manuela; Pulze, Laura; Giardino, Ida; Pettoello-Mantovani, Massimo; D'Apolito, Maria; Guido, Stefano; Masliah, Eliezer; Spencer, Brian; Quaratino, Sonia; Raia, Valeria; Ballabio, Andrea; Maiuri, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">863-875</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulation of unwanted/misfolded proteins in aggregates has been obsd. in airways of patients with cystic fibrosis (CF), a life-threatening genetic disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR).  Here we show how the defective CFTR results in defective autophagy and decreases the clearance of aggresomes.  Defective CFTR-induced upregulation of reactive oxygen species (ROS) and tissue transglutaminase (TG2) drive the crosslinking of beclin 1, leading to sequestration of phosphatidylinositol-3-kinase (PI(3)K) complex III and accumulation of p62, which regulates aggresome formation.  Both CFTR knockdown and the overexpression of green fluorescent protein (GFP)-tagged-CFTRF508del induce beclin 1 downregulation and defective autophagy in non-CF airway epithelia through the ROS-TG2 pathway.  Restoration of beclin 1 and autophagy by either beclin 1 overexpression, cystamine or antioxidants rescues the localization of the beclin 1 interactome to the endoplasmic reticulum and reverts the CF airway phenotype in vitro, in vivo in Scnn1b-transgenic and CftrF508del homozygous mice, and in human CF nasal biopsies.  Restoring beclin 1 or knocking down p62 rescued the trafficking of CFTRF508del to the cell surface.  These data link the CFTR defect to autophagy deficiency, leading to the accumulation of protein aggregates and to lung inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVfOWG7VtDybVg90H21EOLACvtfcHk0lhvhZDDj58f-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSju7%252FF&md5=34a5b1873c0110ea7d28f1018aa414a8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncb2090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2090%26sid%3Dliteratum%253Aachs%26aulast%3DLuciani%26aufirst%3DA.%26aulast%3DVillella%26aufirst%3DV.%2BR.%26aulast%3DEsposito%26aufirst%3DS.%26aulast%3DBrunetti-Pierri%26aufirst%3DN.%26aulast%3DMedina%26aufirst%3DD.%26aulast%3DSettembre%26aufirst%3DC.%26aulast%3DGavina%26aufirst%3DM.%26aulast%3DPulze%26aufirst%3DL.%26aulast%3DGiardino%26aufirst%3DI.%26aulast%3DPettoello-Mantovani%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Apolito%26aufirst%3DM.%26aulast%3DGuido%26aufirst%3DS.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DSpencer%26aufirst%3DB.%26aulast%3DQuaratino%26aufirst%3DS.%26aulast%3DRaia%26aufirst%3DV.%26aulast%3DBallabio%26aufirst%3DA.%26aulast%3DMaiuri%26aufirst%3DL.%26atitle%3DDefective%2520CFTR%2520Induces%2520Aggresome%2520Formation%2520and%2520Lung%2520Inflammation%2520in%2520Cystic%2520Fibrosis%2520through%2520ROS-Mediated%2520Autophagy%2520Inhibition%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D863%26epage%3D875%26doi%3D10.1038%2Fncb2090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span> </span><span class="NLM_article-title">Application and Interpretation of Current Autophagy Inhibitors and Activators</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span><span class="refDoi"> DOI: 10.1038/aps.2013.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Faps.2013.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=23524572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVartLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=625-635&author=Y.+Yangauthor=L.+Huauthor=H.+Zhengauthor=C.+Maoauthor=W.+Huauthor=K.+Xiongauthor=F.+Wangauthor=C.+Liu&title=Application+and+Interpretation+of+Current+Autophagy+Inhibitors+and+Activators&doi=10.1038%2Faps.2013.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Application and interpretation of current autophagy inhibitors and activators</span></div><div class="casAuthors">Yang, Ya-ping; Hu, Li-fang; Zheng, Hui-fen; Mao, Cheng-jie; Hu, Wei-dong; Xiong, Kang-ping; Wang, Fen; Liu, Chun-feng</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-635</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Autophagy is the major intracellular degrdn. system, by which cytoplasmic materials are delivered to and degraded in the lysosome.  As a quality control mechanism for cytoplasmic proteins and organelles, autophagy plays important roles in a variety of human diseases, including neurodegenerative diseases, cancer, cardiovascular disease, diabetes and infectious and inflammatory diseases.  The discovery of ATG genes and the dissection of the signaling pathways involved in regulating autophagy have greatly enriched our knowledge on the occurrence and development of this lysosomal degrdn. pathway.  In addn. to its role in degrdn., autophagy may also promote a type of programmed cell death that is different from apoptosis, termed type II programmed cell death.  Owing to the dual roles of autophagy in cell death and the specificity of diseases, the exact mechanisms of autophagy in various diseases require more investigation.  The application of autophagy inhibitors and activators will help us understand the regulation of autophagy in human diseases, and provide insight into the use of autophagy-targeted drugs.  In this review, we summarize the latest research on autophagy inhibitors and activators and discuss the possibility of their application in human disease therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF6qWsq47jlbVg90H21EOLACvtfcHk0lhxifCgv49E1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVartLg%253D&md5=5440d4cab70344584d5c1b08df328e6b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Faps.2013.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2013.5%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DXiong%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DC.%26atitle%3DApplication%2520and%2520Interpretation%2520of%2520Current%2520Autophagy%2520Inhibitors%2520and%2520Activators%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2013%26volume%3D34%26spage%3D625%26epage%3D635%26doi%3D10.1038%2Faps.2013.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">High doses of cysteamine have been administered chronically to nephropathic cystinosis patients (up to 2 g/day) to enable the clearance of cystine crystals out of the kidney in order to preserve its function. For a review on nephropathic cystinosis, see the following:</p></div><span class="NLM_contrib-group">Wilmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emma, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levtchenko, E. N.</span><span> </span><span class="NLM_article-title">The Pathogenesis of Cystinosis: Mechanisms Beyond Cystine Accummulation</span> <span class="citation_source-journal">Am. J. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">F905</span><span class="NLM_x">–</span> <span class="NLM_lpage">F916</span><span class="refDoi"> DOI: 10.1152/ajprenal.00318.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1152%2Fajprenal.00318.2010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=F905-F916&author=M.+Wilmerauthor=F.+Emmaauthor=E.+N.+Levtchenko&title=The+Pathogenesis+of+Cystinosis%3A+Mechanisms+Beyond+Cystine+Accummulation&doi=10.1152%2Fajprenal.00318.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00318.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00318.2010%26sid%3Dliteratum%253Aachs%26aulast%3DWilmer%26aufirst%3DM.%26aulast%3DEmma%26aufirst%3DF.%26aulast%3DLevtchenko%26aufirst%3DE.%2BN.%26atitle%3DThe%2520Pathogenesis%2520of%2520Cystinosis%253A%2520Mechanisms%2520Beyond%2520Cystine%2520Accummulation%26jtitle%3DAm.%2520J.%2520Phys.%26date%3D2010%26volume%3D299%26spage%3DF905%26epage%3DF916%26doi%3D10.1152%2Fajprenal.00318.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><div class="note"><p class="first last">For a review on autophagy and cystic fibrosis, see the following:</p></div><span class="NLM_contrib-group">Junkins, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-J.</span><span> </span><span class="NLM_article-title">The Emerging Potential of Autophagy-Based Therapies in the Treatment of Cystic Fibrosis Lung Infections</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.4161/auto.27750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.27750" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=538-547&author=R.+D.+Junkinsauthor=C.+McCormickauthor=T.-J.+Lin&title=The+Emerging+Potential+of+Autophagy-Based+Therapies+in+the+Treatment+of+Cystic+Fibrosis+Lung+Infections&doi=10.4161%2Fauto.27750"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.4161%2Fauto.27750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.27750%26sid%3Dliteratum%253Aachs%26aulast%3DJunkins%26aufirst%3DR.%2BD.%26aulast%3DMcCormick%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DT.-J.%26atitle%3DThe%2520Emerging%2520Potential%2520of%2520Autophagy-Based%2520Therapies%2520in%2520the%2520Treatment%2520of%2520Cystic%2520Fibrosis%2520Lung%2520Infections%26jtitle%3DAutophagy%26date%3D2014%26volume%3D10%26spage%3D538%26epage%3D547%26doi%3D10.4161%2Fauto.27750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">De Stefano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villella, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Gregorio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettoello-Mantovani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venerando, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raia, V.</span><span> </span><span class="NLM_article-title">Restoration of CFTR Function in Patients with Cystic Fibrosis Carrying the F508del-CFTR Mutation</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2053</span><span class="NLM_x">–</span> <span class="NLM_lpage">2074</span><span class="refDoi"> DOI: 10.4161/15548627.2014.973737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2F15548627.2014.973737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=25350163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=2053-2074&author=D.+De+Stefanoauthor=V.+R.+Villellaauthor=S.+Espositoauthor=A.+Toscoauthor=A.+Sepeauthor=F.+De+Gregorioauthor=L.+Salvadoriauthor=R.+Grassiaauthor=C.+A.+Leoneauthor=G.+De+Rosaauthor=M.+Maiuriauthor=M.+Pettoello-Mantovaniauthor=S.+Guidoauthor=A.+Bossiauthor=A.+Zolinauthor=A.+Venerandoauthor=L.+A.+Pinnaauthor=A.+Mehtaauthor=G.+Bonaauthor=G.+Kroemerauthor=L.+Maiuriauthor=V.+Raia&title=Restoration+of+CFTR+Function+in+Patients+with+Cystic+Fibrosis+Carrying+the+F508del-CFTR+Mutation&doi=10.4161%2F15548627.2014.973737"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation</span></div><div class="casAuthors">De Stefano, Daniela; Villella, Valeria R.; Esposito, Speranza; Tosco, Antonella; Sepe, Angela; De Gregorio, Fabiola; Salvadori, Laura; Grassia, Rosa; Leone, Carlo A.; De Rosa, Giuseppe; Maiuri, Maria C.; Pettoello-Mantovani, Massimo; Guido, Stefano; Bossi, Anna; Zolin, Anna; Venerando, Andrea; Pinna, Lorenzo A.; Mehta, Anil; Bona, Gianni; Kroemer, Guido; Maiuri, Luigi; Raia, Valeria</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2053-2074, 22 pp.</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Restoration of BECN1/Beclin 1-dependent autophagy and depletion of SQSTM1/p62 by genetic manipulation or autophagy-stimulatory proteostasis regulators, such as cystamine, have pos. effects on mouse models of human cystic fibrosis (CF).  These measures rescue the functional expression of the most frequent pathogenic CFTR mutant, F508del, at the respiratory epithelial surface and reduce lung inflammation in CftrF508del homozygous mice.  Cysteamine, the reduced form of cystamine, is an FDA-approved drug.  Here, we report that oral treatment with cysteamine greatly reduces the mortality rate and improves the phenotype of newborn mice bearing the F508del-CFTR mutation.  Cysteamine was also able to increase the plasma membrane expression of the F508del-CFTR protein in nasal epithelial cells from F508del homozygous CF patients, and these effects persisted for 24 h after cysteamine withdrawal.  Importantly, this cysteamine effect after washout was further sustained by the sequential administration of epigallocatechin gallate (EGCG), a green tea flavonoid, both in vivo, in mice, and in vitro, in primary epithelial cells from CF patients.  In a pilot clin. trial involving 10 F508del-CFTR homozygous CF patients, the combination of cysteamine and EGCG restored BECN1, reduced SQSTM1 levels and improved CFTR function from nasal epithelial cells in vivo, correlating with a decrease of chloride concns. in sweat, as well as with a redn. of the abundance of TNF/TNF-alpha (tumor necrosis factor) and CXCL8 (chemokine [C-X-C motif] ligand 8) transcripts in nasal brushing and TNF and CXCL8 protein levels in the sputum.  Altogether, these results suggest that optimal schedules of cysteamine plus EGCG might be used for the treatment of CF caused by the F508del-CFTR mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2A54UTj_n7Vg90H21EOLACvtfcHk0lhxifCgv49E1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKitb0%253D&md5=1b100eab0e1f08d91ec61c98ea80f6ab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4161%2F15548627.2014.973737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F15548627.2014.973737%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStefano%26aufirst%3DD.%26aulast%3DVillella%26aufirst%3DV.%2BR.%26aulast%3DEsposito%26aufirst%3DS.%26aulast%3DTosco%26aufirst%3DA.%26aulast%3DSepe%26aufirst%3DA.%26aulast%3DDe%2BGregorio%26aufirst%3DF.%26aulast%3DSalvadori%26aufirst%3DL.%26aulast%3DGrassia%26aufirst%3DR.%26aulast%3DLeone%26aufirst%3DC.%2BA.%26aulast%3DDe%2BRosa%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DM.%26aulast%3DPettoello-Mantovani%26aufirst%3DM.%26aulast%3DGuido%26aufirst%3DS.%26aulast%3DBossi%26aufirst%3DA.%26aulast%3DZolin%26aufirst%3DA.%26aulast%3DVenerando%26aufirst%3DA.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DBona%26aufirst%3DG.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DL.%26aulast%3DRaia%26aufirst%3DV.%26atitle%3DRestoration%2520of%2520CFTR%2520Function%2520in%2520Patients%2520with%2520Cystic%2520Fibrosis%2520Carrying%2520the%2520F508del-CFTR%2520Mutation%26jtitle%3DAutophagy%26date%3D2014%26volume%3D10%26spage%3D2053%26epage%3D2074%26doi%3D10.4161%2F15548627.2014.973737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tosco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Gregorio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stefano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sana, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buonpensiero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pasqua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guido, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lusa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiuri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raia, V.</span><span> </span><span class="NLM_article-title">A Novel Treatment of Cystic Fibrosis Acting On-Target: Cysteamine plus Epigallocatechin Gallate for the Autophagy-Dependent Rescue of Class II-Mutated CFTR</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1393</span><span class="refDoi"> DOI: 10.1038/cdd.2016.22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fcdd.2016.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=27035618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvVahtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1380-1393&author=A.+Toscoauthor=F.+De+Gregorioauthor=S.+Espositoauthor=D.+De+Stefanoauthor=I.+Sanaauthor=E.+Ferrariauthor=A.+Sepeauthor=L.+Salvadoriauthor=P.+Buonpensieroauthor=A.+Di+Pasquaauthor=R.+Grassiaauthor=C.+A.+Leoneauthor=S.+Guidoauthor=G.+De+Rosaauthor=S.+Lusaauthor=G.+Bonaauthor=G.+Stollauthor=M.+C.+Maiuriauthor=A.+Mehtaauthor=G.+Kroemerauthor=L.+Maiuriauthor=V.+Raia&title=A+Novel+Treatment+of+Cystic+Fibrosis+Acting+On-Target%3A+Cysteamine+plus+Epigallocatechin+Gallate+for+the+Autophagy-Dependent+Rescue+of+Class+II-Mutated+CFTR&doi=10.1038%2Fcdd.2016.22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR</span></div><div class="casAuthors">Tosco, A.; De Gregorio, F.; Esposito, S.; De Stefano, D.; Sana, I.; Ferrari, E.; Sepe, A.; Salvadori, L.; Buonpensiero, P.; Di Pasqua, A.; Grassia, R.; Leone, C. A.; Guido, S.; De Rosa, G.; Lusa, S.; Bona, G.; Stoll, G.; Maiuri, M. C.; Mehta, A.; Kroemer, G.; Maiuri, L.; Raia, V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1380-1393</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We previously reported that the combination of two safe proteostasis regulators, cysteamine and epigallocatechin gallate (EGCG), can be used to improve deficient expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in patients homozygous for the CFTR Phe508del mutation.  Here we provide the proof-of-concept that this combination treatment restored CFTR function and reduced lung inflammation (P<0.001) in Phe508del/Phe508del or Phe508del/null-Cftr (but not in Cftr-null mice), provided that such mice were autophagy-competent.  Primary nasal cells from patients bearing different class II CFTR mutations, either in homozygous or compd. heterozygous form, responded to the treatment in vitro.  We assessed individual responses to cysteamine plus EGCG in a single-center, open-label phase-2 trial.  The combination treatment decreased sweat chloride from baseline, increased both CFTR protein and function in nasal cells, restored autophagy in such cells, decreased CXCL8 and TNF-α in the sputum, and tended to improve respiratory function.  These pos. effects were particularly strong in patients carrying Phe508del CFTR mutations in homozygosity or heterozygosity.  However, a fraction of patients bearing other CFTR mutations failed to respond to therapy.  Importantly, the same patients whose primary nasal brushed cells did not respond to cysteamine plus EGCG in vitro also exhibited deficient therapeutic responses in vivo.  Altogether, these results suggest that the combination treatment of cysteamine plus EGCG acts 'on-target' because it can only rescue CFTR function when autophagy is functional (in mice) and improves CFTR function when a rescuable protein is expressed (in mice and men).  These results should spur the further clin. development of the combination treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGPNDLbqZzmLVg90H21EOLACvtfcHk0lhgfM_UEVL_BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvVahtLo%253D&md5=68938d9da2e6ea2909bf953c419cf9a9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2016.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2016.22%26sid%3Dliteratum%253Aachs%26aulast%3DTosco%26aufirst%3DA.%26aulast%3DDe%2BGregorio%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DS.%26aulast%3DDe%2BStefano%26aufirst%3DD.%26aulast%3DSana%26aufirst%3DI.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DSepe%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DL.%26aulast%3DBuonpensiero%26aufirst%3DP.%26aulast%3DDi%2BPasqua%26aufirst%3DA.%26aulast%3DGrassia%26aufirst%3DR.%26aulast%3DLeone%26aufirst%3DC.%2BA.%26aulast%3DGuido%26aufirst%3DS.%26aulast%3DDe%2BRosa%26aufirst%3DG.%26aulast%3DLusa%26aufirst%3DS.%26aulast%3DBona%26aufirst%3DG.%26aulast%3DStoll%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DM.%2BC.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DMaiuri%26aufirst%3DL.%26aulast%3DRaia%26aufirst%3DV.%26atitle%3DA%2520Novel%2520Treatment%2520of%2520Cystic%2520Fibrosis%2520Acting%2520On-Target%253A%2520Cysteamine%2520plus%2520Epigallocatechin%2520Gallate%2520for%2520the%2520Autophagy-Dependent%2520Rescue%2520of%2520Class%2520II-Mutated%2520CFTR%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D1380%26epage%3D1393%26doi%3D10.1038%2Fcdd.2016.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Jing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, K.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, K.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kweon, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, W.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K.</span><span> </span><span class="NLM_article-title">Docosahexaenoic Acid Induces Autophagy through p53/AMPK/mTOR Signaling and Promotes Apoptosis in Human Cancer Cells Harboring Wild-Type p53</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1358</span><span class="refDoi"> DOI: 10.4161/auto.7.11.16658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.7.11.16658" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=1348-1358&author=K.+Jingauthor=K.-S.+Songauthor=S.+Shinauthor=N.+Kimauthor=S.+Jeongauthor=H.-R.+Ohauthor=J.-H.+Parkauthor=K.-S.+Seoauthor=J.-Y.+Heoauthor=J.+Hanauthor=J.-I.+Parkauthor=C.+Hanauthor=T.+Wuauthor=G.+R.+Kweonauthor=S.+K.+Parkauthor=W.-H.+Yoonauthor=B.+D.+Hwangauthor=K.+Lim&title=Docosahexaenoic+Acid+Induces+Autophagy+through+p53%2FAMPK%2FmTOR+Signaling+and+Promotes+Apoptosis+in+Human+Cancer+Cells+Harboring+Wild-Type+p53&doi=10.4161%2Fauto.7.11.16658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.11.16658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.11.16658%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DK.-S.%26aulast%3DShin%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DJeong%26aufirst%3DS.%26aulast%3DOh%26aufirst%3DH.-R.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DSeo%26aufirst%3DK.-S.%26aulast%3DHeo%26aufirst%3DJ.-Y.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DJ.-I.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DKweon%26aufirst%3DG.%2BR.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DYoon%26aufirst%3DW.-H.%26aulast%3DHwang%26aufirst%3DB.%2BD.%26aulast%3DLim%26aufirst%3DK.%26atitle%3DDocosahexaenoic%2520Acid%2520Induces%2520Autophagy%2520through%2520p53%252FAMPK%252FmTOR%2520Signaling%2520and%2520Promotes%2520Apoptosis%2520in%2520Human%2520Cancer%2520Cells%2520Harboring%2520Wild-Type%2520p53%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26spage%3D1348%26epage%3D1358%26doi%3D10.4161%2Fauto.7.11.16658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Williams-Bey, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boularan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vural, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, N.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan-Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehrl, J. H.</span><span> </span><span class="NLM_article-title">Omega-3 Free Fatty Acids Suppress Macrophage Inflammasome Activation by Inhibiting NF-kappaB Activation and Enhancing Autophagy</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e97957</span><span class="refDoi"> DOI: 10.1371/journal.pone.0097957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1371%2Fjournal.pone.0097957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e97957&author=Y.+Williams-Beyauthor=C.+Boularanauthor=A.+Vuralauthor=N.-N.+Huangauthor=I.-Y.+Hwangauthor=C.+Shan-Shiauthor=J.+H.+Kehrl&title=Omega-3+Free+Fatty+Acids+Suppress+Macrophage+Inflammasome+Activation+by+Inhibiting+NF-kappaB+Activation+and+Enhancing+Autophagy&doi=10.1371%2Fjournal.pone.0097957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0097957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0097957%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams-Bey%26aufirst%3DY.%26aulast%3DBoularan%26aufirst%3DC.%26aulast%3DVural%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DN.-N.%26aulast%3DHwang%26aufirst%3DI.-Y.%26aulast%3DShan-Shi%26aufirst%3DC.%26aulast%3DKehrl%26aufirst%3DJ.%2BH.%26atitle%3DOmega-3%2520Free%2520Fatty%2520Acids%2520Suppress%2520Macrophage%2520Inflammasome%2520Activation%2520by%2520Inhibiting%2520NF-kappaB%2520Activation%2520and%2520Enhancing%2520Autophagy%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De97957%26doi%3D10.1371%2Fjournal.pone.0097957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mizushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimori, T.</span><span> </span><span class="NLM_article-title">How to Interpret LC3 Immunoblotting</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.4161/auto.4600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.4600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=17611390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOhs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=542-545&author=N.+Mizushimaauthor=T.+Yoshimori&title=How+to+Interpret+LC3+Immunoblotting&doi=10.4161%2Fauto.4600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">How to interpret LC3 immunoblotting</span></div><div class="casAuthors">Mizushima, Noboru; Yoshimori, Tamotsu</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-545</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Microtubule-assocd. protein light chain 3 (LC3) is now widely used to monitor autophagy.  One approach is to detect LC3 conversion (LC3-I to LC3-II) by immunoblot anal. because the amt. of LC3-II is clearly correlated with the no. of autophagosomes.  However, LC3-II itself is degraded by autophagy, making interpretation of the results of LC3 immunoblotting problematic.  Furthermore, the amt. of LC3 at a certain time point does not indicate autophagic flux, and therefore, it is important to measure the amt. of LC3-II delivered to lysosomes by comparing LC3-II levels in the presence and absence of lysosomal protease inhibitors.  Another problem with this method is that LC3-II tends to be much more sensitive to be detected by immunoblotting than LC3-I.  Accordingly, simple comparison of LC3-I and LC3-II, or summation of LC3-I and LC3-II for ratio detns., may not be appropriate, and rather, the amt. of LC3-II can be compared between samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruWJOF3diCsrVg90H21EOLACvtfcHk0likK7WN56JfDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOhs7jL&md5=f82d6ff49bcfdb0804ddc77c32d03300</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2Fauto.4600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.4600%26sid%3Dliteratum%253Aachs%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DYoshimori%26aufirst%3DT.%26atitle%3DHow%2520to%2520Interpret%2520LC3%2520Immunoblotting%26jtitle%3DAutophagy%26date%3D2007%26volume%3D3%26spage%3D542%26epage%3D545%26doi%3D10.4161%2Fauto.4600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">We have evaluated the fatty acid cysteamine <b>1</b> in cultured primary homozygous F508del-CFTR hBE cells from different donors (KKCFFT006F and CFFT028H) and have observed a similar level of autophagy activation (data not shown).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Neuberger, T.; Burton, B.; Clark, H.; Van Goor, F.</span> In  <span class="citation_source-book">Cystic Fibrosis</span>; <span class="NLM_contrib-group">Amaral, M. D.; Kunzelmann, K.</span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Chapter 4, pp  <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1007%2F978-1-61779-117-8_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=39-54&author=T.+Neuberger&author=B.+Burton&author=H.+Clark&author=F.+Van+Goorauthor=M.+D.+Amaral&author=K.+Kunzelmann&title=Cystic+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-117-8_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-61779-117-8_4%26sid%3Dliteratum%253Aachs%26aulast%3DNeuberger%26aufirst%3DT.%26btitle%3DCystic%2520Fibrosis%26aulast%3DAmaral%26aufirst%3DM.%2BD.%26pub%3DHumana%2520Press%26date%3D2011%26spage%3D39%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Cholon, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinney, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulcher, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esther, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokholyan, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randell, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentzsch, M.</span><span> </span><span class="NLM_article-title">Potentiator Ivacaftor Abrogates Pharmacological Correction of ΔF508 CFTR in Cystic Fibrosis</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">246ra96</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3008680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1126%2Fscitranslmed.3008680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=25101886" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=246ra96&author=D.+M.+Cholonauthor=N.+L.+Quinneyauthor=M.+L.+Fulcherauthor=C.+R.+Estherauthor=J.+Dasauthor=N.+V.+Dokholyanauthor=S.+H.+Randellauthor=R.+C.+Boucherauthor=M.+Gentzsch&title=Potentiator+Ivacaftor+Abrogates+Pharmacological+Correction+of+%CE%94F508+CFTR+in+Cystic+Fibrosis&doi=10.1126%2Fscitranslmed.3008680"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3008680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3008680%26sid%3Dliteratum%253Aachs%26aulast%3DCholon%26aufirst%3DD.%2BM.%26aulast%3DQuinney%26aufirst%3DN.%2BL.%26aulast%3DFulcher%26aufirst%3DM.%2BL.%26aulast%3DEsther%26aufirst%3DC.%2BR.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DDokholyan%26aufirst%3DN.%2BV.%26aulast%3DRandell%26aufirst%3DS.%2BH.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DGentzsch%26aufirst%3DM.%26atitle%3DPotentiator%2520Ivacaftor%2520Abrogates%2520Pharmacological%2520Correction%2520of%2520%25CE%2594F508%2520CFTR%2520in%2520Cystic%2520Fibrosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D246ra96%26doi%3D10.1126%2Fscitranslmed.3008680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Veit, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avramescu, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdomo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phuan, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagdany, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apaja, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szollosi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkbeiner, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegedus, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, G. L.</span><span> </span><span class="NLM_article-title">Some Gating Potentiators, Including Ivacaftor, Diminish ΔF508-CFTR Functional Expression</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">246ra97</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3008889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1126%2Fscitranslmed.3008889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=25101887" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=246ra97&author=G.+Veitauthor=R.+G.+Avramescuauthor=D.+Perdomoauthor=P.+W.+Phuanauthor=M.+Bagdanyauthor=P.+M.+Apajaauthor=F.+Borotauthor=D.+Szollosiauthor=Y.-S.+Wuauthor=W.+E.+Finkbeinerauthor=T.+Hegedusauthor=A.+S.+Verkmanauthor=G.+L.+Lukacs&title=Some+Gating+Potentiators%2C+Including+Ivacaftor%2C+Diminish+%CE%94F508-CFTR+Functional+Expression&doi=10.1126%2Fscitranslmed.3008889"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3008889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3008889%26sid%3Dliteratum%253Aachs%26aulast%3DVeit%26aufirst%3DG.%26aulast%3DAvramescu%26aufirst%3DR.%2BG.%26aulast%3DPerdomo%26aufirst%3DD.%26aulast%3DPhuan%26aufirst%3DP.%2BW.%26aulast%3DBagdany%26aufirst%3DM.%26aulast%3DApaja%26aufirst%3DP.%2BM.%26aulast%3DBorot%26aufirst%3DF.%26aulast%3DSzollosi%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DY.-S.%26aulast%3DFinkbeiner%26aufirst%3DW.%2BE.%26aulast%3DHegedus%26aufirst%3DT.%26aulast%3DVerkman%26aufirst%3DA.%2BS.%26aulast%3DLukacs%26aufirst%3DG.%2BL.%26atitle%3DSome%2520Gating%2520Potentiators%252C%2520Including%2520Ivacaftor%252C%2520Diminish%2520%25CE%2594F508-CFTR%2520Functional%2520Expression%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D246ra97%26doi%3D10.1126%2Fscitranslmed.3008889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">We have also evaluated the fatty acid cysteamine conjugate <b>1</b> by itself (without the presence of the CFTR corrector lumacaftor) and have observed no significant change in the CFTR chloride current (data not shown).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Upon changing the differentiation medium to Coon’s F12 medium, the plate was incubated for 4 h in a CO<sub>2</sub> free incubator prior to <i>I</i><sub>EQ</sub> measurements. With the chronic ivacaftor preincubation protocol, we have found that the longer 4 h incubation period in Coon’s F12 medium was helpful, since it allowed primary hBE cells to process and hydrolyze the lipophilic fatty acid conjugate <b>1</b> more completely. Without this longer incubation time, some of the precipitated, oily fatty acid conjugates could interfere with the current recording; the results became more variable and harder to interpret.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">Additional TECC-24 assay data for this run, as well as for other runs, are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">In this TECC-24 assay setup using cells from the same donor (KKCFFT006F), we have also evaluated <b>1</b> at concentrations as low as 0.075 μM and still observed a statistically significant increase in the AUC. This data set is shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Dekkers, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegerinck, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jonge, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronsveld, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssens, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Winter-de Groot, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandsma, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, N. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijvelds, M. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholte, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwenhuis, E. E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Brink, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clevers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Ent, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middendorp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beekman, J. M.</span><span> </span><span class="NLM_article-title">A Funtional CFTR Assay Using Primary Cystic Fibrosis Intestinal Organoids</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span><span class="refDoi"> DOI: 10.1038/nm.3201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fnm.3201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=23727931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFWqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=939-945&author=J.+F.+Dekkersauthor=C.+L.+Wiegerinckauthor=H.+R.+de+Jongeauthor=I.+Bronsveldauthor=H.+M.+Janssensauthor=K.+M.+de+Winter-de+Grootauthor=A.+M.+Brandsmaauthor=N.+W.+M.+de+Jongauthor=M.+J.+C.+Bijveldsauthor=B.+J.+Scholteauthor=E.+E.+S.+Nieuwenhuisauthor=S.+van+den+Brinkauthor=H.+Cleversauthor=C.+K.+van+der+Entauthor=S.+Middendorpauthor=J.+M.+Beekman&title=A+Funtional+CFTR+Assay+Using+Primary+Cystic+Fibrosis+Intestinal+Organoids&doi=10.1038%2Fnm.3201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A functional CFTR assay using primary cystic fibrosis intestinal organoids</span></div><div class="casAuthors">Dekkers, Johanna F.; Wiegerinck, Caroline L.; de Jonge, Hugo R.; Bronsveld, Inez; Janssens, Hettie M.; de Winter-de Groot, Karin M.; Brandsma, Arianne M.; de Jong, Nienke W. M.; Bijvelds, Marcel J. C.; Scholte, Bob J.; Nieuwenhuis, Edward E. S.; van den Brink, Stieneke; Clevers, Hans; van der Ent, Cornelis K.; Middendorp, Sabine; Beekman, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">939-945</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We recently established conditions allowing for long-term expansion of epithelial organoids from intestine, recapitulating essential features of the in vivo tissue architecture.  Here we apply this technol. to study primary intestinal organoids of people suffering from cystic fibrosis, a disease caused by mutations in CFTR, encoding cystic fibrosis transmembrane conductance regulator.  Forskolin induces rapid swelling of organoids derived from healthy controls or wild-type mice, but this effect is strongly reduced in organoids of subjects with cystic fibrosis or in mice carrying the Cftr F508del mutation and is absent in Cftr-deficient organoids.  This pattern is phenocopied by CFTR-specific inhibitors.  Forskolin-induced swelling of in vitro-expanded human control and cystic fibrosis organoids corresponds quant. with forskolin-induced anion currents in freshly excised ex vivo rectal biopsies.  Function of the CFTR F508del mutant protein is restored by incubation at low temp., as well as by CFTR-restoring compds.  This relatively simple and robust assay will facilitate diagnosis, functional studies, drug development and personalized medicine approaches in cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp13MmQ8EOOYLVg90H21EOLACvtfcHk0lgS9GkKME4_Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFWqsrw%253D&md5=598d7aa08b0ee5a698cc0c35dd2d1c93</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnm.3201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3201%26sid%3Dliteratum%253Aachs%26aulast%3DDekkers%26aufirst%3DJ.%2BF.%26aulast%3DWiegerinck%26aufirst%3DC.%2BL.%26aulast%3Dde%2BJonge%26aufirst%3DH.%2BR.%26aulast%3DBronsveld%26aufirst%3DI.%26aulast%3DJanssens%26aufirst%3DH.%2BM.%26aulast%3Dde%2BWinter-de%2BGroot%26aufirst%3DK.%2BM.%26aulast%3DBrandsma%26aufirst%3DA.%2BM.%26aulast%3Dde%2BJong%26aufirst%3DN.%2BW.%2BM.%26aulast%3DBijvelds%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DScholte%26aufirst%3DB.%2BJ.%26aulast%3DNieuwenhuis%26aufirst%3DE.%2BE.%2BS.%26aulast%3Dvan%2Bden%2BBrink%26aufirst%3DS.%26aulast%3DClevers%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BEnt%26aufirst%3DC.%2BK.%26aulast%3DMiddendorp%26aufirst%3DS.%26aulast%3DBeekman%26aufirst%3DJ.%2BM.%26atitle%3DA%2520Funtional%2520CFTR%2520Assay%2520Using%2520Primary%2520Cystic%2520Fibrosis%2520Intestinal%2520Organoids%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D939%26epage%3D945%26doi%3D10.1038%2Fnm.3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kellogg, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovtun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leece, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeves, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteman, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdison, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, R. V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, R. J.</span><span> </span><span class="NLM_article-title">Disulfide-Linked Antibody-Maytansinoid Conjugates: Optimization of in vivo Activity by Varying the Steric Hindrance at Carbon Atoms Adjacent to the Disulfide Linkage</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.1021/bc100480a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc100480a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=717-727&author=B.+A.+Kelloggauthor=L.+Garrettauthor=Y.+Kovtunauthor=K.+C.+Laiauthor=B.+Leeceauthor=M.+Millerauthor=G.+Payneauthor=R.+Steevesauthor=K.+R.+Whitemanauthor=W.+Widdisonauthor=H.+Xieauthor=R.+Singhauthor=R.+V.+J.+Chariauthor=J.+M.+Lambertauthor=R.+J.+Lutz&title=Disulfide-Linked+Antibody-Maytansinoid+Conjugates%3A+Optimization+of+in+vivo+Activity+by+Varying+the+Steric+Hindrance+at+Carbon+Atoms+Adjacent+to+the+Disulfide+Linkage&doi=10.1021%2Fbc100480a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage</span></div><div class="casAuthors">Kellogg, Brenda A.; Garrett, Lisa; Kovtun, Yelena; Lai, Katharine C.; Leece, Barbara; Miller, Michael; Payne, Gillian; Steeves, Rita; Whiteman, Kathleen R.; Widdison, Wayne; Xie, Hongsheng; Singh, Rajeeva; Chari, Ravi V. J.; Lambert, John M.; Lutz, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">717-727</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this report, we describe the synthesis of a panel of disulfide-linked huC242 (anti-CanAg) antibody maytansinoid conjugates (AMCs), which have varying levels of steric hindrance around the disulfide bond, in order to investigate the relationship between stability to redn. of the disulfide linker and antitumor activity of the conjugate in vivo.  The conjugates were first tested for stability to redn. by dithiothreitol in vitro and for plasma stability in CD1 mice.  It was found that the conjugates having the more sterically hindered disulfide linkages were more stable to reductive cleavage of the maytansinoid in both settings.  When the panel of conjugates was tested for in vivo efficacy in two human colon cancer xenograft models in SCID mice, it was found that the conjugate with intermediate disulfide bond stability having two Me groups on the maytansinoid side of the disulfide bond and no Me groups on the linker side of the disulfide bond (huC242-SPDB-DM4) displayed the best efficacy.  The ranking of in vivo efficacies of the conjugates was not predicted by their in vitro potencies, since all conjugates were highly active in vitro, including a huC242-SMCC-DM1 conjugate with a noncleavable linkage which showed only marginal activity in vivo.  These data suggest that factors in addn. to intrinsic conjugate potency and conjugate half-life in plasma influence the magnitude of antitumor activity obsd. for an AMC in vivo.  We provide evidence that bystander killing of neighboring nontargeted tumor cells by diffusible cytotoxic metabolites produced from target cell processing of disulfide-linked antibody-maytansinoid conjugates may be one addnl. factor contributing to the activity of these conjugates in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGmGw-cH238bVg90H21EOLACvtfcHk0lj1mwD8CXYjrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsro%253D&md5=ef2969ceaaea23e81da2edf06f62ea7e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbc100480a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc100480a%26sid%3Dliteratum%253Aachs%26aulast%3DKellogg%26aufirst%3DB.%2BA.%26aulast%3DGarrett%26aufirst%3DL.%26aulast%3DKovtun%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DK.%2BC.%26aulast%3DLeece%26aufirst%3DB.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DPayne%26aufirst%3DG.%26aulast%3DSteeves%26aufirst%3DR.%26aulast%3DWhiteman%26aufirst%3DK.%2BR.%26aulast%3DWiddison%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DChari%26aufirst%3DR.%2BV.%2BJ.%26aulast%3DLambert%26aufirst%3DJ.%2BM.%26aulast%3DLutz%26aufirst%3DR.%2BJ.%26atitle%3DDisulfide-Linked%2520Antibody-Maytansinoid%2520Conjugates%253A%2520Optimization%2520of%2520in%2520vivo%2520Activity%2520by%2520Varying%2520the%2520Steric%2520Hindrance%2520at%2520Carbon%2520Atoms%2520Adjacent%2520to%2520the%2520Disulfide%2520Linkage%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D717%26epage%3D727%26doi%3D10.1021%2Fbc100480a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">In this rat PK experiment, the plasma levels of cysteamine <b>12</b> and bis-geminal cysteamine <b>13</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) were not determined. However, in a separate PK experiment involving Sprague Dawley rats that have been surgically implanted with indwelling jugular vein cannula and portal vein cannula (similarly dosed orally at 30 mg/kg) only trace quantities of these two metabolites were detectable in the peripheral plasma. Niacin, nicotinuric acid <b>14</b>, and the thiol-nicotinamide metabolite <b>11</b> could not be detected in the peripheral plasma. A significant first pass metabolism of <b>11</b> had presumably taken place, since a significant quantity of it was detected in the portal circulation (metabolite <b>11</b>; portal <i>C</i><sub>max</sub> = 3129 ± 564 ng/mL, portal AUC<sub>last</sub> = 5888 ± 1297 h·ng/mL).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">Compound <b>5</b> has also been dosed orally (100 mg/kg b.i.d.) in a mouse PK/tissue distribution study over a 3.5 day period in order to assess autophagy activation in the various tissues. Both the parent compound and the biologically active metabolite <b>1</b> were detected in plasma and lung tissues. Compound <b>5</b> has also been administered to the Beagle dog orally with multiple doses over a 14 day period. The results from these studies will be discussed in more detail in a separate communication.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Levine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deretic, V.</span><span> </span><span class="NLM_article-title">Unveiling the Roles of Autophagy in Innate and Adaptive Immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span><span class="refDoi"> DOI: 10.1038/nri2161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Fnri2161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=17767194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOrtbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=767-777&author=B.+Levineauthor=V.+Deretic&title=Unveiling+the+Roles+of+Autophagy+in+Innate+and+Adaptive+Immunity&doi=10.1038%2Fnri2161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Unveiling the roles of autophagy in innate and adaptive immunity</span></div><div class="casAuthors">Levine, Beth; Deretic, Vojo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">767-777</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells digest portions of their interiors in a process known as autophagy to recycle nutrients, remodel, and dispose of unwanted cytoplasmic constituents.  This ancient pathway, conserved from yeast to humans, is now emerging as a central player in the immunol. control of bacterial, parasitic, and viral infections.  The process of autophagy may degrade intracellular pathogens, deliver endogenous antigens to MHC class II-loading compartments, direct viral nucleic acids to Toll-like receptors, and regulate T-cell homeostasis.  This review describes the mechanisms of autophagy and highlights recent advances relevant to the role of autophagy in innate and adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmlHAwhNEYdrVg90H21EOLACvtfcHk0lj1mwD8CXYjrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOrtbnM&md5=925371512ee525495f2ae6028c7597ae</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnri2161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2161%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DDeretic%26aufirst%3DV.%26atitle%3DUnveiling%2520the%2520Roles%2520of%2520Autophagy%2520in%2520Innate%2520and%2520Adaptive%2520Immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26spage%3D767%26epage%3D777%26doi%3D10.1038%2Fnri2161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Amano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakagawa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimori, T.</span><span> </span><span class="NLM_article-title">Autophagy in Innate Immunity against Intracellular Bacteria</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1093/jb/mvj162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1093%2Fjb%2Fmvj162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=16954534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKns7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2006&pages=161-166&author=A.+Amanoauthor=I.+Kakagawaauthor=T.+Yoshimori&title=Autophagy+in+Innate+Immunity+against+Intracellular+Bacteria&doi=10.1093%2Fjb%2Fmvj162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy in innate immunity against intracellular bacteria</span></div><div class="casAuthors">Amano, Atsuo; Nakagawa, Ichiro; Yoshimori, Tamotsu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-166</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Many pathogenic bacteria can invade phagocytic and non-phagocytic cells and colonize them intracellularly, then become disseminated to other cells.  The endocytic degrdn. pathway is thought to be the only prevention against such intracellular pathogens.  Autophagy, a fundamental cellular homeostasis pathway that operates with the intracellular degrdn./recycling system, causes the turnover of cellular components by delivering portions of the cytoplasm and organelles to lysosomes.  Recently, we reported that autophagic degrdn. is a previously unrecognized effector of host innate immunity.  Streptococcus pyogenes (Group A Streptococcus; GAS) successfully enters human epithelial cells via endocytosis.  GAS immediately escapes from the endosomes to the cytoplasm and gains a replicative niche, after which GAS in the cytoplasm is trapped in autophagosome-like compartments and degraded upon fusion with lysosomes.  This process indicates that autophagy plays a protective role in infectious diseases.  We also found that autophagic degrdn. was induced against Staphylococcus aureus, while methicillin-resistant S. aureus were resistant to autophagic degrdn.  The present review focuses on the protective function of autophagy against bacterial invasion of cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPV5-XOHa4lrVg90H21EOLACvtfcHk0lj1mwD8CXYjrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKns7jN&md5=0c7cf9ec5c298dd71626a4fb4bd5cc0e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvj162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvj162%26sid%3Dliteratum%253Aachs%26aulast%3DAmano%26aufirst%3DA.%26aulast%3DKakagawa%26aufirst%3DI.%26aulast%3DYoshimori%26aufirst%3DT.%26atitle%3DAutophagy%2520in%2520Innate%2520Immunity%2520against%2520Intracellular%2520Bacteria%26jtitle%3DJ.%2520Biochem.%26date%3D2006%26volume%3D140%26spage%3D161%26epage%3D166%26doi%3D10.1093%2Fjb%2Fmvj162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Cripps, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clancy, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyd, J.</span><span> </span><span class="NLM_article-title">Pulmonary Immunity to <i>Pseudomonas aeruginosa</i></span> <span class="citation_source-journal">Immunol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span><span class="refDoi"> DOI: 10.1038/icb.1995.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1038%2Ficb.1995.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=8595919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A280%3ADyaK287mslSgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1995&pages=418-424&author=A.+W.+Crippsauthor=M.+L.+Dunkleyauthor=R.+L.+Clancyauthor=J.+Kyd&title=Pulmonary+Immunity+to+Pseudomonas+aeruginosa&doi=10.1038%2Ficb.1995.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary immunity to Pseudomonas aeruginosa</span></div><div class="casAuthors">Cripps A W; Dunkley M L; Clancy R L; Kyd J</div><div class="citationInfo"><span class="NLM_cas:title">Immunology and cell biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">418-24</span>
        ISSN:<span class="NLM_cas:issn">0818-9641</span>.
    </div><div class="casAbstract">Pseudomonas aeruginosa, an opportunistic bacterial pathogen, is a major course of morbidity and mortality in subjects with compromised respiratory function despite the significant advances in therapeutic practices.  The bacteria produces an armoury of products which modify its infective niche to ensure bacterial survival.  The role of antibody in protection against pulmonary infection remains poorly defined.  Protection appears to be associated with opsonizing antibody whilst some other antibody responses may be deleterious and promote further lung damage.  Cell mediated responses are clearly important in protection against infection.  This review proposes a vaccine strategy aimed at enhancing specific T cell responses in the lung which, though T cell-derived cytokines, drive the recruitment of neutrophils to the lung and the subsequent activation of these cells results in the clearance of bacteria from the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPPrY_q8l_CEcLvDNbOD4DfW6udTcc2eZSjFy204Aqpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287mslSgsA%253D%253D&md5=129ac594e610e59f697fcae44ddb96b4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Ficb.1995.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ficb.1995.65%26sid%3Dliteratum%253Aachs%26aulast%3DCripps%26aufirst%3DA.%2BW.%26aulast%3DDunkley%26aufirst%3DM.%2BL.%26aulast%3DClancy%26aufirst%3DR.%2BL.%26aulast%3DKyd%26aufirst%3DJ.%26atitle%3DPulmonary%2520Immunity%2520to%2520Pseudomonas%2520aeruginosa%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D1995%26volume%3D73%26spage%3D418%26epage%3D424%26doi%3D10.1038%2Ficb.1995.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Hauser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Meir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColley, S. A.</span><span> </span><span class="NLM_article-title">Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1128/CMR.00036-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1128%2FCMR.00036-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=21233507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=29-70&author=A.+R.+Hauserauthor=M.+Jainauthor=M.+Bar-Meirauthor=S.+A.+McColley&title=Clinical+Significance+of+Microbial+Infection+and+Adaptation+in+Cystic+Fibrosis&doi=10.1128%2FCMR.00036-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical significance of microbial infection and adaptation in cystic fibrosis</span></div><div class="casAuthors">Hauser, Alan R.; Jain, Manu; Bar-Meir, Maskit; McColley, Susanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-70</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  A select group of microorganisms inhabit the airways of individuals with cystic fibrosis.  Once established within the pulmonary environment in these patients, many of these microbes adapt by altering aspects of their structure and physiol.  Some of these microbes and adaptations are assocd. with more rapid deterioration in lung function and overall clin. status, whereas others appear to have little effect.  Here we review current evidence supporting or refuting a role for the different microbes and their adaptations in contributing to poor clin. outcomes in cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaDbwWkf1qarVg90H21EOLACvtfcHk0lhMwcLj95TTuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSgu70%253D&md5=591006729c2c2b1962828510af021b34</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FCMR.00036-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00036-10%26sid%3Dliteratum%253Aachs%26aulast%3DHauser%26aufirst%3DA.%2BR.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DBar-Meir%26aufirst%3DM.%26aulast%3DMcColley%26aufirst%3DS.%2BA.%26atitle%3DClinical%2520Significance%2520of%2520Microbial%2520Infection%2520and%2520Adaptation%2520in%2520Cystic%2520Fibrosis%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2011%26volume%3D24%26spage%3D29%26epage%3D70%26doi%3D10.1128%2FCMR.00036-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Buchanan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elborn, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schock, B.</span><span> </span><span class="NLM_article-title">Role of CFTR, <i>Pseudomonas aeruginosa</i> and Toll-like Receptors in Cystic Fibrosis lung inflammation</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.1042/BST0370863</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1042%2FBST0370863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=19614608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVOju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=863-867&author=P.+J.+Buchananauthor=R.+K.+Ernstauthor=J.+S.+Elbornauthor=B.+Schock&title=Role+of+CFTR%2C+Pseudomonas+aeruginosa+and+Toll-like+Receptors+in+Cystic+Fibrosis+lung+inflammation&doi=10.1042%2FBST0370863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation</span></div><div class="casAuthors">Buchanan, Paul J.; Ernst, Robert K.; Elborn, J. Stuart; Schock, Bettina</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">863-867</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  CF (cystic fibrosis) is a severe autosomal recessive disease most common in Northwest European populations.  Underlying mutations in the CFTR (CF transmembrane conductance regulator) gene cause deregulation of ion transport and subsequent dehydration of the airway surface liq., producing a viscous mucus layer on the airway surface of CF patients.  This layer is readily colonized by bacteria such as Pseudomonas aeruginosa.  Owing to the resulting environment and treatment strategies, the bacteria acquire genetic modifications such as antibiotic resistance, biofilm formation, antimicrobial peptide resistance and pro-inflammatory lipid A structures.  Lipid A is a component of the lipopolysaccharide cell wall present on bacteria and is recognized by TLR4 (Toll-like receptor 4).  Its detection elicits a pro-inflammatory response that is heightened over time due to the addn. of fatty acids to the lipid A structure.  Eradication of bacteria from the lungs of CF patients becomes increasingly difficult and eventually leads to mortality.  In the present review, we describe the role of lipid A as a virulent factor of Ps. aeruginosa; however, it appears that further work is needed to investigate the role of CFTR in the innate immune response and in modifying the pathogen-host interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq6Z-YJvo4s7Vg90H21EOLACvtfcHk0lhMwcLj95TTuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVOju7o%253D&md5=dea5bc3ddc7c5c4916ec1e429d619a44</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1042%2FBST0370863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0370863%26sid%3Dliteratum%253Aachs%26aulast%3DBuchanan%26aufirst%3DP.%2BJ.%26aulast%3DErnst%26aufirst%3DR.%2BK.%26aulast%3DElborn%26aufirst%3DJ.%2BS.%26aulast%3DSchock%26aufirst%3DB.%26atitle%3DRole%2520of%2520CFTR%252C%2520Pseudomonas%2520aeruginosa%2520and%2520Toll-like%2520Receptors%2520in%2520Cystic%2520Fibrosis%2520lung%2520inflammation%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2009%26volume%3D37%26spage%3D863%26epage%3D867%26doi%3D10.1042%2FBST0370863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Garcia-Medina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunne, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brody, S. L.</span><span> </span><span class="NLM_article-title"><i>Pseudomonas aeruginosa</i> Acquires Biofilm-like Properties within Airway Epithelial Cells</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">8298</span><span class="NLM_x">–</span> <span class="NLM_lpage">8305</span><span class="refDoi"> DOI: 10.1128/IAI.73.12.8298-8305.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1128%2FIAI.73.12.8298-8305.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=16299327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlertrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=8298-8305&author=R.+Garcia-Medinaauthor=W.+M.+Dunneauthor=P.+K.+Singhauthor=S.+L.+Brody&title=Pseudomonas+aeruginosa+Acquires+Biofilm-like+Properties+within+Airway+Epithelial+Cells&doi=10.1128%2FIAI.73.12.8298-8305.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells</span></div><div class="casAuthors">Garcia-Medina, Raquel; Dunne, W. Michael; Singh, Pradeep K.; Brody, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8298-8305</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pseudomonas aeruginosa can notably cause both acute and chronic infection.  While several virulence factors are implicated in the acute phase of infection, advances in understanding bacterial pathogenesis suggest that chronic P. aeruginosa infection is related to biofilm formation.  However, the relationship between these two forms of disease is not well understood.  Accumulating evidence indicates that, during acute infection, P. aeruginosa enters epithelial cells, a process viewed as either a host-mediated defense response or a pathogenic mechanism to avoid host-mediated killing.  We investigated the possibility that epithelial cell entry during early P. aeruginosa-epithelial cell contact favors bacterial survival and is linked to chronic infection.  Using electron microscopy and confocal microscopy to analyze primary culture airway epithelial cells infected with P. aeruginosa, we found that epithelial cells developed pod-like clusters of intracellular bacteria with regional variation in protein expression.  Extracellular gentamicin added to the medium after acute infection led to the persistence of intracellular P. aeruginosa for at least 3 days.  Importantly, compared to bacterial culture under planktonic conditions, the intracellular bacteria were insensitive to growth inhibition or killing by antibiotics that were capable of intraepithelial cell penetration.  These findings suggest that P. aeruginosa can use airway epithelial cells as a sanctuary for persistence and develop a reversible antibiotic resistance phenotype characteristic of biofilm physiol. that can contribute to development of chronic infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq4GrLZ5VIcbVg90H21EOLACvtfcHk0li2SiPKU4piLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlertrzN&md5=4fe1bebcdf98f4699559d898ab06de43</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FIAI.73.12.8298-8305.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.73.12.8298-8305.2005%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Medina%26aufirst%3DR.%26aulast%3DDunne%26aufirst%3DW.%2BM.%26aulast%3DSingh%26aufirst%3DP.%2BK.%26aulast%3DBrody%26aufirst%3DS.%2BL.%26atitle%3DPseudomonas%2520aeruginosa%2520Acquires%2520Biofilm-like%2520Properties%2520within%2520Airway%2520Epithelial%2520Cells%26jtitle%3DInfect.%2520Immun.%26date%3D2005%26volume%3D73%26spage%3D8298%26epage%3D8305%26doi%3D10.1128%2FIAI.73.12.8298-8305.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yuan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laturnus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span> </span><span class="NLM_article-title">Autophagy Plays an Essential Role in the Clearance of <i>Pseudomonas aeruginosa</i> by Alveolar Macrophages</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1242/jcs.094573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1242%2Fjcs.094573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=22302984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFShsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=507-515&author=K.+Yuanauthor=C.+Huangauthor=J.+Foxauthor=D.+Laturnusauthor=E.+Carlsonauthor=B.+Zhangauthor=Q.+Yinauthor=H.+Gaoauthor=M.+Wu&title=Autophagy+Plays+an+Essential+Role+in+the+Clearance+of+Pseudomonas+aeruginosa+by+Alveolar+Macrophages&doi=10.1242%2Fjcs.094573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy plays an essential role in the clearance of Pseudomonas aeruginosa by alveolar macrophages</span></div><div class="casAuthors">Yuan, Kefei; Huang, Canhua; Fox, John; Laturnus, Donna; Carlson, Edward; Zhang, Binjie; Yin, Qi; Gao, Hongwei; Wu, Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">507-515</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Intracellular bacteria have been shown to cause autophagy, which impacts infectious outcomes, whereas extracellular bacteria have not been reported to activate autophagy.  Here, we demonstrate that Pseudomonas aeruginosa, a Gram-neg. extracellular bacterium, activates autophagy with considerably increased LC3 punctation in both an alveolar macrophage cell line (MH-S) and primary alveolar macrophages.  Using the LC3 Gly120 mutant, we successfully demonstrated a hallmark of autophagy, conjugation of LC3 to phosphatidylethanolamine (PE).  The accumulation of typical autophagosomes with double membranes was identified morphol. by transmission electron microscopy (TEM).  Furthermore, the increase of PE-conjugated LC3 was indeed induced by infection rather than inhibition of lysosome degrdn.  P. aeruginosa induced autophagy through the classical beclin-1-Atg7-Atg5 pathway as detd. by specific siRNA anal.  Rapamycin and IFN-γ (autophagy inducers) augmented bacterial clearance, whereas beclin-1 and Atg5 knockdown reduced intracellular bacteria.  Thus, P. aeruginosa-induced autophagy represents a host protective mechanism, providing new insight into the pathogenesis of this infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobyePGYZQZ9bVg90H21EOLACvtfcHk0li2SiPKU4piLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFShsbk%253D&md5=3815a9f0189c8693a3132ae79b5fcac8</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1242%2Fjcs.094573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.094573%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DLaturnus%26aufirst%3DD.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DM.%26atitle%3DAutophagy%2520Plays%2520an%2520Essential%2520Role%2520in%2520the%2520Clearance%2520of%2520Pseudomonas%2520aeruginosa%2520by%2520Alveolar%2520Macrophages%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2012%26volume%3D125%26spage%3D507%26epage%3D515%26doi%3D10.1242%2Fjcs.094573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Junkins, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-J.</span><span> </span><span class="NLM_article-title">Autophagy Enhances Bacterial Clearance during <i>P. aeruginosa</i> Lung Infection</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e72263</span><span class="refDoi"> DOI: 10.1371/journal.pone.0072263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1371%2Fjournal.pone.0072263" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e72263&author=R.+D.+Junkinsauthor=A.+Shenauthor=K.+Rosenauthor=C.+McCormickauthor=T.-J.+Lin&title=Autophagy+Enhances+Bacterial+Clearance+during+P.+aeruginosa+Lung+Infection&doi=10.1371%2Fjournal.pone.0072263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0072263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0072263%26sid%3Dliteratum%253Aachs%26aulast%3DJunkins%26aufirst%3DR.%2BD.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DRosen%26aufirst%3DK.%26aulast%3DMcCormick%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DT.-J.%26atitle%3DAutophagy%2520Enhances%2520Bacterial%2520Clearance%2520during%2520P.%2520aeruginosa%2520Lung%2520Infection%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De72263%26doi%3D10.1371%2Fjournal.pone.0072263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Abdulrahman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khweek, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caution, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotrange, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelaziz, D. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosales-Reyes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montione, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlesinger, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wewers, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valvano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amer, A. O.</span><span> </span><span class="NLM_article-title">Autophagy Stimulation by Rapamycin Suppresses Lung Inflammation and Infection by <i>Burkholderia cenocepacia</i> in a Model of Cystic Fibrosis</span> <span class="citation_source-journal">Autophagy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span><span class="refDoi"> DOI: 10.4161/auto.7.11.17660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.4161%2Fauto.7.11.17660" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=1359-1370&author=B.+Abdulrahmanauthor=A.+A.+Khweekauthor=A.+Akhterauthor=K.+Cautionauthor=S.+Kotrangeauthor=D.+H.+A.+Abdelazizauthor=C.+Newlandauthor=R.+Rosales-Reyesauthor=B.+Koppauthor=K.+McCoyauthor=R.+Montioneauthor=L.+S.+Schlesingerauthor=M.+A.+Gavrilinauthor=M.+D.+Wewersauthor=M.+Valvanoauthor=A.+O.+Amer&title=Autophagy+Stimulation+by+Rapamycin+Suppresses+Lung+Inflammation+and+Infection+by+Burkholderia+cenocepacia+in+a+Model+of+Cystic+Fibrosis&doi=10.4161%2Fauto.7.11.17660"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42c&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.11.17660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.11.17660%26sid%3Dliteratum%253Aachs%26aulast%3DAbdulrahman%26aufirst%3DB.%26aulast%3DKhweek%26aufirst%3DA.%2BA.%26aulast%3DAkhter%26aufirst%3DA.%26aulast%3DCaution%26aufirst%3DK.%26aulast%3DKotrange%26aufirst%3DS.%26aulast%3DAbdelaziz%26aufirst%3DD.%2BH.%2BA.%26aulast%3DNewland%26aufirst%3DC.%26aulast%3DRosales-Reyes%26aufirst%3DR.%26aulast%3DKopp%26aufirst%3DB.%26aulast%3DMcCoy%26aufirst%3DK.%26aulast%3DMontione%26aufirst%3DR.%26aulast%3DSchlesinger%26aufirst%3DL.%2BS.%26aulast%3DGavrilin%26aufirst%3DM.%2BA.%26aulast%3DWewers%26aufirst%3DM.%2BD.%26aulast%3DValvano%26aufirst%3DM.%26aulast%3DAmer%26aufirst%3DA.%2BO.%26atitle%3DAutophagy%2520Stimulation%2520by%2520Rapamycin%2520Suppresses%2520Lung%2520Inflammation%2520and%2520Infection%2520by%2520Burkholderia%2520cenocepacia%2520in%2520a%2520Model%2520of%2520Cystic%2520Fibrosis%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26spage%3D1359%26epage%3D1370%26doi%3D10.4161%2Fauto.7.11.17660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Bonfield, T.; Liu, F.; Chandran, S.; Fahrner, R.; Lee, D.; Nichols, A.; Picarella, D.; Ting, A.; Webb, S.; Wensley, A.; Yeager, M.; Vu, C. B.</span><span> </span><span class="NLM_article-title">CAT-5571 as a Novel Autophagy Activator that Enhances the Clearance of <i>Pseudomonas aeruginosa</i></span>. Presented at the 30th Annual North America Cystic Fibrosis Conferences, Orange County, FL, Oct 27–29,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span>Poster 223.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+Bonfield&author=F.+Liu&author=S.+Chandran&author=R.+Fahrner&author=D.+Lee&author=A.+Nichols&author=D.+Picarella&author=A.+Ting&author=S.+Webb&author=A.+Wensley&author=M.+Yeager&author=C.+B.+Vu&title=CAT-5571+as+a+Novel+Autophagy+Activator+that+Enhances+the+Clearance+of+Pseudomonas+aeruginosa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBonfield%26aufirst%3DT.%26atitle%3DCAT-5571%2520as%2520a%2520Novel%2520Autophagy%2520Activator%2520that%2520Enhances%2520the%2520Clearance%2520of%2520Pseudomonas%2520aeruginosa%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Milne, J. C.; Jirousek, M. R.; Bemis, J. E.; Vu, C. B.; Ting, A.</span><span> </span><span class="NLM_article-title">Bis-Fatty Acid Conjugates and Their Uses Thereof</span>. WO 2012115695,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+C.+Milne&author=M.+R.+Jirousek&author=J.+E.+Bemis&author=C.+B.+Vu&author=A.+Ting&title=Bis-Fatty+Acid+Conjugates+and+Their+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMilne%26aufirst%3DJ.%2BC.%26atitle%3DBis-Fatty%2520Acid%2520Conjugates%2520and%2520Their%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dohil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic Studies of Cysteamine Bitartrate Delayed-Release</span> <span class="citation_source-journal">Clin. Pharm. Drug Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1002/cpdd.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1002%2Fcpdd.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=27121672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ymsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=178-185&author=R.+Dohilauthor=P.+Rioux&title=Pharmacokinetic+Studies+of+Cysteamine+Bitartrate+Delayed-Release&doi=10.1002%2Fcpdd.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic studies of cysteamine bitartrate delayed-release</span></div><div class="casAuthors">Dohil, Ranjan; Rioux, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-185</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A twice-daily microsphere formulation of cysteamine bitartrate has been developed for cystinosis and other potential applications.  To date, there are no published pharmacokinetic data for cysteamine bitartrate delayed-release in healthy adults.  Three randomized open-label, crossover studies to det. the effects of fasting, high fat, and carbohydrate meals on the bioavailability of cysteamine bitartrate delayed-release (600 mg) administered in capsule or sprinkle form to healthy adults.  Adverse events were monitored.  Fifty-eight adults were studied.  Cysteamine absorption (AUC0-24 h) was the same for capsule and sprinkle forms during all meal/fasting states.  The AUC0-24 h for capsules while fasted, 30 and 120 min before a carbohydrate meal and during a high fat meal were 6,313 ± 329, 4,616 ± 878, 6,691 ± 669, 2,572 ± 295 min × μM, resp., and the mean Cmax values were 29.4 ± 1.7, 20.7 ± 4.9, 31.6 ± 3.0, and 10.9 ± 1.7 μM, resp.  The mean Tmax following fasting and high fat meal were about 3 and 6 h, resp.  Minor transient GI adverse events occurred.  Cysteamine bitartrate delayed-release capsule and sprinkle forms are bioequivalent and optimal absorption occurs during fasting state.  High fat diet reduces drug absorption, increases the Tmax and should be avoided at the time of drug ingestion.  Cysteamine bitartrate delayed-release (RP103) is best ingested >30 min before a carbohydrate-rich meal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOe1va0KVDWLVg90H21EOLACvtfcHk0ljCqN_uYpSW4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ymsrbM&md5=eaca9b3a8139c4037d208830d3e684d6</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.12%26sid%3Dliteratum%253Aachs%26aulast%3DDohil%26aufirst%3DR.%26aulast%3DRioux%26aufirst%3DP.%26atitle%3DPharmacokinetic%2520Studies%2520of%2520Cysteamine%2520Bitartrate%2520Delayed-Release%26jtitle%3DClin.%2520Pharm.%2520Drug%2520Dev.%26date%3D2013%26volume%3D2%26spage%3D178%26epage%3D185%26doi%3D10.1002%2Fcpdd.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit45b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blattler, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinson, A. R.</span><span> </span><span class="NLM_article-title">An Amplified Assay for Thiols based on Reactivation of Papain</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1006/abio.1993.1384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;key=10.1006%2Fabio.1993.1384" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=1993&pages=49-56&author=R.+Singhauthor=W.+A.+Blattlerauthor=A.+R.+Collinson&title=An+Amplified+Assay+for+Thiols+based+on+Reactivation+of+Papain&doi=10.1006%2Fabio.1993.1384"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1006%2Fabio.1993.1384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1993.1384%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DBlattler%26aufirst%3DW.%2BA.%26aulast%3DCollinson%26aufirst%3DA.%2BR.%26atitle%3DAn%2520Amplified%2520Assay%2520for%2520Thiols%2520based%2520on%2520Reactivation%2520of%2520Papain%26jtitle%3DAnal.%2520Biochem.%26date%3D1993%26volume%3D213%26spage%3D49%26epage%3D56%26doi%3D10.1006%2Fabio.1993.1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i25"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01539">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_55311"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01539">10.1021/acs.jmedchem.6b01539</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Autophagy activation, details of runs depicted in <a class="ref internalNav" href="#fig7">Figures 7</a>–<a id="rightTab-" class=" internalNav" href="#fig9">9</a> and <a id="rightTab-" class=" internalNav" href="#fig14">14</a>, effect of FBS on chloride current, and evaluations of compounds <b>1</b> and <b>5</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_001.pdf">jm6b01539_si_001.pdf (1.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01539/suppl_file/jm6b01539_si_002.csv">jm6b01539_si_002.csv (0.31 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01539&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01539%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-1%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01539" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999ae16f67d1f3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
